
<html lang="en"     class="pb-page"  data-request-id="08ae86a1-25bf-422b-98af-8df90629d49a"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;article:article:10.1021/jm900314j;issue:issue:10.1021/jmcmar.2009.52.issue-15;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Identification of Inhibitors of Checkpoint Kinase 1 through Template Screening" /></meta><meta name="dc.Creator" content="Thomas P.  Matthews" /></meta><meta name="dc.Creator" content="Suki  Klair" /></meta><meta name="dc.Creator" content="Samantha  Burns" /></meta><meta name="dc.Creator" content="Kathy  Boxall" /></meta><meta name="dc.Creator" content="Michael  Cherry" /></meta><meta name="dc.Creator" content="Martin  Fisher" /></meta><meta name="dc.Creator" content="Isaac M.  Westwood" /></meta><meta name="dc.Creator" content="Michael I.  Walton" /></meta><meta name="dc.Creator" content="Tatiana  McHardy" /></meta><meta name="dc.Creator" content="Kwai-Ming J.  Cheung" /></meta><meta name="dc.Creator" content="Rob  Van Montfort" /></meta><meta name="dc.Creator" content="David  Williams" /></meta><meta name="dc.Creator" content="G. Wynne  Aherne" /></meta><meta name="dc.Creator" content="Michelle D.  Garrett" /></meta><meta name="dc.Creator" content="John  Reader" /></meta><meta name="dc.Creator" content="Ian  Collins" /></meta><meta name="dc.Description" content="Checkpoint kinase 1 (CHK1) is an oncology target of significant current interest. Inhibition of CHK1 abrogates DNA damage-induced cell cycle checkpoints and sensitizes p53 deficient cancer cells to..." /></meta><meta name="Description" content="Checkpoint kinase 1 (CHK1) is an oncology target of significant current interest. Inhibition of CHK1 abrogates DNA damage-induced cell cycle checkpoints and sensitizes p53 deficient cancer cells to..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="July 2, 2009" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm900314j" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2009 American Chemical Society" /></meta><meta name="citation_fulltext_world_readable" content=""/></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm900314j" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm900314j" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm900314j" /></link>
        
    
    

<title>Identification of Inhibitors of Checkpoint Kinase 1 through Template Screening | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm900314j" /></meta><meta property="og:title" content="Identification of Inhibitors of Checkpoint Kinase 1 through Template Screening" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900314j/production/images/large/jm-2009-00314j_0010.jpeg" /></meta><meta property="og:description" content="Checkpoint kinase 1 (CHK1) is an oncology target of significant current interest. Inhibition of CHK1 abrogates DNA damage-induced cell cycle checkpoints and sensitizes p53 deficient cancer cells to genotoxic therapies. Using template screening, a fragment-based approach to small molecule hit generation, we have identified multiple CHK1 inhibitor scaffolds suitable for further optimization. The sequential combination of in silico low molecular weight template selection, a high concentration biochemical assay and hit validation through protein−ligand X-ray crystallography provided 13 template hits from an initial in silico screening library of ca. 15000 compounds. The use of appropriate counter-screening to rule out nonspecific aggregation by test compounds was essential for optimum performance of the high concentration bioassay. One low molecular weight, weakly active purine template hit was progressed by iterative structure-based design to give submicromolar pyrazolopyridines with good ligand efficiency and appropriate CHK1-mediated cellular activity in HT29 colon cancer cells." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm900314j"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm900314j">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm900314j&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm900314j&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm900314j&amp;href=/doi/10.1021/jm900314j" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2009</span><span class="cit-fg-volume">, 52</span><span class="cit-fg-issue">, 15</span><span class="cit-fg-pageRange">, 4810-4819</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/52/15" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm900357y" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm900372w" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Identification of Inhibitors of Checkpoint Kinase 1 through Template Screening</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Thomas+P.++Matthews">Thomas P. Matthews</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Suki++Klair">Suki Klair</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Samantha++Burns">Samantha Burns</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kathy++Boxall">Kathy Boxall</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael++Cherry">Michael Cherry</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Martin++Fisher">Martin Fisher</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Isaac+M.++Westwood">Isaac M. Westwood</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael+I.++Walton">Michael I. Walton</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tatiana++McHardy">Tatiana McHardy</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kwai-Ming+J.++Cheung">Kwai-Ming J. Cheung</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rob++Van+Montfort">Rob Van Montfort</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=David++Williams">David Williams</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=G.+Wynne++Aherne">G. Wynne Aherne</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michelle+D.++Garrett">Michelle D. Garrett</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John++Reader">John Reader</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ian++Collins">Ian Collins</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Cancer Research UK Centre for Cancer Therapeutics</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Sections of Cancer Therapeutics and Structural Biology</span></div><div class="aff-info" id="aff4"><span class="aff-text">The Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey SM2 5NG, U.K.</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Sareum Ltd, 2 Iconix Park, Pampisford, Cambridge CB22 3EG, U.K.</span></div><div class="corresp-info"><strong>*</strong>To whom correspondence should be addressed. Phone +44 208 7224317. Fax: +44 208 7224126. E-mail: <a href="/cdn-cgi/l/email-protection#9cf5fdf2b2fff3f0f0f5f2efdcf5ffeeb2fdffb2e9f7"><span class="__cf_email__" data-cfemail="4b222a2565282427272225380b222839652a28653e20">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm900314j&amp;href=/doi/10.1021%2Fjm900314j" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2009</span></span><span class="cit-volume">, 52</span><span class="cit-issue">, 15</span><span class="cit-pageRange">, 4810–4819</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">July 2, 2009</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>12 March 2009</li><li><span class="item_label"><b>Published</b> online</span>2 July 2009</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 13 August 2009</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm900314j" title="DOI URL">https://doi.org/10.1021/jm900314j</a></div><div class="article_header-article-copyright"><strong>Copyright © 2009 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/page/rightslinkno.jsp">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"><a href="/page/policy/authorchoice_termsofuse.html"><img src="/pb-assets/images/programsLogos/OA_Icons_Ac-1612971054130.svg" alt="ACS AuthorChoice" /></img><span>ACS AuthorChoice</span></a></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm900314j"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">4169</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">32</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm900314j" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Identification of Inhibitors of Checkpoint Kinase 1 through Template Screening&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Thomas&quot;,&quot;last_name&quot;:&quot;P. Matthews&quot;},{&quot;first_name&quot;:&quot;Suki&quot;,&quot;last_name&quot;:&quot;Klair&quot;},{&quot;first_name&quot;:&quot;Samantha&quot;,&quot;last_name&quot;:&quot;Burns&quot;},{&quot;first_name&quot;:&quot;Kathy&quot;,&quot;last_name&quot;:&quot;Boxall&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;Cherry&quot;},{&quot;first_name&quot;:&quot;Martin&quot;,&quot;last_name&quot;:&quot;Fisher&quot;},{&quot;first_name&quot;:&quot;Isaac&quot;,&quot;last_name&quot;:&quot;M. Westwood&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;I. Walton&quot;},{&quot;first_name&quot;:&quot;Tatiana&quot;,&quot;last_name&quot;:&quot;McHardy&quot;},{&quot;first_name&quot;:&quot;Kwai-Ming&quot;,&quot;last_name&quot;:&quot;J. Cheung&quot;},{&quot;first_name&quot;:&quot;Rob&quot;,&quot;last_name&quot;:&quot;Van Montfort&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;Williams&quot;},{&quot;first_name&quot;:&quot;G.&quot;,&quot;last_name&quot;:&quot;Wynne Aherne&quot;},{&quot;first_name&quot;:&quot;Michelle&quot;,&quot;last_name&quot;:&quot;D. Garrett&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;Reader&quot;},{&quot;first_name&quot;:&quot;Ian&quot;,&quot;last_name&quot;:&quot;Collins&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2009&quot;,&quot;month&quot;:&quot;07&quot;,&quot;day&quot;:&quot;02&quot;,&quot;issue&quot;:&quot;15&quot;,&quot;volume&quot;:&quot;52&quot;,&quot;pages&quot;:&quot;4810-4819&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm900314j&quot;},&quot;abstract&quot;:&quot;Checkpoint kinase 1 (CHK1) is an oncology target of significant current interest. Inhibition of CHK1 abrogates DNA damage-induced cell cycle checkpoints and sensitizes p53 deficient cancer cells to genotoxic therapies. Using template screening, a fragment-based approach to small molecule hit generation, we have identified multiple CHK1 inhibitor scaffolds suitable for further optimization. The sequential combination of in silico low molecular weight template selection, a high concentration biochemical assay and hit validation through protein−ligand X-ray crystallography provided 13 template hits from an initial in silico screening library of ca. 15000 compounds. The use of appropriate counter-screening to rule out nonspecific aggregation by test compounds was essential for optimum performance of the high concentration bioassay. One low molecular weight, weakly active purine template hit was progressed by iterative structure-based design to give submicromolar pyrazolopyridines with good ligand efficiency and a&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm900314j&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm900314j" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm900314j&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm900314j" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm900314j&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm900314j" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm900314j&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm900314j&amp;href=/doi/10.1021/jm900314j" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm900314j" /></input><a href="/doi/pdf/10.1021/jm900314j" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm900314j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm900314j%26sid%3Dliteratum%253Aachs%26pmid%3D19572549%26genre%3Darticle%26aulast%3DMatthews%26date%3D2009%26atitle%3DIdentification%2Bof%2BInhibitors%2Bof%2BCheckpoint%2BKinase%2B1%2Bthrough%2BTemplate%2BScreening%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D52%26issue%3D15%26spage%3D4810%26epage%3D4819%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291439" title="Genetics">Genetics</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/52/15" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900314j/production/images/medium/jm-2009-00314j_0010.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900314j/production/images/large/jm-2009-00314j_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900314j&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Checkpoint kinase 1 (CHK1) is an oncology target of significant current interest. Inhibition of CHK1 abrogates DNA damage-induced cell cycle checkpoints and sensitizes p53 deficient cancer cells to genotoxic therapies. Using template screening, a fragment-based approach to small molecule hit generation, we have identified multiple CHK1 inhibitor scaffolds suitable for further optimization. The sequential combination of in silico low molecular weight template selection, a high concentration biochemical assay and hit validation through protein−ligand X-ray crystallography provided 13 template hits from an initial in silico screening library of ca. 15000 compounds. The use of appropriate counter-screening to rule out nonspecific aggregation by test compounds was essential for optimum performance of the high concentration bioassay. One low molecular weight, weakly active purine template hit was progressed by iterative structure-based design to give submicromolar pyrazolopyridines with good ligand efficiency and appropriate CHK1-mediated cellular activity in HT29 colon cancer cells.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01785" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01785" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The genomic integrity of replicating cells is maintained by a network of sensors that monitor DNA and control ordered progression through the cell cycle. In response to DNA damage, this network serves to activate checkpoints at various stages of the cell cycle that delay progression, allowing cells to repair the damage or directing them to programmed cell death if the damage is too severe.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> Many well established cancer chemotherapies and radiotherapy exert their therapeutic effect through damage to DNA. The activation of cell cycle checkpoints provides an opportunity for cancer cells, as well as normal cells, to repair DNA damage and therefore reduce the effect of, or become resistant to, DNA-damaging treatments.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> The G1 checkpoint mediated by p53 is a major barrier to genomic instability, but over half of all cancers are functionally defective for the p53 pathway.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> These tumor cells are more reliant on the S and G2/M checkpoints to repair damage. Therefore drugs that abrogate the DNA damage-induced S and G2/M checkpoints should selectively sensitize p53 deficient cancer cells to genotoxic cancer therapies.<a onclick="showRef(event, 'ref3 ref5 ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref3 ref5 ref6 ref7">(3, 5-7)</a></div><div class="NLM_p">Checkpoint kinase 1 (CHK1<a class="ref internalNav" href="#fn7" aria-label="a">a</a><div class="NLM_fn" id="fn7">a<p class="last">Abbreviations: AlphaScreen, amplified luminescent proximity homogeneous assay screen; ATR, ataxia-telangiectasia mutated and rad3-related; CDK, cyclin dependent kinase; CHK1, checkpoint kinase 1; HTS, high throughput screening; LE, ligand efficiency.</p></div>) is a serine/threonine kinase that is phosphorylated and activated by the upstream kinase ataxia-telangiectasia mutated and rad3-related (ATR) in response to DNA damage. ATR itself is activated by DNA damage or replication stress that causes double- or single-strand breaks in DNA, initiating a signaling cascade culminating in cell cycle arrest in the S and G2/M phase.<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8, 9)</a> Activated CHK1 signals to several proteins to bring about cell cycle arrest, in particular the CDC25 family of phosphatases. CDC25 phosphatases are essential to dephosphorylate and activate the cyclin dependent kinase (CDK)/cyclin complexes that drive cell cycle progression. CHK1-mediated-phosphorylation of the CDC25 proteins has been shown to block their ability to dephosphorylate CDKs, through inhibiting the direct interaction of CDC25 proteins with CDKs, sequestration in the cytoplasm, or ubiquitin-mediated degradation, thus leading to cell cycle arrest.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Because cells lacking intact p53-dependent G1 checkpoints are particularly reliant on S and G2/M checkpoints, they are more sensitive to chemotherapeutic treatment in the presence of a CHK1 inhibitor.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Inhibition of CHK1 by siRNA<a onclick="showRef(event, 'ref5 ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref5 ref11 ref12">(5, 11, 12)</a> or small molecules<a onclick="showRef(event, 'ref7 ref13 ref14 ref15 ref16 ref17 ref18 ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref7 ref13 ref14 ref15 ref16 ref17 ref18 ref19 ref20">(7, 13-20)</a> has been shown to abrogate cell cycle arrest, leading to premature mitotic entry and enhanced tumor cell death following DNA damage by a range of chemotherapeutics. In particular, a number of ATP-competitive inhibitors of CHK1 have been shown to sensitize tumors to DNA-damaging agents in preclinical animal models<a onclick="showRef(event, 'ref18 ref19 ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref18 ref19 ref20 ref21">(18-21)</a> and ATP-competitive CHK1 inhibitors are now in phase I clinical trials.<a onclick="showRef(event, 'ref19 ref20 ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref19 ref20 ref21 ref22">(19-22)</a></div><div class="NLM_p">Several distinct chemotypes have been identified as CHK1 inhibitors, and these have been extensively reviewed<a onclick="showRef(event, 'ref14 ref21 ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref14 ref21 ref22 ref23">(14, 21-23)</a> (Chart <a class="ref internalNav" href="#cht1" aria-label=""></a>). A collection of scaffolds have been developed based on the indolocarbazole natural product kinase inhibitor staurosporine and its analogue UCN-01.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Most other published CHK1 inhibitors originate from hits discovered by high throughput screening (HTS) of large conventional compound libraries.<a onclick="showRef(event, 'ref15 ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref15 ref16 ref17">(15-17)</a> In some cases, HTS was combined with preliminary in silico screening to reduce the size of the biochemical screen and enhance the hit rate.<a onclick="showRef(event, 'ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref25 ref26">(25, 26)</a> The development of small molecule CHK1 inhibitors from these sources has been aided by the availability of the X-ray crystal structure of the enzyme<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> and protein−ligand complexes.<a onclick="showRef(event, 'ref15 ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref15 ref16 ref17">(15-17)</a></div><figure id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900314j/production/images/medium/jm-2009-00314j_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900314j/production/images/large/jm-2009-00314j_0004.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Structures of Selected Published Clinical Candidate CHK1 Inhibitors</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900314j/production/images/large/jm-2009-00314j_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900314j&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Fragment-based screening offers an alternative approach for small molecule hit generation.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> A potential benefit of fragment screening is that chemical diversity space can be probed effectively using a smaller number of molecules than is possible with conventional HTS libraries. Low molecular weight fragments may have weak binding affinities, outside the range of conventional biochemical assays, necessitating the use of biophysical screening techniques (NMR, X-ray crystallography, or surface plasmon resonance) to detect interactions with the target protein. Despite the low affinity of the fragment hits, they are often bound with high ligand efficiency (LE) and thus serve as good platforms for elaboration to more potent ligands.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Structural data on the binding mode of the fragments is essential, however, if the weak initial hits are to be progressed rapidly to tractable lead compounds. We have used a template-based approach to identify new inhibitors of CHK1, which balances the efficiency of a biochemical assay for screening compound activity with the desirability of starting with small, ligand-efficient structures to maximize the probability of developing a “druglike” inhibitor during optimization. The templates are therefore low molecular weight structures, which are large enough to have detectable binding at high micromolar levels in a high concentration biochemical assay yet small enough to benefit from the higher coverage of diversity space offered by fragments.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Hits from the high concentration CHK1 kinase assay were validated by crystallography of the bound complex to provide the necessary structural information, enabling progression to more potent inhibitors.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11573" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11573" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The structural features and calculated physicochemical parameters used to select the template screening set in this work are outlined in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>. In general, these cover the overlap between the property space proposed for fragment libraries employed in biophysical screening and that proposed for “leadlike” compounds in HTS.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> The upper limits to size, lipophilicity, and functional group count allow for addition of atoms during lead optimization while still remaining in “druglike” chemical space. Approximately 15000 templates were identified from commercially available compound collections using these library filters. To select appropriate templates for biochemical screening, a pharmacophore search was performed using the pharmacophore tools within MOE (Chemical Computing Group)<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> to identify compounds with the features of potential kinase inhibitors.</div><div class="NLM_p">Template structures were matched to five conserved features within the kinase ATP site in its active conformation, as illustrated in Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>. The query was built from an overlay of the structure of multiple published ligands in CHK1 using a combination of the protein and ligand structures to define the position of the pharmacophore points. A match to at least three of the five points defined was required to warrant a hit. Volume constraints were also applied to limit the scope of the search, with the intent of reducing the number of false positives identified in the pharmacophore search. To allow for some leeway in movement of individual protein residues, exclusion volume spheres defined by radii of 2.0 Å were placed at each of the protein heavy atom positions surrounding the ATP-binding site in the structure of CHK1 (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1IA8">1IA8</a>). These volumes were amalgamated into a single volume definition, and molecules were rejected if an atom from the pharmacophore-matching pose fell within the excluded volume. Hits from the search were clustered by structural type, focusing on the core rings of each compound, and representatives from each cluster were chosen by visual inspection. In total, 361 templates were selected for biochemical screening.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Properties Defining the Templates</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="" /></col></colgroup><thead><tr valign="top"><th align="left">property</th><th align="char">template values</th></tr></thead><tbody><tr valign="top"><td align="left">no. of heavy atoms</td><td align="char">8−24</td></tr><tr valign="top"><td align="left">CLogP</td><td align="char">−2 to 4</td></tr><tr valign="top"><td align="left">total H-bond donors and acceptors</td><td align="char">1−6</td></tr><tr valign="top"><td align="left">rotatable bonds</td><td align="char">0−6</td></tr><tr valign="top"><td align="left">no. of rings</td><td align="char">1−3</td></tr></tbody></table></div></div><figure id="fig1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900314j/production/images/medium/jm-2009-00314j_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900314j/production/images/large/jm-2009-00314j_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. CHK1 ATP-binding site pharmacophore used for the virtual screen of commercially available templates.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900314j/production/images/large/jm-2009-00314j_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900314j&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The focused set of 361 compounds was evaluated in a 384-well format Amplified Luminescent Proximity Homogeneous Assay Screen (AlphaScreen)<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> for inhibition of CHK1 kinase activity, measured by the reduction in phosphorylation of a CHK1 substrate peptide. The assay was adapted for screening at high ligand concentration (250 μM), with each test plate run under three different conditions. First, compounds were tested six times in the standard AlphaScreen format to achieve a high level of confidence. The screen was then run in triplicate with the inclusion of a detergent (0.01% Triton X) to eliminate potential false positives due to aggregation of poorly soluble compounds at the high concentration.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Finally, the plates were counterscreened three times in the presence of phosphorylated substrate peptide to eliminate compounds interfering with the AlphaScreen signal. False positives in AlphaScreen assays have been observed due to compound fluorescence or reaction with the singlet oxygen generated in the screen.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a></div><div class="NLM_p">Two levels of hits were classified from this screening data. The first set of compounds selected inhibited CHK1 activity by more than 25% at 250 μM in at least 5/6 of the replicate AlphaScreen assays and retained this activity in at least 2/3 of the assays in the presence of detergent. Compounds were not classified as hits if apparent inhibition was observed in the presence of phosphorylated peptide. This identified nine high-confidence hits showing inhibition of CHK1 between 35 and 79% at 250 μM. To maximize the potential output from the screen, 13 further compounds were selected that inhibited CHK1 by more than 25% at 250 μM in at least 3/6 of the multiple assay runs while not giving inhibition in the assay interference counter screen, but showed some reduction in activity when assayed in the presence of detergent.</div><div class="NLM_p">The 22 template hits from the bioassay were validated using X-ray crystallography by soaking into crystals of the apo-CHK1 kinase domain. Hits were grouped by structural classes, and where a group contained several compounds, representative members were selected for crystallography. Soaking experiments were therefore set up with eight of the high confidence hits and seven of the lower confidence hits. From these 15 chemically diverse structures, nine (<b>1−9</b>) were confirmed to bind in the ATP-binding site of CHK1 by X-ray crystallography (Chart <a class="ref internalNav" href="#cht2" aria-label=""></a>, Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). The final hit-rate of the screen was approximately 0.06% from the virtual template set (2.5% from the 361 assayed compounds). The overall screening cascade is summarized in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>. Importantly, the validation rate by crystallography was much greater for the high confidence hits than for the lower confidence compounds that showed a reduction in activity when assayed in the presence of detergent. Of the nine high confidence hits, soaking experiments were carried out with eight distinct chemotypes, of which seven were confirmed by crystallographic analysis (compounds <b>3</b>−<b>9</b>). In contrast, of the 13 lower confidence hits, seven distinct chemotypes were selected for X-ray crystallography but only two compounds, <b>1</b> and <b>2</b>, were confirmed as ATP-competitive binders to CHK1. This supports the application of counter screens for potential compound aggregation to increase the useful output of low affinity, high concentration screens of this type. Although the hit <b>2</b> was found to bind in the ATP-binding site of CHK1, this compound failed to show CHK1 inhibition at high concentration in a DELFIA-based kinase assay developed to support medicinal chemistry progression of the compounds (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Thus the significantly lower activity of <b>2</b> recorded in the AlphaScreen in the presence of detergent is more representative of the targeted biological potency of the compound. In contrast, the biological activities of the high confidence hits <b>5</b>−<b>9</b> in the initial screens were all confirmed in the second assay format.</div><figure id="cht2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Chart 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900314j/production/images/medium/jm-2009-00314j_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900314j/production/images/large/jm-2009-00314j_0005.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 2. Chemical Structures of the Nine Template Hits Validated by CHK1 Crystallography<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900314j/production/images/large/jm-2009-00314j_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900314j&amp;id=cht2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Chart a</span>Compounds <b>1</b> and <b>2</b> were lower confidence hits from the bioassay, which showed some nonspecific inhibition, while compounds <b>3</b>−<b>9</b> were high confidence hits that showed similar activity in the presence and absence of Triton X-100 detergent in the bioassay.</p></p></figure><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. CHK1 Inhibition by Crystallographically Validated Template Hits <b>1</b>−<b>9</b> in High Concentration AlphaScreen and DELFIA Assays</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="center" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col></colgroup><thead><tr valign="top"><th align="center">crystallographically validated hits</th><th align="left" char=".">AlphaScreen % inhibition at 250 (±SD) μM<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th align="left" char=".">AlphaScreen +0.01% Triton-X100 (% inhibition at 250 μM ± SD)<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></th><th align="left">DELFIA (% inhibition at 100 μM)<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top"><td align="center"><b>1</b></td><td align="char" char=".">26.4 (±6.9)</td><td align="char" char=".">6.5 (±3.2)</td><td align="left">nd</td></tr><tr valign="top"><td align="center"><b>2</b></td><td align="char" char=".">40.9 (±8.4)</td><td align="char" char=".">14.2 (±3.3)</td><td align="left">0%</td></tr><tr valign="top"><td align="center"><b>3</b></td><td align="char" char=".">41.9 (±2.5)</td><td align="char" char=".">41.5 (±1.7)</td><td align="left">nd<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td></tr><tr valign="top"><td align="center"><b>4</b></td><td align="char" char=".">50.1 (±5.0)</td><td align="char" char=".">52.8 (±1.1)</td><td align="left">nd</td></tr><tr valign="top"><td align="center"><b>5</b></td><td align="char" char=".">51.4 (±1.2)</td><td align="char" char=".">43.1 (±3.0)</td><td align="left">27%</td></tr><tr valign="top"><td align="center"><b>6</b></td><td align="char" char=".">38.5 (±3.2)</td><td align="char" char=".">45.3 (±1.6)</td><td align="left">IC<sub>50</sub> = 52 μM (46, 57)<a class="ref internalNav" href="#t2fn5" aria-label="e">e</a></td></tr><tr valign="top"><td align="center"><b>7</b></td><td align="char" char=".">36.9 (±1.7)</td><td align="char" char=".">39.9 (±4.5)</td><td align="left">33%<a class="ref internalNav" href="#t2fn5" aria-label="e">e</a></td></tr><tr valign="top"><td align="center"><b>8</b></td><td align="char" char=".">35.7 (±1.3)</td><td align="char" char=".">33.5 (±12.8)</td><td align="left">32%</td></tr><tr valign="top"><td align="center"><b>9</b></td><td align="char" char=".">75.7 (±1.0)</td><td align="char" char=".">63.0 (±0.7)</td><td align="left">IC<sub>50</sub> = 42 μM (28, 58)<a class="ref internalNav" href="#t2fn5" aria-label="e">e</a></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Mean (±SD) for <i>n</i> = 6 determinations. Positive control staurosporine gave 73 (±9.9) % inhibition @ 25 nM.</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">Mean (±SD) for <i>n</i> = 3 determinations. Positive control staurosporine gave 73 (±15) % inhibition @ 25 nM.</p></div><div class="footnote" id="t2fn3"><sup>c</sup><p class="last">Single determination. Standard inhibitor staurosporine gave IC<sub>50</sub> = 2.1 (±1.8) nM.</p></div><div class="footnote" id="t2fn4"><sup>d</sup><p class="last">nd = not determined.</p></div><div class="footnote" id="t2fn5"><sup>e</sup><p class="last">Mean of 2 independent determinations, individual values in parentheses.</p></div></div></div><figure id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900314j/production/images/medium/jm-2009-00314j_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900314j/production/images/large/jm-2009-00314j_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Summary of the template screening cascade and hit validation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900314j/production/images/large/jm-2009-00314j_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900314j&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">All nine validated hits bound in the ATP pocket. However, the core structures, binding modes and degree of hydrogen bonding to the kinase hinge region, varied. Templates <b>1</b>−<b>4</b> showed only weak, single hydrogen bond contacts to the hinge region despite the presence of multiple hydrogen-bond donors and acceptors in the molecules. In contrast, templates <b>5</b>−<b>9</b> were more firmly anchored in the binding site with bi- or tridentate hydrogen bonding to the hinge region. These latter hits were considered more promising as the presence of stronger polar interactions to the starting template should reduce the chance of encountering major changes to the binding mode during the elaboration of the inhibitors.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> The CHK1 crystal structures of five of these validated hits, <b>5</b>−<b>9</b>, are shown in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>. A structural overlay of the hits shows that they occupied similar space relative to the hinge region of the kinase (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>F). The thiazolo[5,4-<i>c</i>]azepin-4-one <b>5</b> adopted a bidentate hinge-binding pose, with the lactam forming hydrogen bonds to the backbone amides of Glu85 and Cys87 in CHK1 (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>A). The core of <b>5</b> occupied the cleft of the ATP-binding site with the pendant acetamide substitutent located close to Glu91 on the solvent-exposed specificity surface. The tricycle <b>6</b> also adopted a bidentate hinge-binding pose, with two hydrogen bonds from the pyrimidinone functionality to Glu85 and Cys87 (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>B). The pyrimidinone was also hydrogen-bonded through a neighboring water molecule to the side chain of Ser147. The water molecule was situated at the mouth of a highly conserved interior pocket of CHK1 defined principally by residues Val68, Asn59, and Glu55 in which a trio of water molecules is typically observed.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> The remainder of the tricycle was directed toward the solvent with the cyclohexane located near the specificity surface formed by residues Gly89, Gly90, and Glu91. Unique among this set of hits, the aminothiazole <b>7</b> bound to the hinge region in a tridendate manner with the primary amine hydrogen-bonding to Glu85, and the thiazole nitrogen and <i>tert</i>-butyl substituted amine to the amino and carbonyl functionality of Cys87, respectively (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>C). The phenyl ketone of <b>7</b> was pointed into the ribose-binding pocket, while the <i>tert-</i>butylamino group emerged from the ATP-site near the specificity surface. The cocrystal structure of <b>8</b> bound to CHK1 showed bidentate hydrogen bonding between the imidazolone motif of the ligand and the backbone amides of Glu85 and Cys87 (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>D). The pendant thiophene was directed over the specificity surface toward solvent, while the thiomethylether pointed toward the water-filled pocket within CHK1. The initial elaboration of the purine <b>9</b>, which binds in the ATP site of CHK1 (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>E) and has an IC<sub>50</sub> of 42 μM and a calculated LE = 0.42 kcal mol<sup>−1</sup> heavy atom<sup>−1</sup>, is discussed below as an example of several weakly active but ligand efficient template hits from this screen that were progressed to more potent CHK1 inhibitors using structure-based drug design.</div><figure id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900314j/production/images/medium/jm-2009-00314j_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900314j/production/images/large/jm-2009-00314j_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Crystal structures of hits <b>5</b> (A), <b>6</b> (B), <b>7</b> (C), <b>8</b> (D), and <b>9</b> (E) in the ATP binding pocket of CHK1. Panel F: Overlay of hits <b>5</b>−<b>9</b> relative to the hinge-region of CHK1, orange = <b>5</b>, gray = <b>6</b>, red = <b>7</b>, cyan = <b>8</b>, green = <b>9</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900314j/production/images/large/jm-2009-00314j_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900314j&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The crystal structure of 4-(9<i>H</i>-purin-6-yl)morpholine <b>9</b> bound to CHK1 confirmed the expected hydrogen bonds between N-3 and N-9 of the purine with the backbone amides of Cys87 and Glu85, respectively (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>A). This binding mode has been reported for other purine-derived kinase inhibitors.<a onclick="showRef(event, 'ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref38 ref39">(38, 39)</a> Importantly, this is not equivalent to the binding of the purine moiety of ATP or ADP, where the heterocycle is in a very different orientation, with hydrogen bonding to the hinge region from N-1 of the purine and a 6-NH<sub>2</sub> substituent. The morpholine substituent of <b>9</b> did not appear to make specific contacts with the protein backbone but extended toward the ribose pocket. A limited number of analogues containing small polar side chains at C-2 or C-3 directed toward the ribose pocket were synthesized, including carboxylic acid, <i>N</i>-(<i>tert</i>-butyloxycarbonyloxy)amine, and amine groups. From these, the racemic morpholine analogue <b>10</b> bearing a methylamino group at C-2 gave increased potency and maintained LE relative to the hit (<b>10</b>, LE = 0.42 kcal mol<sup>−1</sup> heavy atom<sup>−1</sup>) (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). A crystal structure confirmed the purine remained as the hinge binding component, while the pendant primary amine formed a network of polar interactions in the ribose pocket of CHK1 (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>B). The amine bound directly to the backbone carbonyl of Glu134 and interacted with the side chains of Asn135 and Ser147 mediated by a water molecule. The amine was also close (ca. 3.4 Å) to the terminal carboxylate of Glu91.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Biological Activities and Ligand Efficiencies of Analogues of the Template Hit <b>9</b></div></div></div><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col /></col></colgroup><tbody><tr valign="top"><td><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900314j/production/images/medium/jm-2009-00314j_0003.gif" alt="" id="fx1" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">Mean of 2 independent determinations in DELFIA format, individual values in parentheses. Standard inhibitor staurosporine gave IC<sub>50</sub> = 2.1 (±1.8) nM.</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">Single determination.</p></div></div></div><div class="NLM_p">We sought to alter the purine heterocyclic core at an early stage to explore novel inhibitors that retained the key nitrogens atoms to interact with the hinge region while providing new substitution vectors to explore additional regions of the binding site. Comparison of the crystal structures of the purines <b>9</b> and <b>10</b> with the structures of the other template hits <b>5</b>−<b>8</b> indicated that the purines lacked a substitution vector toward the kinase specificity surface (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>F). This was introduced through switching to the pyrazolopyridine scaffold, resulting initially in the more potent ester <b>11</b>. Although pyrazolopyridines are well-known as kinase inhibitor scaffolds,<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> the introduction of the 4-(2-aminomethylmorpholin-4-yl) substituent led to novel compounds.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> The reduced LE of <b>11</b> was recovered when the ester was replaced by a 5-bromo substituent to give <b>12</b>. The crystal structure of <b>12</b> showed a change in the orientation and conformation of the morpholine ring to deliver the pendant amine for direct interaction with the carboxylate of Glu91 (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>C). The morpholine adopted a twisted conformation with respect to the plane of the bicycle as a result of a steric clash with the 5-bromo substituent. A possible weak interaction with a water molecule at the edge of the interior pocket was also detected (ca. 3.5 Å).</div><div class="NLM_p">Substitution at C-5 of the pyrazolopyridine by thiophene (<b>13</b>) or phenyl (<b>14</b>) retained the submicromolar activity and acceptable LE. The crystal structure of <b>14</b> showed the morpholine ring adopting a near-identical conformation to that observed in <b>12</b> but with the pendant phenyl adopting a torsion of ca. 56°. In refining the structures of racemic <b>10</b>, <b>12</b>, and <b>14</b>, it was generally possible to obtain a reasonable fit for either enantiomer of the morpholine side chains to the observed electron density by changes to the conformation of the ring. The single enantiomers of <b>14</b> were synthesized and tested but showed no appreciable enantiodiscrimination for binding to CHK1, emphasizing the conformational flexibility of the 2-aminomethylmorpholine.</div><figure id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900314j/production/images/medium/jm-2009-00314j_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900314j/production/images/large/jm-2009-00314j_0009.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Details of the binding of <b>9</b> (A), <b>10</b> (B), <b>12</b> (C), and <b>14</b> (D) to CHK1 kinase domain. Residues and side chains not involved in binding are omitted for clarity. Water molecules detected in the interior pocket of CHK1 or hydrogen bonded to the inhibitors are shown as red spheres. Hydrogen bonds to the inhibitors are shown as dashed green lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900314j/production/images/large/jm-2009-00314j_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900314j&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The pyrazolopyridines were profiled for selectivity and cellular activity (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). Some selectivity was seen for inhibition of CHK1 over the unrelated checkpoint kinase CHK2 (8−60-fold). The possible difference in therapeutic outcome of dual CHK1 and CHK2 inhibition, as opposed to selective CHK1 inhibition, remains to be determined. siRNA studies suggest that the CHK1 inhibitor phenotype dominates and is not necessarily enhanced by the simultaneous inhibition of CHK2.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Compounds <b>11</b>−<b>14</b> showed little inhibition of the cell cycle kinase CDK1. This is important for the interpretation of cellular checkpoint abrogation assays as inhibition of CDK1 will lead to interruptions in the cell cycle, independent of CHK1-mediated effects.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> The compounds were assessed in p53<sup>−/−</sup> HT29 colon cancer cells for their ability to abrogate the G2-M checkpoint arrest induced by treatment with etoposide. HT29 and certain other p53<sup>−/−</sup> colon cancer cell lines have been shown to have increased sensitivity to CHK1 inhibitors in vitro and in vivo.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> Compounds <b>11</b>−<b>13</b> abrogated the G2-M checkpoint in HT29 cells at concentrations 10−20-fold above the CHK1 inhibitory IC<sub>50</sub> values. These compounds were also active in the growth inhibition assay, with some 2−3-fold selectivity for the CHK1-mediated cellular effect over general cytotoxicity. The phenyl substituted analogue (<i><b>R</b></i>)-<b>14</b> did not show similar cellular activity, with no abrogation of the G2-M checkpoint detectable. We speculate that this might reflect undetermined off-target activities of the compound and underlines the importance of measuring cellular activity as well as inhibition of target biochemical activity in the progression of hits.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Selectivity and Cellular Data for Selected Compounds</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top"><th align="left">no.</th><th align="left">CHK1<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a> IC<sub>50</sub> (μM)</th><th align="left" char=".">CHK2<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a> IC<sub>50</sub> (μM)</th><th align="left" char=".">CDK1<a class="ref internalNav" href="#t4fn3" aria-label="c">c</a> % inhibition at 100 μM</th><th align="left">abrogation of G2 checkpoint<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a> IC<sub>50</sub> (μM)</th><th align="left">96 h SRB<a class="ref internalNav" href="#t4fn5" aria-label="e">e</a> GI<sub>50</sub> (μM)</th></tr></thead><tbody><tr valign="top"><td align="left"><b>11</b></td><td align="left">1.2</td><td align="char" char=".">74</td><td align="char" char=".">3</td><td align="left">19 (17, 20)</td><td align="left">64 (60, 68)</td></tr><tr valign="top"><td align="left"><b>12</b></td><td align="left">0.39 (0.33, 0.45)<a class="ref internalNav" href="#t4fn6" aria-label="f">f</a></td><td align="char" char=".">7.4</td><td align="char" char=".">37</td><td align="left">5 (3.9, 6)</td><td align="left">16 (14, 18)</td></tr><tr valign="top"><td align="left"><b>13</b></td><td align="left">0.29</td><td align="char" char=".">4.6</td><td align="char" char=".">48</td><td align="left">6 (7, 5)</td><td align="left">10.5 (10, 11)</td></tr><tr valign="top"><td align="left"><i><b>R</b></i><b>-14</b></td><td align="left">0.70 (0.52, 0.88)<a class="ref internalNav" href="#t4fn6" aria-label="f">f</a></td><td align="char" char=".">5.9</td><td align="char" char=".">43</td><td align="left">>50</td><td align="left">40<a class="ref internalNav" href="#t4fn7" aria-label="g">g</a></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">Single determination in DELFIA format. Standard inhibitor staurosporine gave IC<sub>50</sub> = 2.1 (±1.8) nM.</p></div><div class="footnote" id="t4fn2"><sup>b</sup><p class="last">Single determination in DELFIA format. Standard inhibitor staurosporine gave IC<sub>50</sub> = 27 (±8) nM</p></div><div class="footnote" id="t4fn3"><sup>c</sup><p class="last">Single determination in DELFIA format. Standard inhibitor staurosporine gave IC<sub>50</sub> = 18 (±4) nM</p></div><div class="footnote" id="t4fn4"><sup>d</sup><p class="last">Mean of 2 independent determinations in HT29 cells treated with etoposide to induce G2/M arrest, individual values in parentheses. Standard inhibitor staurosporine gave IC<sub>50</sub> = 0.0017 (±0.0004) μM.</p></div><div class="footnote" id="t4fn5"><sup>e</sup><p class="last">Mean of 2 independent determinations in HT29 cells, individual values in parentheses. Assay standard etoposide gave GI<sub>50</sub> = 0.73 (±0.13) μM.</p></div><div class="footnote" id="t4fn6"><sup>f</sup><p class="last">Mean of 2 independent determinations, individual values in parentheses.</p></div><div class="footnote" id="t4fn7"><sup>g</sup><p class="last">single determination.</p></div></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57011" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57011" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">We have shown that the template screening strategy described above is an effective means to generate new inhibitors of the checkpoint kinase CHK1. The combination of in silico template design, a high concentration AlphaScreen biochemical assay for primary hit detection, followed by confirmation using protein−ligand X-ray crystallography provided multiple validated template hits. This proved an attractive hit generation approach for CHK1 and is likely to be more widely applicable for other targets for which a robust high concentration bioassay is available. Our data reinforces the value of appropriate counter-screening to rule out nonspecific aggregation by test compounds in the high concentration bioassay. Although some poorly active templates can indeed be valid hits, and weak activity is expected for molecules in this molecular weight range, a much better validated hit rate was observed from those primary hits where no nonspecific inhibitory effect was detected. We have shown the rapid progression of one purine template hit using the initial structural information to give a more potent inhibitor and the subsequent application of iterative structure-based design to quickly generate submicromolar pyrazolopyridine inhibitors with good ligand efficiency. The pyrazolopyridine core possesses substitution patterns that should allow access to the key regions in CHK1 that are associated with highly specific inhibition. Although the pyrazolopyridines represent early stage leads, the compounds have appropriate CHK1-mediated cellular activity and successfully abrogate the G2-M checkpoint HT29 colon cancer cells. This demonstrates the ability of the template screen to efficiently identify progressible hit matter suitable for further optimisation.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_42644" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_42644" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Synthetic Chemistry</h3><div class="NLM_p">(4-(9<i>H</i>-Purin-6-yl)morpholin-2-yl)methanamine (<b>10</b>) was prepared by direct nucleophilic aromatic substitution of 6-chloropurine with commercially available racemic <i>tert</i>-butyl morpholin-2-ylmethylcarbamate, followed by acid deprotection. Compound <b>11</b> was prepared from ethyl 4-chloro-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine-5-carboxylate<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> in a similar manner. The pyrazalopyridine bicyclic core was prepared from paramethoxybenzyl protected pyrazolopyridone <b>15</b> as previously described by Misra<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). Chlorination of <b>15</b> using phosphorus oxychloride at 110 °C also removed the paramethoxybenzyl group, and introduction of the morpholin-2-ylmethylamine by S<sub>N</sub>Ar displacement followed by deprotection yielded <b>12</b>. An advanced intermediate <b>16</b> with the paramethoxybenzyl protecting group still intact was formed by lowering the temperature of the chlorination step to 60 °C, followed by nucleophilic substitution as before. Suzuki couplings to the protected 5-bromopyrazolopyridine <b>16</b>, followed by dual deprotection by stirring overnight at 40 °C in trifluoroacetic acid, gave the thienyl and phenyl substituted compounds <b>13</b> and <b>14</b>.</div><figure id="sch1" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900314j/production/images/medium/jm-2009-00314j_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900314j/production/images/large/jm-2009-00314j_0001.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900314j/production/images/large/jm-2009-00314j_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900314j&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) POCl<sub>3</sub>, 110°C; (ii) <i>tert</i>-butyl morpholin-2-ylmethylcarbamate, Et<sub>3</sub>N, <i>n</i>-BuOH, 100°C (53% over 2 steps); (iii) 4M HCl−dioxane, rt (8%); (iv) POCl<sub>3</sub>, 60°C (79%); (v) <i>tert</i>-butyl morpholin-2-ylmethylcarbamate, Et<sub>3</sub>N, <i>n</i>-BuOH, 100°C (49%); (vi) ArB(OH)<sub>2</sub>, Pd(dppf)Cl<sub>2</sub>, Na<sub>2</sub>CO<sub>3</sub>, H<sub>2</sub>O, MeCN, 140°C, microwave; (vii) CF<sub>3</sub>CO<sub>2</sub>H, 40°C (16−41% over 2 steps).</p></p></figure><div class="NLM_p"><i>tert</i>-Butyl morpholin-2-ylmethylcarbamate was prepared as either enantiomer starting from the appropriate 3-amino-1,2-propanediol <b>17</b> as described by Brenner et al.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). For example, the 2-hydroxymethylmorpholine <b>18</b><a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> was <i>O</i>-tosylated. Displacement of the tosylate by azide, reduction, and protection of the primary amine gave the bis-carbamate <b>19</b>. Selective deprotection of the secondary amine was achieved by exposure to acid at low temperature (5 °C) to give <b>20</b>, from which the synthesis followed a similar path to that for the racemate. The intermediate <b>20</b> was reacted with 5-bromo-4-chloro-1-(4-methoxybenzyl)-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine to give the coupled product <b>21</b>. Suzuki coupling to <b>21</b> and double <i>N</i>-deprotection with trifluoroacetic acid gave <i><b>R</b></i>-<b>14</b>. The <i>S</i>-enantiomer of <b>14</b> was prepared in similar fashion.</div><figure id="sch2" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900314j/production/images/medium/jm-2009-00314j_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900314j/production/images/large/jm-2009-00314j_0002.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900314j/production/images/large/jm-2009-00314j_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900314j&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) TsCl, Et<sub>3</sub>N, DMAP, CH<sub>2</sub>Cl<sub>2</sub>, 0°C → rt (85%); (ii) NaN<sub>3</sub>, DMF, 80°C; (iii) NH<sub>4</sub><sup>+</sup>HCO<sub>2</sub><sup>−</sup>, Pd/C, MeOH, rt; (iv) Cbz-Cl, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, rt (42% over 3 steps); (v) 4M HCl-dioxane, 0°C → 5°C (83%); (vi) 5-bromo-4-chloro-1-(4-methoxybenzyl)-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine, Et<sub>3</sub>N, <i>n</i>-BuOH, 160°C, microwave (67%); (vii) PhB(OH)<sub>2</sub>, Pd(dppf)Cl<sub>2</sub>, Na<sub>2</sub>CO<sub>3</sub>, H<sub>2</sub>O, MeCN, 140°C, microwave (48%); (viii) CF<sub>3</sub>CO<sub>2</sub>H, 40°C (55%).</p></p></figure></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> General Synthetic Chemistry</h3><div class="NLM_p last">Reactions were carried out under N<sub>2</sub>. Organic solutions were dried over MgSO<sub>4</sub> or Na<sub>2</sub>SO<sub>4</sub>. Starting materials and solvents were purchased from commercial suppliers and were used without further purification. Microwave reactions were carried out using a Biotage Initiator 60 microwave reactor. Flash silica chromatography was performed using Merck silica gel 60 (0.025−0.04 mm). Ion exchange chromatography was performed using Isolute Flash SCX-II (acidic) or Flash NH2 (basic) resin cartridges. <sup>1</sup>H NMR spectra were recorded on a Bruker AMX500 instrument using internal deuterium locks. Chemical shifts (δ) are reported relative to TMS (δ = 0) and/or referenced to the solvent in which they were measured. Combined HPLC−MS analyses were recorded using a Waters Alliance 2795 separations module and Waters/Micromass LCT mass detector with electrospray ionization (+ve or −ve ion mode as indicated) and with HPLC performed using Supelco DISCOVERY C18, 50 mm × 4.6 mm or 30 mm × 4.6 mm i.d. columns, at a temperature of 22 °C with gradient elution of 10−90% MeOH/0.1% aqueous formic acid at a flow rate of 1 mL/min and a run time of 6 min. Compounds were detected at 254 nm using a Waters 2487 dual λ absorbance detector. All tested compounds gave ≥95% purity as determined by this method. All purified synthetic intermediates gave ≥95% purity as determined by this method except where indicated in the text. High-resolution mass spectra were measured on an Agilent 6210 ToF HPLC−MS with a Phenomenex Gemini 3 μm C18 (3 cm × 4.6 mm i.d.) column.</div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> (4-(9<i>H</i>-Purin-6-yl)morpholin-2-yl)methanamine (<b>10</b>)</h3><div class="NLM_p last">A solution of <i>tert</i>-butyl morpholin-2-ylmethylcarbamate (0.115 g, 0.53 mmol), 6-chloro-9<i>H</i>-purine (0.035 g, 0.23 mmol), and Et<sub>3</sub>N (0.058 mL, 0.42 mmol) in NMP (1.1 mL) was heated in a microwave reactor at 140 °C for 2 × 5 min. The solvent was removed in vacuo, and the residue was purified by preparative HPLC to afford <i>tert</i>-butyl(4-(9<i>H</i>-purin-6-yl)morpholin-2-yl)methylcarbamate (0.035 g, 0.10 mmol, 46%). LC−MS <i>m</i>/<i>z</i> 357 (M + Na<sup>+</sup>), <i>R</i><sub>t</sub> = 2.05 min. <sup>1</sup>H NMR (MeOH-<i>d</i><sub>4</sub>) δ 1.48 (9H, s), 3.02 (1H, t, <i>J</i> = 12.0 Hz), 3.26 (2H, dt, <i>J</i> = 6.0, 1.0 Hz), 3.30 (1H, m), 3.62 (1H, m), 3.70 (1H, dd, <i>J</i> = 11.5, 2.5 Hz), 4.05 (1H, ddd, <i>J</i> = 11.5, 3.5, 1.5 Hz), 5.28 (2H, m), 6.80 (1H, t, <i>J =</i> 5.5 Hz), 8.04 (1H, s), 8.25 (1H, s). 4 M HCl in dioxane (0.1 mL, 0.40 mmol) was added to a suspension of a portion of the carbamate (0.020 g, 0.06 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (1 mL), and the mixture was stirred at rt for 4.5 h. The suspension was then dissolved in MeOH and loaded onto an MP-TsOH resin cartridge (500 mg). The cartridge was washed with MeOH, and the product was eluted with 2 M ammonia in MeOH. The solvent was removed in vacuo to afford (4-(9<i>H</i>-purin-6-yl)morpholin-2-yl)methanamine (<b>10</b>) (0.013 g, 0.06 mmol, 93%). LC−MS <i>m</i>/<i>z</i> 235 (M + H<sup>+</sup>), <i>R</i><sub>t</sub> = 0.68 min. Hi-Res LC−MS calcd for C<sub>10</sub>H<sub>15</sub>N<sub>6</sub>O, 235.13019, found 235.13017 (M + H<sup>+</sup>). <sup>1</sup>H NMR (MeOH-<i>d</i><sub>4</sub>) δ 2.77−2.88 (2H, m), 3.05 (1H, dd, <i>J</i> = 13.0, 10.5 Hz), 3.30 (1H, m), 3.62 (1H, m), 3.73 (1H, ddd, <i>J</i> = 11.5, 11.5, 2.5 Hz), 4.08 (1H, ddd, <i>=</i> 11.5, 3.5, 1.5 Hz), 5.25 (2H, m), 8.05 (1H, s), 8.25 (1H, s).</div></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Ethyl 4-(2-(Aminomethyl)morpholino)-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine-5-carboxylate (<b>11</b>)</h3><div class="NLM_p last">A solution of <i>tert</i>-butyl morpholin-2-ylmethylcarbamate (0.134 g, 0.62 mmol), ethyl 4-chloro-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine-5-carboxylate,<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> (0.142 g, 0.63 mmol) and Et<sub>3</sub>N (0.26 mL, 1.87 mmol) in <i>n</i>-BuOH (2.5 mL) was heated at 120 °C in a microwave reactor for 60 min. The mixture was cooled, and the yellow solid was collected by filtration, redissolved in EtOAc (15 mL), and washed with brine (10 mL) and water (10 mL). The organic layer was concentrated to give ethyl 4-(2-((<i>tert</i>-butoxycarbonylamino)methyl)morpholino)-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine-5-carboxylate as a yellow solid (0.11 g, 0.27 mmol, 44%). LC−MS <i>m</i>/<i>z</i> 406 (M + H<sup>+</sup>), <i>R</i><sub>t</sub> = 4.12 min. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.30 (3H, t, <i>J</i> = 7.5 Hz), 1.40 (9H, s), 2.95−3.20 (4H, m), 3.54 (1H, d, <i>J</i> = 13 Hz), 3.60−3.75 (3H, m), 3.94 (1H, d, <i>J</i> = 11.5 Hz), 4.25 (2H, q, <i>J</i> = 7.5 Hz), 7.00 (1H, s, broad), 8.24 (1H, s), 8.52 (1H, s). A portion of the carbamate (0.028 g, 0.07 mmol) was dissolved in methanol (3 mL), and CF<sub>3</sub>CO<sub>2</sub>H (2 mL) was added. The solution was refluxed for 16 h. The mixture was concentrated and the residue was purified by ion exchange chromatography on SCX-II acidic resin (2 g) eluting with MeOH then 2 M NH<sub>3</sub>−MeOH. The basic fractions were combined and concentrated to give <b>11</b> as a yellow oil (0.020 g, 0.065 mmol, 93%). LC−MS <i>m</i>/<i>z</i> 306 (M + H<sup>+</sup>), <i>R</i><sub>t</sub> = 1.22 min. Hi-Res LC−MS calcd for C<sub>19</sub>H<sub>28</sub>N<sub>5</sub>O<sub>5</sub> 406.2085, found 406.2097 (M + H<sup>+</sup>). <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 1.40 (3H, t, <i>J</i> = 7.5 Hz), 2.75−2.90 (2H, m), 3.25 (1H, dd, <i>J</i> = 10, 12.5 Hz), 3.45−3.55 (1H, m), 3.65 (1H, d, <i>J</i> = 12.5 Hz), 3.75 (1H, d, <i>J</i> = 11.5 Hz), 3.84−3.90 (2H, m), 4.05 (1H, d, <i>J</i> = 11 Hz), 4.30 (2H, q, <i>J</i> = 7.5 Hz), 8.28 (1H, s), 8.65 (1H, s).</div></div><div id="sec3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> (4-(5-Bromo-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridin-4-yl)morpholin-2-yl)methanamine (<b>12</b>)</h3><div class="NLM_p last">A suspension of 5-bromo-1-(4-methoxybenzyl)-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridin-4(7<i>H</i>)-one (<b>15</b>)<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> (0.10 g, 0.30 mmol) in POCl<sub>3</sub> (2.5 mL, 27 mmol) was heated at 110 °C for 3 h. The solution was cooled, and volatile components were removed by evaporation. The remaining syrup was poured into ice−water and extracted with EtOAc (3 × 20 mL). The combined organic layers were washed with brine, dried, and concentrated to give a crude mixture containing 5-bromo-4-chloro-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine as the major component. LC−MS <i>m</i>/<i>z</i> 232, 234 (M + H<sup>+</sup>), <i>R</i><sub>t</sub> = 4.43 min, purity = 52%. The crude material was added to a solution of <i>tert</i>-butyl morpholin-2-ylmethylcarbamate (0.098 g, 0.45 mmol) and Et<sub>3</sub>N (0.14 mL, 0.99 mmol) in <i>n</i>-BuOH (1.87 mL) and was heated at 100 °C for 18 h. The mixture was cooled, concentrated, and purified by preparative TLC, eluting with 5% MeOH−CH<sub>2</sub>Cl<sub>2</sub> to give <i>tert</i>-butyl (4-(5-bromo-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridin-4-yl)morpholin-2-yl)methylcarbamate as a yellow powder (0.066 g, 53% over two steps). LC−MS <i>m</i>/<i>z</i> 412, 414 (M + H<sup>+</sup>), <i>R</i><sub>t</sub> = 4.60 min. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 1.47 (9H, s), 3.20 (1H, t, <i>J</i> = 11 Hz), 3.26−3.32 (1H, m), 3.37−3.56 (1H, m), 3.88−3.42 (2H, m), 3.82−3.86 (3H, m), 4.07 (1H, d, <i>J</i> = 11.5 Hz), 8.18 (1H, s), 8.48 (1H, s). A portion of the carbamate (0.033 g, 0.08 mmol) was dissolved in dioxane (0.5 mL), and 4 M HCl in dioxane (0.5 mL, 2.0 mmol) was added. The solution was stirred at rt for 18 h. The solution was concentrated, and the residue was dissolved in MeOH and purified by ion exchange chromatography on Isolute SCX II acidic resin (2 g), eluting with MeOH and then 1 M NH<sub>3</sub>−MeOH. Preparative TLC, eluting with 1:20:79 Et<sub>3</sub>N:MeOH:CH<sub>2</sub>Cl<sub>2</sub>, gave <b>12</b> as an off-white amorphous powder (0.002 g, 0.0064 mmol, 8%). LC−MS <i>m</i>/<i>z</i> 312, 314 (M + H<sup>+</sup>), <i>R</i><sub>t</sub> = 1.63 min. Hi-Res LC−MS calcd for C<sub>11</sub>H<sub>15</sub>BrN<sub>5</sub>O 312.04545, found 312.04543 (M + H<sup>+</sup>). <sup>1</sup>H NMR (500 MHz, MeOH-<i>d</i><sub>4</sub>) δ 2.85−2.93 (2H, m), 3.20 (1H, dt, <i>J</i> = 2.0, 10.0 Hz), 3.41−3.46 (1H, m), 3.81−3.86 (2H, m), 3.89−3.94 (2H, m), 4.10−4.13 (1H, m), 8.29 (1H, s), 8.40 (1H, s).</div></div><div id="sec3_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> (4-(5-(Thiophen-3-yl)-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridin-4-yl)morpholin-2-yl)methanamine (<b>13</b>)</h3><div class="NLM_p last">A suspension of <b>15</b><a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> (0.20 mg, 0.60 mmol) in POCl<sub>3</sub> (5 mL, 54 mmol) was heated at 60 °C for 18 h. The mixture was cooled, and volatile components were removed by evaporation. The remaining syrup was poured into ice−water and extracted with EtOAc (3 × 20 mL). The combined extracts were washed with brine, dried, and concentrated to give 5-bromo-4-chloro-1-(4-methoxybenzyl)-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine as an off-white amorphous powder (0.166 g, 0.47 mmol, 79%). LC−MS <i>m</i>/<i>z</i> 352, 354 (M + H<sup>+</sup>), <i>R</i><sub>t</sub> = 5.70 min, purity = 91%. <sup>1</sup>H NMR (500 MHz, MeOH-<i>d</i><sub>4</sub>) δ 3.70 (3H, s), 5.61 (2H, s), 6.86 (2H, d, <i>J</i> = 8.5 Hz), 7.22 (2H, d, <i>J</i> = 8.5 Hz), 8.29 (1H, s), 8.79 (1H, s). A portion of the material (0.10 g, 0.28 mmol) was dissolved in warmed <i>n</i>-BuOH (1.2 mL), and <i>tert</i>-butyl morpholin-2-ylmethylcarbamate (0.135 g, 0.62 mmol) and Et<sub>3</sub>N (0.18 mL, 1.31 mmol) were added. The reaction mixture was heated in a microwave reactor at 160 °C for 3 h. The mixture was cooled and concentrated. Flash column chromatography on silica, eluting with a gradient of EtOAc−hexanes, gave <b>16</b> as a white amorphous powder (0.074 g, 49%). LC−MS <i>m</i>/<i>z</i> 532, 534 (M + H<sup>+</sup>), <i>R</i><sub>t</sub> = 5.49 min. <sup>1</sup>H NMR (500 MHz, MeOH-<i>d</i><sub>4</sub>) δ 1.45 (9H, s), 3.11−3.15 (1H, m), 3.19−3.27 (2H, m), 3.36−3.41 (1H, m), 3.52−3.59 (1H, m), 3.73 (3H, s), 3.77−3.94 (3H, m), 4.03−4.05 (1H, m), 5.54 (2H, s), 6.82 (2H, d, <i>J</i> = 8.5 Hz), 7.22 (2H, d, <i>J</i> = 8.5 Hz), 8.24 (1H, s), 8.42 (1H, s). A portion of <b>16</b> (16 mg, 0.030 mmol) was dissolved in warmed MeCN (0.56 mL) before 3-thienylboronic acid (8 mg, 0.060 mmol), Na<sub>2</sub>CO<sub>3</sub> (8 mg, 0.075 mmol), Pd(dppf)·CH<sub>2</sub>Cl<sub>2</sub> complex (2.2 mg, 10 mol %), and water (0.11 mL) were added. The reaction vial was capped and purged with N<sub>2</sub> for 5 min. The reaction mixture was heated in a microwave reactor at 140 °C for 30 min. The cooled solution was filtered through celite, washing with fresh MeCN and MeOH. The organic filtrates were combined and the volatiles were removed in vacuo to give crude <i>tert</i>-butyl (4-(1-(4-methoxybenzyl)-5-(thiophen-3-yl)-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridin-4-yl)morpholin-2-yl)methylcarbamate. LC−MS <i>m</i>/<i>z</i> 536 (M + H<sup>+</sup>); <i>R</i><sub>t</sub> = 5.47 min, 58% purity. The crude material was dissolved in CF<sub>3</sub>CO<sub>2</sub>H (1 mL) and stirred at 40 °C under N<sub>2</sub> for 18 h. The solution was concentrated, and the residue was dissolved in DMF/MeOH before ion exchange chromatography on Isolute SCX II acidic resin (2 g), eluting with MeOH and then 1 M NH<sub>3</sub>−MeOH. Preparative TLC, eluting with 1:10:89 NH<sub>3</sub>:MeOH:CH<sub>2</sub>Cl<sub>2</sub>, gave <b>13</b> as a white amorphous powder (3.9 mg, 41% over 2 steps). LC−MS <i>m</i>/<i>z</i> 316 (M + H<sup>+</sup>), <i>R</i><sub>t</sub> = 0.93 min. Hi-Res LC−MS calcd for C<sub>15</sub>H<sub>18</sub>N<sub>5</sub>OS 316.12266, found 316.12310 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, MeOH-<i>d</i><sub>4</sub>) δ, 2.65−2.75 (2H, m), 2.97 (1H, dd, <i>J</i> = 10.0, 12.0), 3.24 (1H, td, <i>J</i> = 3.2, 12.1), 3.47−3.52 (1H, m), 3.58 (1H, dt, <i>J</i> = 2.0, 12.0), 3.60−3.66 (2H, m), 3.70 (1H, td, <i>J</i> = 2.5, 11.5), 3.89 (1H, ddd, <i>J</i> = 1.5, 3.0, 11.5), 7.40 (1H, dd, <i>J</i> = 1.5, 5.0), 7.52 (1H, dd, <i>J</i> = 1.5, 3.0), 7.57 (1H, dd, <i>J</i> = 3.0, 5.0), 8.20 (s, 1H), 8.32 (s, 1H),</div></div><div id="sec3_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> (4-(5-Phenyl-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridin-4-yl)morpholin-2-yl)methanamine (<b>14</b>)</h3><div class="NLM_p last">(16% over two steps from <b>16</b>). LC−MS <i>m</i>/<i>z</i> 310 (M + H<sup>+</sup>), <i>R</i><sub>t</sub> = 0.67 min. Hi-Res LC−MS calcd for C<sub>17</sub>H<sub>19</sub>N<sub>5</sub>O 310.16624, found 310.16629 (M + H<sup>+</sup>). <sup>1</sup>H NMR (500 MHz, MeOH-<i>d</i><sub>4</sub>) δ 2.89−2.95 (2H, m), 3.05 (1H, dd, <i>J</i> = 10.0, 12.0 Hz), 3.20−3.26 (1H, m), 3.47−3.49 (1H, m), 3.60−3.65 (1H, m), 3.74−3.79 (1H, m), 3.86−3.89 (1H, m), 7.37−7.41 (1H, m), 7.51 (2H, t, <i>J</i> = 7.5 Hz), 7.56 (2H, dd, <i>J</i> = 1.5, 7.5 Hz), 8.14 (1H, s), 8.32 (1H, s).</div></div></div><div class="NLM_back"><div class="article_supporting-info" id=""><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19"><a href="/doi/suppl/10.1021/jm900314j">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74673" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74673" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Experimental procedures for the preparation of compounds <b>19</b>, <b>20</b>, <b>21</b>, (<i><b>R</b></i>)-<b>14</b>, and (<i><b>S</b></i>)-<b>14</b>. Experimental procedures and CHK1 inhibitory data for the preparation of additional analogues related to compounds <b>9</b> and <b>10</b>. Methods for high concentration CHK1 AlphaScreen, DELFIA enzyme inhibition assays for CHK1, CHK2, and CDK1, G2 checkpoint abrogation assay, SRB cytotoxicity assay. Methods for crystal structure determination of CHK1−inhibitor complexes, crystallographic information on the structures of <b>5</b>−<b>10</b>, <b>12</b>, <b>14</b>. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm900314j/suppl_file/jm900314j_si_001.pdf">jm900314j_si_001.pdf (121.26 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm900314j" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13824" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13824" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ian Collins</span> - <span class="hlFld-Affiliation affiliation">Cancer Research UK Centre for Cancer Therapeutics</span>; 
    <span class="hlFld-Affiliation affiliation">Sections of Cancer Therapeutics and Structural Biology</span>; 
    <span class="hlFld-Affiliation affiliation">The Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey SM2 5NG, U.K.</span>; 
    <span class="hlFld-Affiliation affiliation">Sareum Ltd, 2 Iconix Park, Pampisford, Cambridge CB22 3EG, U.K.</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#c9a0a8a7e7aaa6a5a5a0a7ba89a0aabbe7a8aae7bca2"><span class="__cf_email__" data-cfemail="19707877377a76757570776a59707a6b37787a376c72">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thomas P. Matthews</span> - <span class="hlFld-Affiliation affiliation">Cancer Research UK Centre for Cancer Therapeutics</span>; 
    <span class="hlFld-Affiliation affiliation">Sections of Cancer Therapeutics and Structural Biology</span>; 
    <span class="hlFld-Affiliation affiliation">The Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey SM2 5NG, U.K.</span>; 
    <span class="hlFld-Affiliation affiliation">Sareum Ltd, 2 Iconix Park, Pampisford, Cambridge CB22 3EG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Suki Klair</span> - <span class="hlFld-Affiliation affiliation">Sareum Ltd, 2 Iconix Park, Pampisford, Cambridge CB22 3EG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Samantha Burns</span> - <span class="hlFld-Affiliation affiliation">Cancer Research UK Centre for Cancer Therapeutics</span>; 
    <span class="hlFld-Affiliation affiliation">Sections of Cancer Therapeutics and Structural Biology</span>; 
    <span class="hlFld-Affiliation affiliation">The Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey SM2 5NG, U.K.</span>; 
    <span class="hlFld-Affiliation affiliation">Sareum Ltd, 2 Iconix Park, Pampisford, Cambridge CB22 3EG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kathy Boxall</span> - <span class="hlFld-Affiliation affiliation">Cancer Research UK Centre for Cancer Therapeutics</span>; 
    <span class="hlFld-Affiliation affiliation">Sections of Cancer Therapeutics and Structural Biology</span>; 
    <span class="hlFld-Affiliation affiliation">The Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey SM2 5NG, U.K.</span>; 
    <span class="hlFld-Affiliation affiliation">Sareum Ltd, 2 Iconix Park, Pampisford, Cambridge CB22 3EG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael Cherry</span> - <span class="hlFld-Affiliation affiliation">Sareum Ltd, 2 Iconix Park, Pampisford, Cambridge CB22 3EG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Martin Fisher</span> - <span class="hlFld-Affiliation affiliation">Sareum Ltd, 2 Iconix Park, Pampisford, Cambridge CB22 3EG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Isaac M. Westwood</span> - <span class="hlFld-Affiliation affiliation">Cancer Research UK Centre for Cancer Therapeutics</span>; 
    <span class="hlFld-Affiliation affiliation">Sections of Cancer Therapeutics and Structural Biology</span>; 
    <span class="hlFld-Affiliation affiliation">The Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey SM2 5NG, U.K.</span>; 
    <span class="hlFld-Affiliation affiliation">Sareum Ltd, 2 Iconix Park, Pampisford, Cambridge CB22 3EG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael I. Walton</span> - <span class="hlFld-Affiliation affiliation">Cancer Research UK Centre for Cancer Therapeutics</span>; 
    <span class="hlFld-Affiliation affiliation">Sections of Cancer Therapeutics and Structural Biology</span>; 
    <span class="hlFld-Affiliation affiliation">The Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey SM2 5NG, U.K.</span>; 
    <span class="hlFld-Affiliation affiliation">Sareum Ltd, 2 Iconix Park, Pampisford, Cambridge CB22 3EG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tatiana McHardy</span> - <span class="hlFld-Affiliation affiliation">Cancer Research UK Centre for Cancer Therapeutics</span>; 
    <span class="hlFld-Affiliation affiliation">Sections of Cancer Therapeutics and Structural Biology</span>; 
    <span class="hlFld-Affiliation affiliation">The Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey SM2 5NG, U.K.</span>; 
    <span class="hlFld-Affiliation affiliation">Sareum Ltd, 2 Iconix Park, Pampisford, Cambridge CB22 3EG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kwai-Ming J. Cheung</span> - <span class="hlFld-Affiliation affiliation">Cancer Research UK Centre for Cancer Therapeutics</span>; 
    <span class="hlFld-Affiliation affiliation">Sections of Cancer Therapeutics and Structural Biology</span>; 
    <span class="hlFld-Affiliation affiliation">The Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey SM2 5NG, U.K.</span>; 
    <span class="hlFld-Affiliation affiliation">Sareum Ltd, 2 Iconix Park, Pampisford, Cambridge CB22 3EG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rob Van Montfort</span> - <span class="hlFld-Affiliation affiliation">Cancer Research UK Centre for Cancer Therapeutics</span>; 
    <span class="hlFld-Affiliation affiliation">Sections of Cancer Therapeutics and Structural Biology</span>; 
    <span class="hlFld-Affiliation affiliation">The Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey SM2 5NG, U.K.</span>; 
    <span class="hlFld-Affiliation affiliation">Sareum Ltd, 2 Iconix Park, Pampisford, Cambridge CB22 3EG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David Williams</span> - <span class="hlFld-Affiliation affiliation">Sareum Ltd, 2 Iconix Park, Pampisford, Cambridge CB22 3EG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">G. Wynne Aherne</span> - <span class="hlFld-Affiliation affiliation">Cancer Research UK Centre for Cancer Therapeutics</span>; 
    <span class="hlFld-Affiliation affiliation">Sections of Cancer Therapeutics and Structural Biology</span>; 
    <span class="hlFld-Affiliation affiliation">The Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey SM2 5NG, U.K.</span>; 
    <span class="hlFld-Affiliation affiliation">Sareum Ltd, 2 Iconix Park, Pampisford, Cambridge CB22 3EG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michelle D. Garrett</span> - <span class="hlFld-Affiliation affiliation">Cancer Research UK Centre for Cancer Therapeutics</span>; 
    <span class="hlFld-Affiliation affiliation">Sections of Cancer Therapeutics and Structural Biology</span>; 
    <span class="hlFld-Affiliation affiliation">The Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey SM2 5NG, U.K.</span>; 
    <span class="hlFld-Affiliation affiliation">Sareum Ltd, 2 Iconix Park, Pampisford, Cambridge CB22 3EG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John Reader</span> - <span class="hlFld-Affiliation affiliation">Sareum Ltd, 2 Iconix Park, Pampisford, Cambridge CB22 3EG, U.K.</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61058" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61058" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Dr. N. Proisy for initial synthetic work in the preparation of <b>18</b> and Dr. A. Mirza and M. Richards for assistance in the spectroscopic characterisation of test compounds. This work was supported by Cancer Research UK [CUK] grant numbers C309/A2187, C309/A8274 and C309/A8365. We acknowledge NHS funding to the NIHR Biomedical Research Centre.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_37633" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_37633" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 47 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Walworth, N.</span><span> </span><span class="NLM_article-title">Cell-cycle checkpoint kinases: checking in on the cell cycle</span> <span class="citation_source-journal">Curr. Opin. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">697</span><span class="NLM_x">–</span> <span class="NLM_lpage">704</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm900314j&amp;key=10.1016%2FS0955-0674%2800%2900154-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm900314j&amp;key=11063934" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm900314j&amp;key=1%3ACAS%3A528%3ADC%252BD3cXovVagsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2000&pages=697-704&author=N.+Walworth&title=Cell-cycle+checkpoint+kinases%3A+checking+in+on+the+cell+cycle"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Cell-cycle checkpoint kinases: checking in on the cell cycle</span></div><div class="casAuthors">Walworth, Nancy C.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Cell Biology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">697-704</span>CODEN:
                <span class="NLM_cas:coden">COCBE3</span>;
        ISSN:<span class="NLM_cas:issn">0955-0674</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review, with 80 refs.  In response to DNA damage, cell-cycle checkpoints integrate cell-cycle control with DNA repair.  The idea that checkpoint controls are an integral component of normal cell-cycle progression has arisen as a result of studies in Drosophila and mice.  In addn., an appreciation that DNA damage arises as a natural consequence of cellular metab., including DNA replication itself, has influenced thinking regarding the nature of checkpoint pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-rtR1VBU73rVg90H21EOLACvtfcHk0liTebOqC3tYrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXovVagsLo%253D&md5=457f90681ab2c930480d3b3228502036</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2FS0955-0674%2800%2900154-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0955-0674%252800%252900154-X%26sid%3Dliteratum%253Aachs%26aulast%3DWalworth%26aufirst%3DN.%26atitle%3DCell-cycle%2520checkpoint%2520kinases%253A%2520checking%2520in%2520on%2520the%2520cell%2520cycle%26jtitle%3DCurr.%2520Opin.%2520Cell%2520Biol.%26date%3D2000%26volume%3D12%26spage%3D697%26epage%3D704" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Bartek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukas, J.</span><span> </span><span class="NLM_article-title">Chk1 and Chk2 kinases in checkpoint control and cancer</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">421</span><span class="NLM_x">–</span> <span class="NLM_lpage">429</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=421-429&author=J.+Bartekauthor=J.+Lukas&title=Chk1+and+Chk2+kinases+in+checkpoint+control+and+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBartek%26aufirst%3DJ.%26aulast%3DLukas%26aufirst%3DJ.%26atitle%3DChk1%2520and%2520Chk2%2520kinases%2520in%2520checkpoint%2520control%2520and%2520cancer%26jtitle%3DCancer%2520Cell%26date%3D2003%26volume%3D3%26spage%3D421%26epage%3D429" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leverson, J. D.</span><span> </span><span class="NLM_article-title">New opportunities in chemosensitization and radiosensitization: modulating the DNA-damage response</span> <span class="citation_source-journal">Expert Rev. Anticancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">333</span><span class="NLM_x">–</span> <span class="NLM_lpage">342</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm900314j&amp;key=10.1586%2F14737140.5.2.333" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm900314j&amp;key=15877529" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm900314j&amp;key=1%3ACAS%3A528%3ADC%252BD2MXktlajt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=333-342&author=Y.+Luoauthor=J.+D.+Leverson&title=New+opportunities+in+chemosensitization+and+radiosensitization%3A+modulating+the+DNA-damage+response"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">New opportunities in chemosensitization and radiosensitization: Modulating the DNA-damage response</span></div><div class="casAuthors">Luo, Yan; Leverson, Joel D.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Anticancer Therapy</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">333-342</span>CODEN:
                <span class="NLM_cas:coden">ERATBJ</span>;
        ISSN:<span class="NLM_cas:issn">1473-7140</span>.
    
            (<span class="NLM_cas:orgname">Future Drugs Ltd.</span>)
        </div><div class="casAbstract">A review.  Many current cancer treatments, including certain classes of chemotherapeutics and radiation, induce cytotoxicity by damaging DNA.  However, many cancers are resistant to these therapies, which represents a significant challenge in the clinic.  Thus, modulating DNA-damage responses to selectively enhance the sensitivity of cancer cells to these therapies is highly desirable.  When DNA damage is detected, DNA checkpoint mechanisms are activated to halt cells at various phases of the cell cycle.  Simultaneously, DNA-damage sensors transduce signals to activate DNA-repair mechanisms via de novo expression or post-translational modification of enzymes required for DNA repair.  P53 is the major player in a checkpoint that arrests cells at the G1/S boundary, while checkpoint kinase (Chk)1 is crit. for the G2/M checkpoint and also the S checkpoint that prevents cell cycle progression after replication defects (intra-S-phase checkpoint) or S/M uncoupling (S/M checkpoint).  Poly(ADP-ribose) polymerase is involved in sensing DNA single-strand breaks and inducing DNA repair via poly(ADP-ribosyl)ating various DNA-binding and DNA-repair proteins.  In this review, strategies for implementing small-mol. inhibitors of poly(ADP-ribose) polymerase and Chk1, which are emerging as potential adjuncts to current therapies, are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzQYSJtb4VSrVg90H21EOLACvtfcHk0liTebOqC3tYrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXktlajt7w%253D&md5=0bd7912a0cf8b8cc4ecbdb96b8672782</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1586%2F14737140.5.2.333&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252F14737140.5.2.333%26sid%3Dliteratum%253Aachs%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DLeverson%26aufirst%3DJ.%2BD.%26atitle%3DNew%2520opportunities%2520in%2520chemosensitization%2520and%2520radiosensitization%253A%2520modulating%2520the%2520DNA-damage%2520response%26jtitle%3DExpert%2520Rev.%2520Anticancer%2520Ther.%26date%3D2005%26volume%3D5%26spage%3D333%26epage%3D342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Bourdon, J.-C.</span><span> </span><span class="NLM_article-title">p53 and its isoforms in cancer</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">277</span><span class="NLM_x">–</span> <span class="NLM_lpage">282</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm900314j&amp;key=10.1038%2Fsj.bjc.6603886" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm900314j&amp;key=17637683" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm900314j&amp;key=1%3ACAS%3A528%3ADC%252BD2sXotlSgt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2007&pages=277-282&author=J.-C.+Bourdon&title=p53+and+its+isoforms+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">p53 and its isoforms in cancer</span></div><div class="casAuthors">Bourdon, J.-C.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">277-282</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  P53, p63 and p73 are members of the p53 gene family involved in development, differentiation and response to cellular stress. p53 gene is a transcription factor essential for the prevention of cancer formation.  The p53 pathway is ubiquitously lost in human cancer either by p53 gene mutation (60% of cancers) or by lost of cell signalling upstream and downstream of p53 in the remaining cancers expressing WTp53 gene.  As p53 pathway inactivation is a common denominator to all cancers, the understanding of p53 tumor suppressor activity is likely to bring us closer to cancer therapy.  However, despite all the exptl. evidences showing the importance of p53 in preventing carcinogenesis, it is difficult in clin. studies to link p53 status to cancer treatment and clin. outcome.  The recent discovery that p53 gene encodes for nine different p53 proteins (isoforms) may have a profound impact on our understanding of p53 tumor suppressor activity.  Studies in several tumor types have shown that the nine different p53 isoforms are abnormally expressed in tumor tissues compared to normal cells. p53 protein isoforms modulate p53 transcriptional activity and cell fate outcome in response to stress.  Regulation of p53 function in normal and tumor tissues in man is likely to be more complex than has been hitherto appreciated.  Therefore, the tumor p53 status needs to be detd. more accurately by integrating p53 isoform expression, functional p53 mutation anal. and a panel of antibodies specific of p53 and of its target genes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqf6wgB9kOGm7Vg90H21EOLACvtfcHk0liTebOqC3tYrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXotlSgt78%253D&md5=939a18836ca7ea948adfaf2c4bbd0dcb</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6603886&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6603886%26sid%3Dliteratum%253Aachs%26aulast%3DBourdon%26aufirst%3DJ.-C.%26atitle%3Dp53%2520and%2520its%2520isoforms%2520in%2520cancer%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2007%26volume%3D97%26spage%3D277%26epage%3D282" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sowin, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sham, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fesik, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span> </span><span class="NLM_article-title">Human Chk1 expression is dispensable for somatic cell death and critical for sustaining G2 DNA damage checkpoint</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">543</span><span class="NLM_x">–</span> <span class="NLM_lpage">548</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm900314j&amp;key=10.4161%2Fcbt.2.5.454" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm900314j&amp;key=12813133" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm900314j&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlslWkt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2003&pages=543-548&author=Z.+Chenauthor=Z.+Xiaoauthor=J.+Chenauthor=S.+C.+Ngauthor=T.+Sowinauthor=H.+Shamauthor=S.+Rosenbergauthor=S.+Fesikauthor=H.+Zhang&title=Human+Chk1+expression+is+dispensable+for+somatic+cell+death+and+critical+for+sustaining+G2+DNA+damage+checkpoint"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Human Chk1 expression is dispensable for somatic cell death and critical for sustaining G2 DNA damage checkpoint</span></div><div class="casAuthors">Chen, Zehan; Xiao, Zhan; Chen, Jun; Ng, Shi-Chung; Sowin, Thomas; Sham, Hing; Rosenberg, Saul; Fesik, Steve; Zhang, Haiying</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">543-548</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Mammalian Chk1 is an essential kinase for embryonic development and plays an important role in the cellular response to DNA damage.  However, it remains unclear whether inhibition of Chk1 induces apoptosis in somatic cells.  The uncertainty has become a crit. issue for rationale design of Chk1 mechanism-based anticancer drugs.  Here we show that Chk1 small interfering RNA (siRNA) effectively eliminates Chk1 protein expression without altering the cell cycle profile or inducing apoptosis in various human cancer cell lines under normal conditions.  In the presence of DNA-damaging agents, however, Chk1 siRNA alone is sufficient to abrogate the DNA damage-induced G2 checkpoint and significantly enhance apoptosis.  Cell cycle kinetic profiles show that abrogation of G2 arrest is mediated through shortening of the checkpoint.  We also demonstrate that Chk1 siRNA enhances DNA damage-induced apoptosis in p53-deficient cancer cell lines and augments the growth inhibition conferred by DNA-damaging agents.  These findings imply that Chk1 inhibitors will have low cytotoxicity on their own and can enhance the efficacy of DNA-damaging drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpD0X4IEJ-mh7Vg90H21EOLACvtfcHk0lgI15m-Eiae5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlslWkt7k%253D&md5=13351c9321140baebd0728fd0f7f36a9</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.4161%2Fcbt.2.5.454&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcbt.2.5.454%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DXiao%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DNg%26aufirst%3DS.%2BC.%26aulast%3DSowin%26aufirst%3DT.%26aulast%3DSham%26aufirst%3DH.%26aulast%3DRosenberg%26aufirst%3DS.%26aulast%3DFesik%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DH.%26atitle%3DHuman%2520Chk1%2520expression%2520is%2520dispensable%2520for%2520somatic%2520cell%2520death%2520and%2520critical%2520for%2520sustaining%2520G2%2520DNA%2520damage%2520checkpoint%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2003%26volume%3D2%26spage%3D543%26epage%3D548" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Bucher, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Britten, C. D.</span><span> </span><span class="NLM_article-title">G2 checkpoint abrogation and checkpoint kinase-1 targeting in the treatment of cancer</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">523</span><span class="NLM_x">–</span> <span class="NLM_lpage">528</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm900314j&amp;key=10.1038%2Fsj.bjc.6604208" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm900314j&amp;key=18231106" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm900314j&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhs1KrsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2008&pages=523-528&author=N.+Bucherauthor=C.+D.+Britten&title=G2+checkpoint+abrogation+and+checkpoint+kinase-1+targeting+in+the+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">G2 checkpoint abrogation and checkpoint kinase-1 targeting in the treatment of cancer</span></div><div class="casAuthors">Bucher, N.; Britten, C. D.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">523-528</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Rigorous quality control steps, termed checkpoints, tightly regulate progression through the cell cycle.  DNA-damaging chemotherapy and radiation activate functional cellular checkpoints.  These checkpoints can facilitate DNA repair and promote cell death in unrepaired cells.  There are at least three DNA damage checkpoints - at G1/S, S, and G2/M - as well as a mitotic spindle checkpoint.  Most cancer cells harbor mutations in tumor suppressors and/or oncogenes, which impair certain cell checkpoints.  Inhibiting the remaining cell checkpoints - particularly after exposure of cancer cells to chemotherapy and/or radiation - allows cell death, a strategy now being employed in cancer therapeutics.  With our increasing knowledge of cell cycle regulation, many compds. have been developed to inhibit specific checkpoint components, particularly at the G2/M transition.  One such target is checkpoint kinase-1 (Chk1).  We review here the mol. framework of the cell cycle, the rationale for targeting Chk1, the preclin. concepts related to the development of Chk1 inhibitors, and the efficacy and safety results from Chk1 inhibitors now in phase I/II trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKqRg9PDH1B7Vg90H21EOLACvtfcHk0lgI15m-Eiae5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhs1KrsLc%253D&md5=607123f2a15cbe76fbd2aba55da7d289</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6604208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6604208%26sid%3Dliteratum%253Aachs%26aulast%3DBucher%26aufirst%3DN.%26aulast%3DBritten%26aufirst%3DC.%2BD.%26atitle%3DG2%2520checkpoint%2520abrogation%2520and%2520checkpoint%2520kinase-1%2520targeting%2520in%2520the%2520treatment%2520of%2520cancer%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2008%26volume%3D98%26spage%3D523%26epage%3D528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xue, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bui, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kovar, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tao, Z.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, N.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sham, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J. Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sowin, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span> </span><span class="NLM_article-title">Selective Chk1 inhibitors differentially sensitize p53-deficient cells to cancer therapeutics</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">119</span><span class="NLM_x">, </span> <span class="NLM_fpage">2784</span><span class="NLM_x">–</span> <span class="NLM_lpage">2794</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm900314j&amp;key=10.1002%2Fijc.22198" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm900314j&amp;key=17019715" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm900314j&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1yqt7vK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2006&pages=2784-2794&author=Z.+Chenauthor=X.+Xiaoauthor=W.+Guauthor=J.+Xueauthor=M.+H.+Buiauthor=P.+Kovarauthor=G.+Liauthor=G.+Wangauthor=Z.-F.+Taoauthor=Y.+Tongauthor=N.-H.+Linauthor=H.+L.+Shamauthor=J.+Y.+J.+Wangauthor=T.+J.+Sowinauthor=S.+H.+Rosenbergauthor=H.+Zhang&title=Selective+Chk1+inhibitors+differentially+sensitize+p53-deficient+cells+to+cancer+therapeutics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Selective Chk1 inhibitors differentially sensitize p53-deficient cancer cells to cancer therapeutics</span></div><div class="casAuthors">Chen, Zehan; Xiao, Zhan; Gu, Wen-zhen; Xue, John; Bui, Mai H.; Kovar, Peter; Li, Gaoquan; Wang, Gary; Tao, Zhi-Fu; Tong, Yunsong; Lin, Nan-Horng; Sham, Hing L.; Wang, Jean Y. J.; Sowin, Thomas J.; Rosenberg, Saul H.; Zhang, Haiying</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2784-2794</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">The majority of cancer therapeutics induces DNA damage to kill cells.  Normal proliferating cells undergo cell cycle arrest in response to DNA damage, thus allowing DNA repair to protect the genome.  DNA damage induced cell cycle arrest depends on an evolutionarily conserved signal transduction network in which the Chk1 kinase plays a crit. role.  In mammalian cells, the p53 and RB pathways further augment the cell cycle arrest response to prevent catastrophic cell death.  Given the fact that most tumor cells suffer defects in the p53 and RB pathways, it is likely that tumor cells would depend more on the Chk1 kinase to maintain cell cycle arrest than would normal cells.  Therefore Chk1 inhibition could be used to specifically sensitize tumor cells to DNA-damaging agents.  We have previously shown that siRNA-mediated Chk1 knockdown abrogates DNA damage-induced checkpoints and potentiates the cytotoxicity of several DNA-damaging agents in p53-deficient cell lines.  In this study, we have developed 2 potent and selective Chk1 inhibitors, A-690002 and A-641397, and shown that these compds. abrogate cell cycle checkpoints and potentiate the cytotoxicity of topoisomerase inhibitors and γ-radiation in p53-deficient but not in p53-proficient cells of different tissue origins.  These results indicate that it is feasible to achieve a therapeutic window with 1 or more Chk1 inhibitors in potentiation of cancer therapy based on the status of the p53 pathway in a wide spectrum of tumor types.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWCzPiGB4dXbVg90H21EOLACvtfcHk0lgI15m-Eiae5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1yqt7vK&md5=5b9574d46444ba16210e96de0f8f8f3c</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1002%2Fijc.22198&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.22198%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DXiao%26aufirst%3DX.%26aulast%3DGu%26aufirst%3DW.%26aulast%3DXue%26aufirst%3DJ.%26aulast%3DBui%26aufirst%3DM.%2BH.%26aulast%3DKovar%26aufirst%3DP.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DTao%26aufirst%3DZ.-F.%26aulast%3DTong%26aufirst%3DY.%26aulast%3DLin%26aufirst%3DN.-H.%26aulast%3DSham%26aufirst%3DH.%2BL.%26aulast%3DWang%26aufirst%3DJ.%2BY.%2BJ.%26aulast%3DSowin%26aufirst%3DT.%2BJ.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DZhang%26aufirst%3DH.%26atitle%3DSelective%2520Chk1%2520inhibitors%2520differentially%2520sensitize%2520p53-deficient%2520cells%2520to%2520cancer%2520therapeutics%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2006%26volume%3D119%26spage%3D2784%26epage%3D2794" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Zhou, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartek, J.</span><span> </span><span class="NLM_article-title">Targeting the checkpoint kinases: chemosensitization versus chemoprotection</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">216</span><span class="NLM_x">–</span> <span class="NLM_lpage">225</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm900314j&amp;key=10.1038%2Fnrc1296" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm900314j&amp;key=14993903" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm900314j&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhs1Ggsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=216-225&author=B.+B.+Zhouauthor=J.+Bartek&title=Targeting+the+checkpoint+kinases%3A+chemosensitization+versus+chemoprotection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the checkpoint kinases: chemosensitization versus chemoprotection</span></div><div class="casAuthors">Zhou, Bin-Bing S.; Bartek, Jiri</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">216-225</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  An important part of the cellular response to DNA damage is checkpoint activation - checkpoint kinases CHK1 and CHK2 phosphorylate key proteins to elicit cell-cycle blocks.  Inhibiting these kinases was believed to sensitize tumor cells to cancer treatments that damage DNA, because in the absence of checkpoints and efficient DNA repair, the response would switch to cell death or senescence.  Recent discoveries have, however, highlighted different and expanded roles for CHK1 and CHK2, so should the therapeutic hypothesis that is concerned with targeting so-called checkpoint kinases be modified.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxA1I9VXUZd7Vg90H21EOLACvtfcHk0lhtvENt8K3BwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhs1Ggsr4%253D&md5=c68980da8189320521ead28482259eb8</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnrc1296&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1296%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DB.%2BB.%26aulast%3DBartek%26aufirst%3DJ.%26atitle%3DTargeting%2520the%2520checkpoint%2520kinases%253A%2520chemosensitization%2520versus%2520chemoprotection%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2004%26volume%3D4%26spage%3D216%26epage%3D225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Tse, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carvajal, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scwartz, G. K.</span><span> </span><span class="NLM_article-title">Targeting checkpoint kinase 1 in cancer therapeutics</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1955</span><span class="NLM_x">–</span> <span class="NLM_lpage">1960</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm900314j&amp;key=10.1158%2F1078-0432.CCR-06-2793" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm900314j&amp;key=17404075" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm900314j&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjs12rsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=1955-1960&author=A.+N.+Tseauthor=R.+Carvajalauthor=G.+K.+Scwartz&title=Targeting+checkpoint+kinase+1+in+cancer+therapeutics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Checkpoint Kinase 1 in Cancer Therapeutics</span></div><div class="casAuthors">Tse, Archie N.; Carvajal, Richard; Schwartz, Gary K.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1955-1960</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Progression through the cell cycle is monitored by surveillance mechanisms known as cell cycle checkpoints.  Our knowledge of the biochem. nature of checkpoint regulation during an unperturbed cell cycle and following DNA damage has expanded tremendously over the past decade.  We now know that dysfunction in cell cycle checkpoints leads to genomic instability and contributes to tumor progression, and most agents used for cancer therapy, such as cytotoxic chemotherapy and ionizing radiation, also activate cell cycle checkpoints.  Understanding how checkpoints are regulated is therefore important from the points of view of both tumorigenesis and cancer treatment.  In this review, we present an overview of the mol. hierarchy of the checkpoint signaling network and the emerging role of checkpoint targets, esp. checkpoint kinase 1, in cancer therapy.  Further, we discuss the results of recent clin. trials involving the nonspecific checkpoint kinase 1 inhibitor, UCN-01, and the challenges we face with this new therapeutic approach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqU0LSEvsvnJLVg90H21EOLACvtfcHk0lhtvENt8K3BwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjs12rsbs%253D&md5=9b8666c39ab028672501c655c34c4fb0</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-06-2793&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-06-2793%26sid%3Dliteratum%253Aachs%26aulast%3DTse%26aufirst%3DA.%2BN.%26aulast%3DCarvajal%26aufirst%3DR.%26aulast%3DScwartz%26aufirst%3DG.%2BK.%26atitle%3DTargeting%2520checkpoint%2520kinase%25201%2520in%2520cancer%2520therapeutics%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2007%26volume%3D13%26spage%3D1955%26epage%3D1960" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Lam, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, J. M.</span><span> </span><span class="NLM_article-title">Chk1 versus Cdc25: chking one's levels of cellular proliferation</span> <span class="citation_source-journal">Cell Cycle</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1355</span><span class="NLM_x">–</span> <span class="NLM_lpage">1357</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=1355-1357&author=M.+H.+Lamauthor=J.+M.+Rosen&title=Chk1+versus+Cdc25%3A+chking+one%27s+levels+of+cellular+proliferation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLam%26aufirst%3DM.%2BH.%26aulast%3DRosen%26aufirst%3DJ.%2BM.%26atitle%3DChk1%2520versus%2520Cdc25%253A%2520chking%2520one%2527s%2520levels%2520of%2520cellular%2520proliferation%26jtitle%3DCell%2520Cycle%26date%3D2004%26volume%3D3%26spage%3D1355%26epage%3D1357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Xiao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xue, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sowin, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span> </span><span class="NLM_article-title">Differential roles of checkpoint kinase 1, checkpoint kinase 2, and mitogen-activated protein kinase-activated protein kinase 2 in mediating DNA damage-induced cell cycle arrest: implications for cancer therapy</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1935</span><span class="NLM_x">–</span> <span class="NLM_lpage">1943</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm900314j&amp;key=10.1158%2F1535-7163.MCT-06-0077" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm900314j&amp;key=16928813" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm900314j&amp;key=1%3ACAS%3A528%3ADC%252BD28XosVans7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=1935-1943&author=Z.+Xiaoauthor=J.+Xueauthor=T.+J.+Sowinauthor=H.+Zhang&title=Differential+roles+of+checkpoint+kinase+1%2C+checkpoint+kinase+2%2C+and+mitogen-activated+protein+kinase-activated+protein+kinase+2+in+mediating+DNA+damage-induced+cell+cycle+arrest%3A+implications+for+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Differential roles of checkpoint kinase 1, checkpoint kinase 2, and mitogen-activated protein kinase-activated protein kinase 2 in mediating DNA damage-induced cell cycle arrest: implications for cancer therapy</span></div><div class="casAuthors">Xiao, Zhan; Xue, John; Sowin, Thomas J.; Zhang, Haiying</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1935-1943</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Mammalian cells initiate cell cycle arrest at different phases of the cell cycle in response to various forms of genotoxic stress to allow time for DNA repair, and thus preserving their genomic integrity.  The protein kinases checkpoint kinase 1 (Chk1), checkpoint kinase 2 (Chk2), and mitogen-activated protein kinase-activated protein kinase 2 (MK2) have all been shown to be involved in cell cycle checkpoint control.  Recently, cell cycle checkpoint abrogation has been proposed as one way to sensitize cancer cells to DNA-damaging agents due to the expected induction of mitotic catastrophe.  Due to their overlapping substrate spectra and redundant functions, it is still not clear which kinase is mainly responsible for the cell cycle arrests conferred by clin. relevant chemotherapeutics.  Thus, the issue remains about which kinase is the most therapeutically relevant target and, more importantly, whether multiple kinases might need to be targeted to achieve the best efficacy in light of recent studies showing superior efficacy for pan-receptor tyrosine kinase inhibitors.  To clarify this issue, we investigated the roles of the three kinases in response to different genotoxic stresses through small interfering RNA-mediated specific target knockdowns.  Our result showed that only the down-regulation of Chk1, but not of Chk2 or MK2, abrogated camptothecin- or 5-fluorouracil-induced S-phase arrest or doxorubicin-induced G2-phase arrest.  This was followed by mitotic catastrophe and apoptosis.  Moreover, double inhibition of Chk1 and Chk2 failed to achieve better efficacy than Chk1 inhibition alone; surprisingly, inhibition of MK2, in addn. to Chk1 suppression, partially reversed the checkpoint abrogation and negated mitotic catastrophe.  We further showed that this is due to the fact that in MK2-deficient cells, Cdc25A protein, which is critically required for the mitotic progression following checkpoint abrogation, becomes greatly depleted.  In summary, our findings show that Chk1 is the only relevant checkpoint kinase as a cancer drug target and inhibition of other checkpoint kinases in addn. to Chk1 would be nonproductive.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-Au13f9gHdLVg90H21EOLACvtfcHk0li0AusX-RTr7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XosVans7o%253D&md5=2144e703cacac5049bc937e35fca8713</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-06-0077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-06-0077%26sid%3Dliteratum%253Aachs%26aulast%3DXiao%26aufirst%3DZ.%26aulast%3DXue%26aufirst%3DJ.%26aulast%3DSowin%26aufirst%3DT.%2BJ.%26aulast%3DZhang%26aufirst%3DH.%26atitle%3DDifferential%2520roles%2520of%2520checkpoint%2520kinase%25201%252C%2520checkpoint%2520kinase%25202%252C%2520and%2520mitogen-activated%2520protein%2520kinase-activated%2520protein%2520kinase%25202%2520in%2520mediating%2520DNA%2520damage-induced%2520cell%2520cycle%2520arrest%253A%2520implications%2520for%2520cancer%2520therapy%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2006%26volume%3D5%26spage%3D1935%26epage%3D1943" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Ganzeinelli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrassa, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crippa, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tavecchio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broggini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damia, G.</span><span> </span><span class="NLM_article-title">Checkpoint kinase 1 down-regulation by an inducible small interfering RNA expression system sensitized in vivo tumours to treatment with 5-fluorouracil</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">5131</span><span class="NLM_x">–</span> <span class="NLM_lpage">5141</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm900314j&amp;key=10.1158%2F1078-0432.CCR-08-0304" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm900314j&amp;key=18698031" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=5131-5141&author=M.+Ganzeinelliauthor=L.+Carrassaauthor=F.+Crippaauthor=M.+Tavecchioauthor=M.+Brogginiauthor=G.+Damia&title=Checkpoint+kinase+1+down-regulation+by+an+inducible+small+interfering+RNA+expression+system+sensitized+in+vivo+tumours+to+treatment+with+5-fluorouracil"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-08-0304&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-08-0304%26sid%3Dliteratum%253Aachs%26aulast%3DGanzeinelli%26aufirst%3DM.%26aulast%3DCarrassa%26aufirst%3DL.%26aulast%3DCrippa%26aufirst%3DF.%26aulast%3DTavecchio%26aufirst%3DM.%26aulast%3DBroggini%26aufirst%3DM.%26aulast%3DDamia%26aufirst%3DG.%26atitle%3DCheckpoint%2520kinase%25201%2520down-regulation%2520by%2520an%2520inducible%2520small%2520interfering%2520RNA%2520expression%2520system%2520sensitized%2520in%2520vivo%2520tumours%2520to%2520treatment%2520with%25205-fluorouracil%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2008%26volume%3D14%26spage%3D5131%26epage%3D5141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Collins, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrett, M.</span><span> </span><span class="NLM_article-title">Inhibitors of the cell cycle</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">366</span><span class="NLM_x">–</span> <span class="NLM_lpage">373</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm900314j&amp;key=10.1016%2Fj.coph.2005.04.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm900314j&amp;key=15964238" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm900314j&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlvFKlsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=366-373&author=I.+Collinsauthor=M.+Garrett&title=Inhibitors+of+the+cell+cycle"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the cell division cycle in cancer: CDK and cell cycle checkpoint kinase inhibitors</span></div><div class="casAuthors">Collins, Ian; Garrett, Michelle D.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">366-373</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The cyclin-dependent kinase (CDK) family of serine/threonine kinases regulate progression through each stage of the cell division cycle and as such are major targets for deregulation in cancer.  This has led to the development of several small-mol. inhibitors of CDKs as potential therapeutic agents for the treatment of this disease.  Progression through the cell cycle is also monitored at several positions known as cell cycle checkpoints, 2 of which occur during G1 and G2 in response to DNA damage.  These are often defective in cancer, leading to the suggestion that inhibition of one or both of the cell cycle checkpoint kinases CHK1 and CHK2 may drive a cancer cell that already has defects in its cell cycle checkpoints towards death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlqcFxaO9gh7Vg90H21EOLACvtfcHk0li0AusX-RTr7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlvFKlsL0%253D&md5=40607fa37e866766581683b322829a13</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2005.04.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2005.04.009%26sid%3Dliteratum%253Aachs%26aulast%3DCollins%26aufirst%3DI.%26aulast%3DGarrett%26aufirst%3DM.%26atitle%3DInhibitors%2520of%2520the%2520cell%2520cycle%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2005%26volume%3D5%26spage%3D366%26epage%3D373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Tao, Z.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, N.-H.</span><span> </span><span class="NLM_article-title">Chk1 inhibitors for novel cancer treatment</span> <span class="citation_source-journal">Anticancer Agents Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">377</span><span class="NLM_x">–</span> <span class="NLM_lpage">388</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm900314j&amp;key=10.2174%2F187152006777698132" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm900314j&amp;key=16842237" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm900314j&amp;key=1%3ACAS%3A528%3ADC%252BD28Xms1WksLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=377-388&author=Z.-F.+Taoauthor=N.-H.+Lin&title=Chk1+inhibitors+for+novel+cancer+treatment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Chk1 inhibitors for novel cancer treatment</span></div><div class="casAuthors">Tao, Zhi-Fu; Lin, Nan-Horng</div><div class="citationInfo"><span class="NLM_cas:title">Anti-Cancer Agents in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">377-388</span>CODEN:
                <span class="NLM_cas:coden">AAMCE4</span>;
        ISSN:<span class="NLM_cas:issn">1871-5206</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Chemo- and radiotherapies that target DNA are the mainstay of cancer treatment.  In response to DNA damage, cells are arrested in multiple checkpoints in the cell cycle to allow the damaged DNA to be repaired before progressing into mitosis.  Normal cells are arrested in the G1 phase mediated by the p53 tumor suppressor, and p53-deficient cancer cells are arrested in the S or G2 phase.  Checkpoint kinase 1 (Chk 1) is a serine / threonine protein kinase and a key mediator in the DNA damage-induced checkpoint network.  When the G2 or S checkpoint is abrogated by the inhibition of Chk1, p53-deficient cancer cells undergo mitotic catastrophe and eventually apoptosis, whereas normal cells are still arrested in the G1 phase.  Thus, Chk1 inhibitors can preferentially potentiate the efficacy of DNA damaging agents in cancer cells, and Chk1 is an attractive therapeutic target for cancer treatment, esp. since approx. 50% of all human cancers are p53-deficient.  This review discusses the rationale of Chk1 as an anticancer target, the structural basis for designing Chk1 inhibitors, and recently disclosed Chk1 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqefhJeyP15drVg90H21EOLACvtfcHk0linCJN5ZvdwbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xms1WksLg%253D&md5=e6d5be5846832b30d0c8125d036d8aa8</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.2174%2F187152006777698132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187152006777698132%26sid%3Dliteratum%253Aachs%26aulast%3DTao%26aufirst%3DZ.-F.%26aulast%3DLin%26aufirst%3DN.-H.%26atitle%3DChk1%2520inhibitors%2520for%2520novel%2520cancer%2520treatment%26jtitle%3DAnticancer%2520Agents%2520Med.%2520Chem.%26date%3D2006%26volume%3D6%26spage%3D377%26epage%3D388" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Wang, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mantei, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kovar, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sham, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sowin, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, N.-H.</span><span> </span><span class="NLM_article-title">1-(5-Chloro-2-alkoxyphenyl)-3-(5-cyanopyrazin-2-yl)ureas as potent and selective inhibitors of Chk1 kinase: synthesis, preliminary SAR, and biological activities</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">31118</span><span class="NLM_x">–</span> <span class="NLM_lpage">3121</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=31118-3121&author=G.+T.+Wangauthor=G.+Liauthor=R.+A.+Manteiauthor=Z.+Chenauthor=P.+Kovarauthor=W.+Guauthor=Z.+Xiaoauthor=H.+Zhangauthor=H.+L.+Shamauthor=T.+Sowinauthor=S.+H.+Rosenbergauthor=N.-H.+Lin&title=1-%285-Chloro-2-alkoxyphenyl%29-3-%285-cyanopyrazin-2-yl%29ureas+as+potent+and+selective+inhibitors+of+Chk1+kinase%3A+synthesis%2C+preliminary+SAR%2C+and+biological+activities"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DG.%2BT.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DMantei%26aufirst%3DR.%2BA.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DKovar%26aufirst%3DP.%26aulast%3DGu%26aufirst%3DW.%26aulast%3DXiao%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DSham%26aufirst%3DH.%2BL.%26aulast%3DSowin%26aufirst%3DT.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DLin%26aufirst%3DN.-H.%26atitle%3D1-%25285-Chloro-2-alkoxyphenyl%2529-3-%25285-cyanopyrazin-2-yl%2529ureas%2520as%2520potent%2520and%2520selective%2520inhibitors%2520of%2520Chk1%2520kinase%253A%2520synthesis%252C%2520preliminary%2520SAR%252C%2520and%2520biological%2520activities%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D31118%26epage%3D3121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit15b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Tong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claiborne, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kovar, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Credo, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, W.-Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gwaltney, S. L.,  II</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Judge, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sham, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sowin, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, N.</span><span> </span><span class="NLM_article-title">Discovery of 1,4-dihydroindeno[1,2-<i>c</i>]pyrazoles as a novel class of potent and selective checkpoint kinase 1 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">2759</span><span class="NLM_x">–</span> <span class="NLM_lpage">2767</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15b&amp;dbid=16&amp;doi=10.1021%2Fjm900314j&amp;key=10.1016%2Fj.bmc.2007.01.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15b&amp;dbid=8&amp;doi=10.1021%2Fjm900314j&amp;key=17287122" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15b&amp;dbid=32&amp;doi=10.1021%2Fjm900314j&amp;key=1%3ACAS%3A528%3ADC%252BD2sXivVagt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2007&pages=2759-2767&author=Y.+Tongauthor=A.+Claiborneauthor=K.+D.+Stewartauthor=C.+Parkauthor=P.+Kovarauthor=Z.+Chenauthor=R.+B.+Credoauthor=W.-Z.+Guauthor=S.+L.+Gwaltneyauthor=R.+A.+Judgeauthor=H.+Zhangauthor=S.+H.+Rosenbergauthor=H.+L.+Shamauthor=T.+J.+Sowinauthor=N.+Lin&title=Discovery+of+1%2C4-dihydroindeno%5B1%2C2-c%5Dpyrazoles+as+a+novel+class+of+potent+and+selective+checkpoint+kinase+1+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15bR"><div class="casContent"><span class="casTitleNuber">15b</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 1,4-dihydroindeno[1,2-c]pyrazoles as a novel class of potent and selective checkpoint kinase 1 inhibitors</span></div><div class="casAuthors">Tong, Yunsong; Claiborne, Akiyo; Stewart, Kent D.; Park, Chang; Kovar, Peter; Chen, Zehan; Credo, Robert B.; Gu, Wen-Zhen; Gwaltney, Stephen L.; Judge, Russell A.; Zhang, Haiying; Rosenberg, Saul H.; Sham, Hing L.; Sowin, Thomas J.; Lin, Nan-horng</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2759-2767</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A new class of checkpoint kinase 1 (CHK-1) inhibitors bearing a 1,4-dihydroindeno[1,2-c]pyrazole core was developed after initial hits from high throughput screening.  The efficient hit-to-lead process was facilitated by X-ray crystallog. and led to potent inhibitors (<10 nM) against CHK-1.  X-ray co-crystal structures of bound inhibitors demonstrated that two sub-series of this class of compds., exemplified by 21 and 41, exhibit distinctive hydrogen bonding patterns in the specificity pocket of the active site.  Two compds., 41 and 43, were capable of potentiating doxorubicin and camptothecin, both DNA-damaging agents, in cell proliferation assays (MTS and soft agar assays) and abrogating G2/M checkpoint in a mechanism-based FACS assay.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVp7DNSZaexbVg90H21EOLACvtfcHk0linCJN5ZvdwbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXivVagt7w%253D&md5=0966753ebf59128001db7601ca7d8cee</span></div><a href="/servlet/linkout?suffix=cit15b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2007.01.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2007.01.012%26sid%3Dliteratum%253Aachs%26aulast%3DTong%26aufirst%3DY.%26aulast%3DClaiborne%26aufirst%3DA.%26aulast%3DStewart%26aufirst%3DK.%2BD.%26aulast%3DPark%26aufirst%3DC.%26aulast%3DKovar%26aufirst%3DP.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DCredo%26aufirst%3DR.%2BB.%26aulast%3DGu%26aufirst%3DW.-Z.%26aulast%3DGwaltney%26aufirst%3DS.%2BL.%26aulast%3DJudge%26aufirst%3DR.%2BA.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DSham%26aufirst%3DH.%2BL.%26aulast%3DSowin%26aufirst%3DT.%2BJ.%26aulast%3DLin%26aufirst%3DN.%26atitle%3DDiscovery%2520of%25201%252C4-dihydroindeno%255B1%252C2-c%255Dpyrazoles%2520as%2520a%2520novel%2520class%2520of%2520potent%2520and%2520selective%2520checkpoint%2520kinase%25201%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2007%26volume%3D15%26spage%3D2759%26epage%3D2767" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit15c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sullivan, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hexamer, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasvold, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Przytulinska, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tao, Z.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, W.-Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xue, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bui, M.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merta, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kovar, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouska, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sham, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sowin, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, N.-H.</span><span> </span><span class="NLM_article-title">Design, synthesis and biological activity of 5,10-dihydro-dibenzo[<i>b</i>,<i>e</i>][1,4]diazepin-11-one-based potent and selective Chk-1 inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">4162</span><span class="NLM_x">–</span> <span class="NLM_lpage">4176</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070105d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=4162-4176&author=L.+Wangauthor=G.+M.+Sullivanauthor=L.+A.+Hexamerauthor=R.+T.+Hasvoldauthor=M.+Przytulinskaauthor=Z.-F.+Taoauthor=G.+Liauthor=Z.+Chenauthor=Z.+Xiaoauthor=W.-Z.+Guauthor=J.+Xueauthor=M.-H.+Buiauthor=P.+Mertaauthor=P.+Kovarauthor=J.+J.+Bouskaauthor=H.+Zhangauthor=C.+Parkauthor=K.+D.+Stewartauthor=H.+L.+Shamauthor=T.+J.+Sowinauthor=S.+H.+Rosenbergauthor=N.-H.+Lin&title=Design%2C+synthesis+and+biological+activity+of+5%2C10-dihydro-dibenzo%5Bb%2Ce%5D%5B1%2C4%5Ddiazepin-11-one-based+potent+and+selective+Chk-1+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15c&amp;dbid=16384&amp;doi=10.1021%2Fjm070105d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070105d%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DL.%26aulast%3DSullivan%26aufirst%3DG.%2BM.%26aulast%3DHexamer%26aufirst%3DL.%2BA.%26aulast%3DHasvold%26aufirst%3DR.%2BT.%26aulast%3DPrzytulinska%26aufirst%3DM.%26aulast%3DTao%26aufirst%3DZ.-F.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DXiao%26aufirst%3DZ.%26aulast%3DGu%26aufirst%3DW.-Z.%26aulast%3DXue%26aufirst%3DJ.%26aulast%3DBui%26aufirst%3DM.-H.%26aulast%3DMerta%26aufirst%3DP.%26aulast%3DKovar%26aufirst%3DP.%26aulast%3DBouska%26aufirst%3DJ.%2BJ.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DPark%26aufirst%3DC.%26aulast%3DStewart%26aufirst%3DK.%2BD.%26aulast%3DSham%26aufirst%3DH.%2BL.%26aulast%3DSowin%26aufirst%3DT.%2BJ.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DLin%26aufirst%3DN.-H.%26atitle%3DDesign%252C%2520synthesis%2520and%2520biological%2520activity%2520of%25205%252C10-dihydro-dibenzo%255Bb%252Ce%255D%255B1%252C4%255Ddiazepin-11-one-based%2520potent%2520and%2520selective%2520Chk-1%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D4162%26epage%3D4176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Huang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garbaccio, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraley, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kreatsoulas, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartmann, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stirdivant, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drakas, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rickert, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamilton, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buser, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardwick, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrams, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beck, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lobell, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sepp-Lorenzino, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikuta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sardana, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munshi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reilly, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahan, E.</span><span> </span><span class="NLM_article-title">Development of 6-substituted indolylquinolinones as potent Chek1 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">5907</span><span class="NLM_x">–</span> <span class="NLM_lpage">5912</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=5907-5912&author=S.+Huangauthor=R.+M.+Garbaccioauthor=M.+E.+Fraleyauthor=J.+Steenauthor=C.+Kreatsoulasauthor=G.+Hartmannauthor=S.+Stirdivantauthor=B.+Drakasauthor=K.+Rickertauthor=E.+Walshauthor=K.+Hamiltonauthor=C.+A.+Buserauthor=J.+Hardwickauthor=X.+Maoauthor=M.+Abramsauthor=S.+Beckauthor=W.+Taoauthor=R.+Lobellauthor=L.+Sepp-Lorenzinoauthor=Y.+Yanauthor=M.+Ikutaauthor=J.+Z.+Murphyauthor=V.+Sardanaauthor=S.+Munshiauthor=L.+Kuoauthor=M.+Reillyauthor=E.+Mahan&title=Development+of+6-substituted+indolylquinolinones+as+potent+Chek1+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DS.%26aulast%3DGarbaccio%26aufirst%3DR.%2BM.%26aulast%3DFraley%26aufirst%3DM.%2BE.%26aulast%3DSteen%26aufirst%3DJ.%26aulast%3DKreatsoulas%26aufirst%3DC.%26aulast%3DHartmann%26aufirst%3DG.%26aulast%3DStirdivant%26aufirst%3DS.%26aulast%3DDrakas%26aufirst%3DB.%26aulast%3DRickert%26aufirst%3DK.%26aulast%3DWalsh%26aufirst%3DE.%26aulast%3DHamilton%26aufirst%3DK.%26aulast%3DBuser%26aufirst%3DC.%2BA.%26aulast%3DHardwick%26aufirst%3DJ.%26aulast%3DMao%26aufirst%3DX.%26aulast%3DAbrams%26aufirst%3DM.%26aulast%3DBeck%26aufirst%3DS.%26aulast%3DTao%26aufirst%3DW.%26aulast%3DLobell%26aufirst%3DR.%26aulast%3DSepp-Lorenzino%26aufirst%3DL.%26aulast%3DYan%26aufirst%3DY.%26aulast%3DIkuta%26aufirst%3DM.%26aulast%3DMurphy%26aufirst%3DJ.%2BZ.%26aulast%3DSardana%26aufirst%3DV.%26aulast%3DMunshi%26aufirst%3DS.%26aulast%3DKuo%26aufirst%3DL.%26aulast%3DReilly%26aufirst%3DM.%26aulast%3DMahan%26aufirst%3DE.%26atitle%3DDevelopment%2520of%25206-substituted%2520indolylquinolinones%2520as%2520potent%2520Chek1%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D5907%26epage%3D5912" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Fraley, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steen, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brnardic, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrington, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spencer, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanney, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stirdivant, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drakas, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rickert, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamilton, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buser, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardwick, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beck, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lobell, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sepp-Lorenzino, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikuta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munshi, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kreatsoulas, C.</span><span> </span><span class="NLM_article-title">3-(Indol-2-yl)indazoles as Chek1 kinase inhibitors: Optimization of potency and selectivity via substitution at C6</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">6049</span><span class="NLM_x">–</span> <span class="NLM_lpage">6053</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=6049-6053&author=M.+E.+Fraleyauthor=J.+T.+Steenauthor=E.+J.+Brnardicauthor=K.+L.+Arringtonauthor=K.+L.+Spencerauthor=B.+A.+Hanneyauthor=Y.+Kimauthor=G.+D.+Hartmanauthor=S.+M.+Stirdivantauthor=B.+A.+Drakasauthor=K.+Rickertauthor=E.+S.+Walshauthor=K.+Hamiltonauthor=C.+A.+Buserauthor=J.+Hardwickauthor=W.+Taoauthor=S.+C.+Beckauthor=X.+Maoauthor=R.+B.+Lobellauthor=L.+Sepp-Lorenzinoauthor=Y.+Yanauthor=M.+Ikutaauthor=S.+K.+Munshiauthor=L.+C.+Kuoauthor=C.+Kreatsoulas&title=3-%28Indol-2-yl%29indazoles+as+Chek1+kinase+inhibitors%3A+Optimization+of+potency+and+selectivity+via+substitution+at+C6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFraley%26aufirst%3DM.%2BE.%26aulast%3DSteen%26aufirst%3DJ.%2BT.%26aulast%3DBrnardic%26aufirst%3DE.%2BJ.%26aulast%3DArrington%26aufirst%3DK.%2BL.%26aulast%3DSpencer%26aufirst%3DK.%2BL.%26aulast%3DHanney%26aufirst%3DB.%2BA.%26aulast%3DKim%26aufirst%3DY.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26aulast%3DStirdivant%26aufirst%3DS.%2BM.%26aulast%3DDrakas%26aufirst%3DB.%2BA.%26aulast%3DRickert%26aufirst%3DK.%26aulast%3DWalsh%26aufirst%3DE.%2BS.%26aulast%3DHamilton%26aufirst%3DK.%26aulast%3DBuser%26aufirst%3DC.%2BA.%26aulast%3DHardwick%26aufirst%3DJ.%26aulast%3DTao%26aufirst%3DW.%26aulast%3DBeck%26aufirst%3DS.%2BC.%26aulast%3DMao%26aufirst%3DX.%26aulast%3DLobell%26aufirst%3DR.%2BB.%26aulast%3DSepp-Lorenzino%26aufirst%3DL.%26aulast%3DYan%26aufirst%3DY.%26aulast%3DIkuta%26aufirst%3DM.%26aulast%3DMunshi%26aufirst%3DS.%2BK.%26aulast%3DKuo%26aufirst%3DL.%2BC.%26aulast%3DKreatsoulas%26aufirst%3DC.%26atitle%3D3-%2528Indol-2-yl%2529indazoles%2520as%2520Chek1%2520kinase%2520inhibitors%253A%2520Optimization%2520of%2520potency%2520and%2520selectivity%2520via%2520substitution%2520at%2520C6%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D6049%26epage%3D6053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Teng, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kornmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blasina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Register, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderes, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ninkovic, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grant, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundgren, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kania, R. S.</span><span> </span><span class="NLM_article-title">Structure-based design and synthesis of (5-arylamino-2<i>H</i>-pyrazol-3-yl)-biphenyl-2′,4′-diols as novel and potent human CHK1 inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">5253</span><span class="NLM_x">–</span> <span class="NLM_lpage">5256</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0704604" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=5253-5256&author=M.+Tengauthor=J.+Zhuauthor=M.+D.+Johnsonauthor=P.+Chenauthor=J.+Kornmannauthor=E.+Chenauthor=A.+Blasinaauthor=J.+Registerauthor=K.+Anderesauthor=C.+Rogersauthor=Y.+Dengauthor=S.+Ninkovicauthor=S.+Grantauthor=Q.+Huauthor=K.+Lundgrenauthor=Z.+Pengauthor=R.+S.+Kania&title=Structure-based+design+and+synthesis+of+%285-arylamino-2H-pyrazol-3-yl%29-biphenyl-2%E2%80%B2%2C4%E2%80%B2-diols+as+novel+and+potent+human+CHK1+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm0704604&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0704604%26sid%3Dliteratum%253Aachs%26aulast%3DTeng%26aufirst%3DM.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DJohnson%26aufirst%3DM.%2BD.%26aulast%3DChen%26aufirst%3DP.%26aulast%3DKornmann%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DE.%26aulast%3DBlasina%26aufirst%3DA.%26aulast%3DRegister%26aufirst%3DJ.%26aulast%3DAnderes%26aufirst%3DK.%26aulast%3DRogers%26aufirst%3DC.%26aulast%3DDeng%26aufirst%3DY.%26aulast%3DNinkovic%26aufirst%3DS.%26aulast%3DGrant%26aufirst%3DS.%26aulast%3DHu%26aufirst%3DQ.%26aulast%3DLundgren%26aufirst%3DK.%26aulast%3DPeng%26aufirst%3DZ.%26aulast%3DKania%26aufirst%3DR.%2BS.%26atitle%3DStructure-based%2520design%2520and%2520synthesis%2520of%2520%25285-arylamino-2H-pyrazol-3-yl%2529-biphenyl-2%25E2%2580%25B2%252C4%25E2%2580%25B2-diols%2520as%2520novel%2520and%2520potent%2520human%2520CHK1%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D5253%26epage%3D5256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Tse, A.; Rendahl, K. G.; Sheikh, T.; Cheema, H.; Aardalen, K.; Embry, M.; Ma, S.; Moler, E. J.; Nie, Z. J.; Lopas de Menezes, D. E.; Hibner, B.; Gesner, T. G.; Schwartz, G. K.</span><span> </span><span class="NLM_article-title">CHIR-124, a novel potent inhibitor of Chk1, potentiates the cytotoxicity of topoisomerase 1 poisons in vitro and in vivo</span>. Clin. Cancer Res.<span class="NLM_x"> </span><span class="NLM_year">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">591</span>− <span class="NLM_lpage">602</span>. </span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&pages=591-602&author=A.+Tse&author=K.+G.+Rendahl&author=T.+Sheikh&author=H.+Cheema&author=K.+Aardalen&author=M.+Embry&author=S.+Ma&author=E.+J.+Moler&author=Z.+J.+Nie&author=D.+E.+Lopas+de+Menezes&author=B.+Hibner&author=T.+G.+Gesner&author=G.+K.+Schwartz&title=CHIR-124%2C+a+novel+potent+inhibitor+of+Chk1%2C+potentiates+the+cytotoxicity+of+topoisomerase+1+poisons+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DTse%26aufirst%3DA.%26atitle%3DCHIR-124%252C%2520a%2520novel%2520potent%2520inhibitor%2520of%2520Chk1%252C%2520potentiates%2520the%2520cytotoxicity%2520of%2520topoisomerase%25201%2520poisons%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2007%26volume%3D13%26spage%3D591%26epage%3D602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Blasina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arango, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraynov, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Register, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gant, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ninkovic, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nichols, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderes, K.</span><span> </span><span class="NLM_article-title">Breaching the DNA damage checkpoint with PF-00477736, a novel small-molecule inhibitor of checkpoint kinase 1</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">2394</span><span class="NLM_x">–</span> <span class="NLM_lpage">2404</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm900314j&amp;key=10.1158%2F1535-7163.MCT-07-2391" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm900314j&amp;key=18723486" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm900314j&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVWksL%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=2394-2404&author=A.+Blasinaauthor=J.+Hallinauthor=E.+Chenauthor=M.+E.+Arangoauthor=E.+Kraynovauthor=J.+Registerauthor=S.+Gantauthor=S.+Ninkovicauthor=P.+Chenauthor=T.+Nicholsauthor=P.+O%E2%80%99Connorauthor=K.+Anderes&title=Breaching+the+DNA+damage+checkpoint+with+PF-00477736%2C+a+novel+small-molecule+inhibitor+of+checkpoint+kinase+1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Breaching the DNA damage checkpoint via PF-00477736, a novel small-molecule inhibitor of checkpoint kinase 1</span></div><div class="casAuthors">Blasina, Alessandra; Hallin, Jill; Chen, Enhong; Arango, Maria Elena; Kraynov, Eugenia; Register, James; Grant, Stephan; Ninkovic, Sacha; Chen, Ping; Nichols, Tim; O'Connor, Patrick; Anderes, Kenna</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2394-2404</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Checkpoints are present in all phases of the cell cycle and are regarded as the gatekeepers maintaining the integrity of the genome.  Many conventional agents used to treat cancer impart damage to the genome and activate cell cycle checkpoints.  Many tumors are defective in the tumor suppressor p53 and therefore lack a functional G1 checkpoint.  In these tumors, however, the S-G2 checkpoints remain intact and, in response to DNA damage, arrest cell cycle progression allowing time for DNA repair.  Checkpoint kinase 1 (Chk1) is a key element in the DNA damage response pathway and plays a crucial role in the S-G2-phase checkpoints.  Inhibiting Chk1 represents a therapeutic strategy for creating a "synthetic lethal" response by overriding the last checkpoint defense of tumor cells against the lethal damage induced by DNA-directed chemotherapeutic agents.  Chk1 inhibition is consistent with emerging targeted therapies aiming to exploit mol. differences between normal and cancer cells.  Adding a Chk1 inhibitor to DNA-damaging cytotoxic therapy selectively targets tumors with intrinsic checkpoint defects while minimizing toxicity in checkpoint-competent normal cells.  PF-00477736 was identified as a potent, selective ATP-competitive small-mol. inhibitor that inhibits Chk1 with a Ki of 0.49 nM.  PF-00477736 abrogates cell cycle arrest induced by DNA damage and enhances cytotoxicity of clin. important chemotherapeutic agents, including gemcitabine and carboplatin.  In xenografts, PF-00477736 enhanced the antitumor activity of gemcitabine in a dose-dependent manner.  PF-00477736 combinations were well tolerated with no exacerbation of side effects commonly assocd. with cytotoxic agents. [Mol Cancer Ther 2008;7(8):2394-404].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCAlkcnouhLrVg90H21EOLACvtfcHk0lgUsQbFjRKaNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVWksL%252FP&md5=fc3f9cf9121c207c6fa284b2090ed1c3</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-07-2391&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-07-2391%26sid%3Dliteratum%253Aachs%26aulast%3DBlasina%26aufirst%3DA.%26aulast%3DHallin%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DE.%26aulast%3DArango%26aufirst%3DM.%2BE.%26aulast%3DKraynov%26aufirst%3DE.%26aulast%3DRegister%26aufirst%3DJ.%26aulast%3DGant%26aufirst%3DS.%26aulast%3DNinkovic%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DP.%26aulast%3DNichols%26aufirst%3DT.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DP.%26aulast%3DAnderes%26aufirst%3DK.%26atitle%3DBreaching%2520the%2520DNA%2520damage%2520checkpoint%2520with%2520PF-00477736%252C%2520a%2520novel%2520small-molecule%2520inhibitor%2520of%2520checkpoint%2520kinase%25201%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2008%26volume%3D7%26spage%3D2394%26epage%3D2404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Zabludoff, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grondine, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheehy, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashwell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caleb, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haye, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horn, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janetka, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mouchet, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ready, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenthal, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Queva, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tse, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, A. M.</span><span> </span><span class="NLM_article-title">AZD7762, a novel checkpoint kinase inhibitor, drives checkpoint abrogation and potentiates DNA-targeted therapies</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">2955</span><span class="NLM_x">–</span> <span class="NLM_lpage">2966</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm900314j&amp;key=10.1158%2F1535-7163.MCT-08-0492" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm900314j&amp;key=18790776" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm900314j&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFSmsL7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=2955-2966&author=S.+D.+Zabludoffauthor=C.+Dengauthor=M.+R.+Grondineauthor=A.+M.+Sheehyauthor=S.+Ashwellauthor=B.+L.+Calebauthor=S.+Greenauthor=H.+R.+Hayeauthor=C.+L.+Hornauthor=J.+W.+Janetkaauthor=D.+Liuauthor=E.+Mouchetauthor=S.+Readyauthor=J.+L.+Rosenthalauthor=C.+Quevaauthor=G.+K.+Schwartzauthor=K.+J.+Taylorauthor=A.+N.+Tseauthor=G.+E.+Walkerauthor=A.+M.+White&title=AZD7762%2C+a+novel+checkpoint+kinase+inhibitor%2C+drives+checkpoint+abrogation+and+potentiates+DNA-targeted+therapies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">AZD7762, a novel checkpoint kinase inhibitor, drives checkpoint abrogation and potentiates DNA-targeted therapies</span></div><div class="casAuthors">Zabludoff, Sonya D.; Deng, Chun; Grondine, Michael R.; Sheehy, Adam M.; Ashwell, Susan; Caleb, Benjamin L.; Green, Stephen; Haye, Heather R.; Horn, Candice L.; Janetka, James W.; Liu, Dongfang; Mouchet, Elizabeth; Ready, Shannon; Rosenthal, Judith L.; Queva, Christophe; Schwartz, Gary K.; Taylor, Karen J.; Tse, Archie N.; Walker, Graeme E.; White, Anne M.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2955-2966</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Insights from cell cycle research have led to the hypothesis that tumors may be selectively sensitized to DNA-damaging agents resulting in improved antitumor activity and a wider therapeutic margin.  The theory relies on the observation that the majority of tumors are deficient in the G1-DNA damage checkpoint pathway resulting in reliance on S and G2 checkpoints for DNA repair and cell survival.  The S and G2 checkpoints are regulated by checkpoint kinase 1, a serine/threonine kinase that is activated in response to DNA damage; thus, inhibition of checkpoint kinase 1 signaling impairs DNA repair and increases tumor cell death.  Normal tissues, however, have a functioning G1 checkpoint signaling pathway allowing for DNA repair and cell survival.  Here, we describe the preclin. profile of AZD7762, a potent ATP-competitive checkpoint kinase inhibitor in clin. trials.  AZD7762 has been profiled extensively in vitro and in vivo in combination with DNA-damaging agents and has been shown to potentiate response in several different settings where inhibition of checkpoint kinase results in the abrogation of DNA damage-induced cell cycle arrest.  Dose-dependent potentiation of antitumor activity, when AZD7762 is administered in combination with DNA-damaging agents, has been obsd. in multiple xenograft models with several DNA-damaging agents, further supporting the potential of checkpoint kinase inhibitors to enhance the efficacy of both conventional chemotherapy and radiotherapy and increase patient response rates in a variety of settings. [Mol Cancer Ther 2008;7(9):2955-66].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTXvjs3OaUFrVg90H21EOLACvtfcHk0lirvEAZv32OBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFSmsL7O&md5=b33ff697c6592c9823e85c9bb265c02d</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-08-0492&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-08-0492%26sid%3Dliteratum%253Aachs%26aulast%3DZabludoff%26aufirst%3DS.%2BD.%26aulast%3DDeng%26aufirst%3DC.%26aulast%3DGrondine%26aufirst%3DM.%2BR.%26aulast%3DSheehy%26aufirst%3DA.%2BM.%26aulast%3DAshwell%26aufirst%3DS.%26aulast%3DCaleb%26aufirst%3DB.%2BL.%26aulast%3DGreen%26aufirst%3DS.%26aulast%3DHaye%26aufirst%3DH.%2BR.%26aulast%3DHorn%26aufirst%3DC.%2BL.%26aulast%3DJanetka%26aufirst%3DJ.%2BW.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DMouchet%26aufirst%3DE.%26aulast%3DReady%26aufirst%3DS.%26aulast%3DRosenthal%26aufirst%3DJ.%2BL.%26aulast%3DQueva%26aufirst%3DC.%26aulast%3DSchwartz%26aufirst%3DG.%2BK.%26aulast%3DTaylor%26aufirst%3DK.%2BJ.%26aulast%3DTse%26aufirst%3DA.%2BN.%26aulast%3DWalker%26aufirst%3DG.%2BE.%26aulast%3DWhite%26aufirst%3DA.%2BM.%26atitle%3DAZD7762%252C%2520a%2520novel%2520checkpoint%2520kinase%2520inhibitor%252C%2520drives%2520checkpoint%2520abrogation%2520and%2520potentiates%2520DNA-targeted%2520therapies%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2008%26volume%3D7%26spage%3D2955%26epage%3D2966" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Ashwell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zabludoff, S.</span><span> </span><span class="NLM_article-title">DNA damage detection and repair pathways−recent advances with inhibitors of checkpoint kinases in cancer therapy</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">4032</span><span class="NLM_x">–</span> <span class="NLM_lpage">4037</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm900314j&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnvFylur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=4032-4037&author=S.+Ashwellauthor=S.+Zabludoff&title=DNA+damage+detection+and+repair+pathways%E2%88%92recent+advances+with+inhibitors+of+checkpoint+kinases+in+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">DNA Damage Detection and Repair Pathways-Recent Advances with Inhibitors of Checkpoint Kinases in Cancer Therapy</span></div><div class="casAuthors">Ashwell, Susan; Zabludoff, Sonya</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4032-4037</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Insights from cell cycle research have led to the hypothesis that tumors may be selectivity sensitized to DNA-damaging agents, resulting in improved antitumor activity and a wider therapeutic margin.  The theory relies primarily on the observation that the majority of tumors are deficient in the G1-DNA damage checkpoint pathway, resulting in reliance on S and G2 phase checkpoints for DNA repair and cell survival.  The S and G2 phase checkpoints are predominantly regulated by checkpoint kinase 1; thus, inhibition of checkpoint kinase 1 signaling impairs DNA repair and increases tumor cell death.  Normal tissues, however, have a functioning G1 checkpoint signaling pathway that allows for DNA repair and cell survival.  There is now a large body of preclin. evidence showing that checkpoint kinase inhibitors do indeed enhance the efficacy of both conventional chemotherapy and radiotherapy, and several agents have recently entered clin. trials.  Excitingly, addnl. therapeutic opportunities for checkpoint kinase inhibitors continue to emerge as biol. outside their pivotal role in cell cycle arrest is further elucidated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9wY3TzSvx77Vg90H21EOLACvtfcHk0lirvEAZv32OBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnvFylur4%253D&md5=0de4c1639ae26f12e3efaa82a08bfeec</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAshwell%26aufirst%3DS.%26aulast%3DZabludoff%26aufirst%3DS.%26atitle%3DDNA%2520damage%2520detection%2520and%2520repair%2520pathways%25E2%2588%2592recent%2520advances%2520with%2520inhibitors%2520of%2520checkpoint%2520kinases%2520in%2520cancer%2520therapy%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2008%26volume%3D14%26spage%3D4032%26epage%3D4037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Janetka, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashwell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zabludoff, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyne, P.</span><span> </span><span class="NLM_article-title">Inhibitors of checkpoint kinases: from discovery to the clinic</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">473</span><span class="NLM_x">–</span> <span class="NLM_lpage">486</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2007&pages=473-486&author=J.+W.+Janetkaauthor=S.+Ashwellauthor=S.+Zabludoffauthor=P.+Lyne&title=Inhibitors+of+checkpoint+kinases%3A+from+discovery+to+the+clinic"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJanetka%26aufirst%3DJ.%2BW.%26aulast%3DAshwell%26aufirst%3DS.%26aulast%3DZabludoff%26aufirst%3DS.%26aulast%3DLyne%26aufirst%3DP.%26atitle%3DInhibitors%2520of%2520checkpoint%2520kinases%253A%2520from%2520discovery%2520to%2520the%2520clinic%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2007%26volume%3D10%26spage%3D473%26epage%3D486" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Prudhomme, M.</span><span> </span><span class="NLM_article-title">Novel CHK1 inhibitors</span> <span class="citation_source-journal">Recent Pat. Anti-Cancer Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">55</span><span class="NLM_x">–</span> <span class="NLM_lpage">68</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2006&pages=55-68&author=M.+Prudhomme&title=Novel+CHK1+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPrudhomme%26aufirst%3DM.%26atitle%3DNovel%2520CHK1%2520inhibitors%26jtitle%3DRecent%2520Pat.%2520Anti-Cancer%2520Drug%2520Discovery%26date%3D2006%26volume%3D1%26spage%3D55%26epage%3D68" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Hénon, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conchon, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hugon, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Messaoudi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golsteyn, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prudhomme, M.</span><span> </span><span class="NLM_article-title">Pyrrolocarbazoles as checkpoint 1 kinase inhibitors</span> <span class="citation_source-journal">Anticancer Agents Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">577</span><span class="NLM_x">–</span> <span class="NLM_lpage">597</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm900314j&amp;key=18690823" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm900314j&amp;key=1%3ACAS%3A528%3ADC%252BD1cXps1Ohu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=577-597&author=H.+H%C3%A9nonauthor=E.+Conchonauthor=B.+Hugonauthor=S.+Messaoudiauthor=R.+M.+Golsteynauthor=M.+Prudhomme&title=Pyrrolocarbazoles+as+checkpoint+1+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Pyrrolocarbazoles as checkpoint 1 kinase inhibitors</span></div><div class="casAuthors">Henon, Helene; Conchon, Elisabeth; Hugon, Bernadette; Messaoudi, Samir; Golsteyn, Roy M.; Prudhomme, Michelle</div><div class="citationInfo"><span class="NLM_cas:title">Anti-Cancer Agents in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">577-597</span>CODEN:
                <span class="NLM_cas:coden">AAMCE4</span>;
        ISSN:<span class="NLM_cas:issn">1871-5206</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The carbazole framework is found in many natural compds. of biol. interest.  Indolocarbazoles such as rebeccamycin and staurosporine which are either a topoisomerase I inhibitor (rebeccamycin) or a non selective kinase inhibitor (staurosporine) are bacterial metabolites.  In the search for new antitumor agents, DNA damage checkpoint kinases, in particular Checkpoint kinase 1, have recently emerged as attractive targets for cancer therapy.  This review reports the synthesis and Chk1 inhibitory activities of pyrrolocarbazole compds. bearing four or five fused rings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZ1k6BiMZs7LVg90H21EOLACvtfcHk0lirvEAZv32OBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXps1Ohu7Y%253D&md5=e3bed62fe3f1ef68537ea202184090df</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DH%25C3%25A9non%26aufirst%3DH.%26aulast%3DConchon%26aufirst%3DE.%26aulast%3DHugon%26aufirst%3DB.%26aulast%3DMessaoudi%26aufirst%3DS.%26aulast%3DGolsteyn%26aufirst%3DR.%2BM.%26aulast%3DPrudhomme%26aufirst%3DM.%26atitle%3DPyrrolocarbazoles%2520as%2520checkpoint%25201%2520kinase%2520inhibitors%26jtitle%3DAnticancer%2520Agents%2520Med.%2520Chem.%26date%3D2008%26volume%3D8%26spage%3D577%26epage%3D597" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Lyne, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenny, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosgrove, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zabludoff, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wendeloski, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashwell, S.</span><span> </span><span class="NLM_article-title">Identification of compounds with nanomolar binding affinity for checkpoint kinase-1 using knowledge-based virtual screening</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">1962</span><span class="NLM_x">–</span> <span class="NLM_lpage">1968</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm030504i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1962-1968&author=P.+D.+Lyneauthor=P.+W.+Kennyauthor=D.+A.+Cosgroveauthor=C.+Dengauthor=S.+Zabludoffauthor=J.+J.+Wendeloskiauthor=S.+Ashwell&title=Identification+of+compounds+with+nanomolar+binding+affinity+for+checkpoint+kinase-1+using+knowledge-based+virtual+screening"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm030504i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030504i%26sid%3Dliteratum%253Aachs%26aulast%3DLyne%26aufirst%3DP.%2BD.%26aulast%3DKenny%26aufirst%3DP.%2BW.%26aulast%3DCosgrove%26aufirst%3DD.%2BA.%26aulast%3DDeng%26aufirst%3DC.%26aulast%3DZabludoff%26aufirst%3DS.%26aulast%3DWendeloski%26aufirst%3DJ.%2BJ.%26aulast%3DAshwell%26aufirst%3DS.%26atitle%3DIdentification%2520of%2520compounds%2520with%2520nanomolar%2520binding%2520affinity%2520for%2520checkpoint%2520kinase-1%2520using%2520knowledge-based%2520virtual%2520screening%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D1962%26epage%3D1968" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Foloppe, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, L .M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howes, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, A. G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surgenor, A. E.</span><span> </span><span class="NLM_article-title">Identification of chemically diverse Chk1 inhibitors by receptor-based virtual screening</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">4792</span><span class="NLM_x">–</span> <span class="NLM_lpage">4802</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=4792-4802&author=N.+Foloppeauthor=L+.M.+Fisherauthor=R.+Howesauthor=A.+Potterauthor=A.+G.+S.+Robertsonauthor=A.+E.+Surgenor&title=Identification+of+chemically+diverse+Chk1+inhibitors+by+receptor-based+virtual+screening"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFoloppe%26aufirst%3DN.%26aulast%3DFisher%26aufirst%3DL%2B.M.%26aulast%3DHowes%26aufirst%3DR.%26aulast%3DPotter%26aufirst%3DA.%26aulast%3DRobertson%26aufirst%3DA.%2BG.%2BS.%26aulast%3DSurgenor%26aufirst%3DA.%2BE.%26atitle%3DIdentification%2520of%2520chemically%2520diverse%2520Chk1%2520inhibitors%2520by%2520receptor-based%2520virtual%2520screening%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26spage%3D4792%26epage%3D4802" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Chen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Register, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Margosiak, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tempczyk-Russell, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myers, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundgren, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kan, C.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, P. M.</span><span> </span><span class="NLM_article-title">The 1.7 A crystal structure of human cell cycle checkpoint kinase Chk1: implications for Chk1 regulation</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">681</span><span class="NLM_x">–</span> <span class="NLM_lpage">692</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2000&pages=681-692&author=P.+Chenauthor=C.+Luoauthor=Y.+Dengauthor=K.+Ryanauthor=J.+Registerauthor=S.+Margosiakauthor=A.+Tempczyk-Russellauthor=B.+Nguyenauthor=P.+Myersauthor=K.+Lundgrenauthor=C.-C.+Kanauthor=P.+M.+O%E2%80%99Connor&title=The+1.7+A+crystal+structure+of+human+cell+cycle+checkpoint+kinase+Chk1%3A+implications+for+Chk1+regulation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DP.%26aulast%3DLuo%26aufirst%3DC.%26aulast%3DDeng%26aufirst%3DY.%26aulast%3DRyan%26aufirst%3DK.%26aulast%3DRegister%26aufirst%3DJ.%26aulast%3DMargosiak%26aufirst%3DS.%26aulast%3DTempczyk-Russell%26aufirst%3DA.%26aulast%3DNguyen%26aufirst%3DB.%26aulast%3DMyers%26aufirst%3DP.%26aulast%3DLundgren%26aufirst%3DK.%26aulast%3DKan%26aufirst%3DC.-C.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DP.%2BM.%26atitle%3DThe%25201.7%2520A%2520crystal%2520structure%2520of%2520human%2520cell%2520cycle%2520checkpoint%2520kinase%2520Chk1%253A%2520implications%2520for%2520Chk1%2520regulation%26jtitle%3DCell%26date%3D2000%26volume%3D100%26spage%3D681%26epage%3D692" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Jhoti, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cleasby, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verdonk, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, G.</span><span> </span><span class="NLM_article-title">Fragment-based screening using X-ray crystallography and NMR spectroscopy</span> <span class="citation_source-journal">Curr. Opin. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">485</span><span class="NLM_x">–</span> <span class="NLM_lpage">493</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm900314j&amp;key=10.1016%2Fj.cbpa.2007.07.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm900314j&amp;key=17851109" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm900314j&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtF2rsb3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2007&pages=485-493&author=H.+Jhotiauthor=A.+Cleasbyauthor=M.+Verdonkauthor=G.+Williams&title=Fragment-based+screening+using+X-ray+crystallography+and+NMR+spectroscopy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-based screening using X-ray crystallography and NMR spectroscopy</span></div><div class="casAuthors">Jhoti, Harren; Cleasby, Anne; Verdonk, Marcel; Williams, Glyn</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Chemical Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">485-493</span>CODEN:
                <span class="NLM_cas:coden">COCBF4</span>;
        ISSN:<span class="NLM_cas:issn">1367-5931</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Approaches which start from a study of the interaction of very simple mols. (fragments) with the protein target are proving to be valuable addns. to drug design.  Fragment-based screening allows the complementarity between a protein active site and drug-like mols. to be rapidly and effectively explored, using structural methods.  Recent improvements in the intensities of lab. x-ray sources permits the collection of greater amts. of high-quality diffraction data and were matched by developments in automation, crystn. and data anal.  Developments in NMR screening, including the use of cryogenically cooled NMR probes and 19F-contg. reporter mols. have expanded the scope of this technique, while increasing the availability of binding site and quant. affinity data for the fragments.  Application of these methods has led to a greater knowledge of the chem. variety, structural features and energetics of protein-fragment interactions.  While fragment-based screening has already been shown to reduce the timescales of the drug discovery process, a more detailed characterization of fragment screening hits can reveal unexpected similarities between fragment chemotypes and protein active sites leading to improved understanding of the pharmacophores and the re-use of this information against other protein targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFTfwnJaPUpLVg90H21EOLACvtfcHk0ljalBFdQMkYlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtF2rsb3E&md5=5a4e431308fe3a8d435cea55960dc663</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.cbpa.2007.07.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbpa.2007.07.010%26sid%3Dliteratum%253Aachs%26aulast%3DJhoti%26aufirst%3DH.%26aulast%3DCleasby%26aufirst%3DA.%26aulast%3DVerdonk%26aufirst%3DM.%26aulast%3DWilliams%26aufirst%3DG.%26atitle%3DFragment-based%2520screening%2520using%2520X-ray%2520crystallography%2520and%2520NMR%2520spectroscopy%26jtitle%3DCurr.%2520Opin.%2520Chem.%2520Biol.%26date%3D2007%26volume%3D11%26spage%3D485%26epage%3D493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Hopkins, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groom, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alex, A.</span><span> </span><span class="NLM_article-title">Ligand efficiency: a useful metric for lead selection</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">430</span><span class="NLM_x">–</span> <span class="NLM_lpage">431</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm900314j&amp;key=10.1016%2FS1359-6446%2804%2903069-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm900314j&amp;key=15109945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm900314j&amp;key=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=430-431&author=A.+L.+Hopkinsauthor=C.+R.+Groomauthor=A.+Alex&title=Ligand+efficiency%3A+a+useful+metric+for+lead+selection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand efficiency: a useful metric for lead selection</span></div><div class="casAuthors">Hopkins Andrew L; Groom Colin R; Alex Alexander</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">430-1</span>
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSdMyKW_d6RPeIHSmpohpd0fW6udTcc2eZWQ1DYGhgQKLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D&md5=eb19a1bca53247d0bd9adcb99d5817e6</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2804%2903069-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252804%252903069-7%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26aulast%3DGroom%26aufirst%3DC.%2BR.%26aulast%3DAlex%26aufirst%3DA.%26atitle%3DLigand%2520efficiency%253A%2520a%2520useful%2520metric%2520for%2520lead%2520selection%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2004%26volume%3D9%26spage%3D430%26epage%3D431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Card, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blasdel, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">England, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillette, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fong, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ibrahim, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Artis, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bollag, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milburn, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlessinger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, K. Y.</span><span> </span><span class="NLM_article-title">A family of phosphodiesterase inhibitors discovered by cocrystallography and scaffold-based drug design</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">184</span><span class="NLM_x">–</span> <span class="NLM_lpage">186</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2005&pages=184-186&author=G.+L.+Cardauthor=L.+Blasdelauthor=B.+P.+Englandauthor=C.+Zhangauthor=Y.+Suzukiauthor=S.+Gilletteauthor=D.+Fongauthor=P.+N.+Ibrahimauthor=D.+R.+Artisauthor=G.+Bollagauthor=M.+V.+Milburnauthor=S.+H.+Kimauthor=J.+Schlessingerauthor=K.+Y.+Zhang&title=A+family+of+phosphodiesterase+inhibitors+discovered+by+cocrystallography+and+scaffold-based+drug+design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCard%26aufirst%3DG.%2BL.%26aulast%3DBlasdel%26aufirst%3DL.%26aulast%3DEngland%26aufirst%3DB.%2BP.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DSuzuki%26aufirst%3DY.%26aulast%3DGillette%26aufirst%3DS.%26aulast%3DFong%26aufirst%3DD.%26aulast%3DIbrahim%26aufirst%3DP.%2BN.%26aulast%3DArtis%26aufirst%3DD.%2BR.%26aulast%3DBollag%26aufirst%3DG.%26aulast%3DMilburn%26aufirst%3DM.%2BV.%26aulast%3DKim%26aufirst%3DS.%2BH.%26aulast%3DSchlessinger%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DK.%2BY.%26atitle%3DA%2520family%2520of%2520phosphodiesterase%2520inhibitors%2520discovered%2520by%2520cocrystallography%2520and%2520scaffold-based%2520drug%2520design%26jtitle%3DNat.%2520Biotechnol.%26date%3D2005%26volume%3D23%26spage%3D184%26epage%3D186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Collins, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span> </span><span class="NLM_article-title">New approaches to molecular cancer therapeutics</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">689</span><span class="NLM_x">–</span> <span class="NLM_lpage">700</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm900314j&amp;key=10.1038%2Fnchembio840" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm900314j&amp;key=17108987" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm900314j&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1SrtLfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2006&pages=689-700&author=I.+Collinsauthor=P.+Workman&title=New+approaches+to+molecular+cancer+therapeutics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">New approaches to molecular cancer therapeutics</span></div><div class="casAuthors">Collins, Ian; Workman, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">689-700</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Cancer drug development is leading the way in exploiting mol. biol. and genetic information to develop 'personalized' medicine.  The new paradigm is to develop agents that target the precise mol. pathol. driving the progression of individual cancers.  Drug developers have benefited from decades of academic cancer research and from investment in genomics, genetics and automation; their success is exemplified by high-profile drugs such as Herceptin (trastuzumab), Gleevec (imatinib), Tarceva (erlotinib) and Avastin (bevacizumab).  However, only 5% of cancer drugs entering clin. trials reach marketing approval.  Cancer remains a high unmet medical need, and many potential cancer targets remain undrugged.  In this review we assess the status of the discovery and development of small-mol. cancer therapeutics.  We show how chem. biol. approaches offer techniques for interconnecting elements of the traditional linear progression from gene to drug, thereby providing a basis for increasing speed and success in cancer drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvuRrpAAZbbLVg90H21EOLACvtfcHk0ljXM2ecFkycPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1SrtLfP&md5=f784ada9031f4f7508c5c58fa040de5b</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1038%2Fnchembio840&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio840%26sid%3Dliteratum%253Aachs%26aulast%3DCollins%26aufirst%3DI.%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DNew%2520approaches%2520to%2520molecular%2520cancer%2520therapeutics%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2006%26volume%3D2%26spage%3D689%26epage%3D700" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span>Chemical Computing Group; <a href="http://www.chemcomp.com" class="extLink">http://www.chemcomp.com</a>. Accessed on 24 June 2009.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Chemical+Computing+Group%3B+http%3A%2F%2Fwww.chemcomp.com.+Accessed+on+24+June+2009."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Computing%2520Group" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Von Leoprechting, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumpf, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menzel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reulle, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griebel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valler, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Büttner, F. H.</span><span> </span><span class="NLM_article-title">Miniaturization and validation of a high-throughput serine kinase assay using the AlphaScreen platform</span> <span class="citation_source-journal">J. Biomol. Screen.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">719</span><span class="NLM_x">–</span> <span class="NLM_lpage">725</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm900314j&amp;key=10.1177%2F1087057104268805" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm900314j&amp;key=15634799" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm900314j&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmsFOisg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=719-725&author=A.+Von+Leoprechtingauthor=R.+Kumpfauthor=S.+Menzelauthor=D.+Reulleauthor=R.+Griebelauthor=M.+J.+Vallerauthor=F.+H.+B%C3%BCttner&title=Miniaturization+and+validation+of+a+high-throughput+serine+kinase+assay+using+the+AlphaScreen+platform"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Miniaturization and validation of a high-throughput serine kinase assay using the AlphaScreen platform</span></div><div class="casAuthors">von Leoprechting, Achim; Kumpf, Renate; Menzel, Susanne; Reulle, Dominique; Griebel, Ralf; Valler, Martin J.; Buttner, Frank H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular Screening</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">719-725</span>CODEN:
                <span class="NLM_cas:coden">JBISF3</span>;
        ISSN:<span class="NLM_cas:issn">1087-0571</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">Reducing costs while maintaining the highest readout quality is a precept of modern high-throughput screening.  Given the trend toward nonradiometric screening platforms, this has been a big challenge for some kinase target classes.  Common issues include low sensitivity, susceptibility to nonspecific interference, or the need for costly reagents.  In this study, the authors describe the feasibility of miniaturization of a serine kinase assay using generic reagents in the AlphaScreen format.  They have validated the robustness of this assay in the course of miniaturization from a 35- to 4.375-μL final assay vol. in 384- and 1536-well formats.  Within this vol. range, they consistently obtained Z' values above 0.5 and have investigated the suitability of these assay formats for measuring compd. effects by testing a set of 25 previously identified active compds.  These active compds. were also reliably identified in the miniaturized assay formats.  The results presented here show that the AlphaScreen technol. permits robust and cost-efficient miniaturization of serine/threonine kinase assays.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomQCsTDO5pn7Vg90H21EOLACvtfcHk0ljXM2ecFkycPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmsFOisg%253D%253D&md5=9d3a88967e965643be4924d3bf2656a8</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1177%2F1087057104268805&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057104268805%26sid%3Dliteratum%253Aachs%26aulast%3DVon%2BLeoprechting%26aufirst%3DA.%26aulast%3DKumpf%26aufirst%3DR.%26aulast%3DMenzel%26aufirst%3DS.%26aulast%3DReulle%26aufirst%3DD.%26aulast%3DGriebel%26aufirst%3DR.%26aulast%3DValler%26aufirst%3DM.%2BJ.%26aulast%3DB%25C3%25BCttner%26aufirst%3DF.%2BH.%26atitle%3DMiniaturization%2520and%2520validation%2520of%2520a%2520high-throughput%2520serine%2520kinase%2520assay%2520using%2520the%2520AlphaScreen%2520platform%26jtitle%3DJ.%2520Biomol.%2520Screen.%26date%3D2004%26volume%3D9%26spage%3D719%26epage%3D725" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Ryan, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowe, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, C. W.</span><span> </span><span class="NLM_article-title">Effect of detergent on “promiscuous” inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">3448</span><span class="NLM_x">–</span> <span class="NLM_lpage">3451</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0340896" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=3448-3451&author=A.+J.+Ryanauthor=N.+M.+Grayauthor=P.+N.+Loweauthor=C.+W.+Chung&title=Effect+of+detergent+on+%E2%80%9Cpromiscuous%E2%80%9D+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm0340896&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0340896%26sid%3Dliteratum%253Aachs%26aulast%3DRyan%26aufirst%3DA.%2BJ.%26aulast%3DGray%26aufirst%3DN.%2BM.%26aulast%3DLowe%26aufirst%3DP.%2BN.%26aulast%3DChung%26aufirst%3DC.%2BW.%26atitle%3DEffect%2520of%2520detergent%2520on%2520%25E2%2580%259Cpromiscuous%25E2%2580%259D%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D3448%26epage%3D3451" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Burns, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Travers, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowlands, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newbatt, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrett, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aherne, W.</span><span> </span><span class="NLM_article-title">Identification of small molecule inhibitors of protein kinase B (PKB) in an AlphaScreen high-throughput screen</span> <span class="citation_source-journal">J. Biomol. Screening</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">822</span><span class="NLM_x">–</span> <span class="NLM_lpage">827</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm900314j&amp;key=10.1177%2F1087057106290992" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm900314j&amp;key=16902245" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm900314j&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1SgsLzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2006&pages=822-827&author=S.+Burnsauthor=J.+Traversauthor=I.+Collinsauthor=M.+G.+Rowlandsauthor=Y.+Newbattauthor=N.+Thompsonauthor=M.+D.+Garrettauthor=P.+Workmanauthor=W.+Aherne&title=Identification+of+small+molecule+inhibitors+of+protein+kinase+B+%28PKB%29+in+an+AlphaScreen+high-throughput+screen"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of small-molecule inhibitors of protein kinase B (PKB/AKT) in an AlphaScreen high-throughput screen</span></div><div class="casAuthors">Burns, Samantha; Travers, Jonathan; Collins, Ian; Rowlands, Martin G.; Newbatt, Yvette; Thompson, Neil; Garrett, Michelle D.; Workman, Paul; Aherne, Wynne</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular Screening</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">822-827</span>CODEN:
                <span class="NLM_cas:coden">JBISF3</span>;
        ISSN:<span class="NLM_cas:issn">1087-0571</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">Protein kinase B (PKB/AKT) was identified as a promising cancer drug target downstream of PI3 kinase.  To find novel inhibitors of PKB/AKT kinase activity for progression as anticancer agents, the authors have used a high-throughput screen based on AlphaScreen technol.  A known kinase inhibitor, the isoquinoline H8, was used as a pos. control with mean inhibition in the screen of 43.4% ± 13.1%.  The performance of the screen was highly acceptable with Z' and Z factors of 0.83 ± 0.07 and 0.75 ± 0.04, resp.  A no. of confirmed hits (∼0.1% hit rate) were identified from 63,500 compds. screened.  Five compds. have previously been described as PKB inhibitors, demonstrating the ability of the assay to find authentic inhibitors of the enzyme.  Five hits had the potential to interfere with the assay signal and were deemed to be false positives.  Two compds. were nonspecific inhibitors of PKB as enzyme inhibition in a filter-based assay was markedly reduced in the presence of 0.01% Triton X100.  The authors now include an interference assay during hit confirmation procedures and check compd. activity in the presence of Triton X100 in an attempt to eliminate nonspecific aggregators at an early stage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaOwUuRayl-bVg90H21EOLACvtfcHk0lgQUtl_I3gGkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1SgsLzJ&md5=329182ca4dd153c00cdbf7795b118518</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1177%2F1087057106290992&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057106290992%26sid%3Dliteratum%253Aachs%26aulast%3DBurns%26aufirst%3DS.%26aulast%3DTravers%26aufirst%3DJ.%26aulast%3DCollins%26aufirst%3DI.%26aulast%3DRowlands%26aufirst%3DM.%2BG.%26aulast%3DNewbatt%26aufirst%3DY.%26aulast%3DThompson%26aufirst%3DN.%26aulast%3DGarrett%26aufirst%3DM.%2BD.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DAherne%26aufirst%3DW.%26atitle%3DIdentification%2520of%2520small%2520molecule%2520inhibitors%2520of%2520protein%2520kinase%2520B%2520%2528PKB%2529%2520in%2520an%2520AlphaScreen%2520high-throughput%2520screen%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D2006%26volume%3D11%26spage%3D822%26epage%3D827" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Babaoglu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoichet, B. K.</span><span> </span><span class="NLM_article-title">Deconstructing fragment-based inhibitor discovery</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">658</span><span class="NLM_x">–</span> <span class="NLM_lpage">659</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm900314j&amp;key=10.1038%2Fnchembio831" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm900314j&amp;key=17108979" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2006&pages=658-659&author=K.+Babaogluauthor=B.+K.+Shoichet&title=Deconstructing+fragment-based+inhibitor+discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1038%2Fnchembio831&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio831%26sid%3Dliteratum%253Aachs%26aulast%3DBabaoglu%26aufirst%3DK.%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26atitle%3DDeconstructing%2520fragment-based%2520inhibitor%2520discovery%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2006%26volume%3D2%26spage%3D658%26epage%3D659" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Foloppe, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howes, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kierstan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, A.</span><span> </span><span class="NLM_article-title">Identification of a buried pocket for potent and selective inhibition of CHk1: Prediction and verification</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1792</span><span class="NLM_x">–</span> <span class="NLM_lpage">1804</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=1792-1804&author=N.+Foloppeauthor=L.+M.+Fisherauthor=G.+Francisauthor=R.+Howesauthor=P.+Kierstanauthor=A.+Potter&title=Identification+of+a+buried+pocket+for+potent+and+selective+inhibition+of+CHk1%3A+Prediction+and+verification"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFoloppe%26aufirst%3DN.%26aulast%3DFisher%26aufirst%3DL.%2BM.%26aulast%3DFrancis%26aufirst%3DG.%26aulast%3DHowes%26aufirst%3DR.%26aulast%3DKierstan%26aufirst%3DP.%26aulast%3DPotter%26aufirst%3DA.%26atitle%3DIdentification%2520of%2520a%2520buried%2520pocket%2520for%2520potent%2520and%2520selective%2520inhibition%2520of%2520CHk1%253A%2520Prediction%2520and%2520verification%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26spage%3D1792%26epage%3D1804" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Gibson, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arris, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bentley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyle, F. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curtin, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endicott, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golding, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grant, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jewsbury, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, L. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mesguiche, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newell, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noble, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tucker, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitfield, H. J.</span><span> </span><span class="NLM_article-title">Probing the ATP ribose-binding domain of cyclin-dependent kinases 1 and 2 with O(6)-substituted guanine derivatives</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">3381</span><span class="NLM_x">–</span> <span class="NLM_lpage">3393</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm020056z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=3381-3393&author=A.+E.+Gibsonauthor=C.+E.+Arrisauthor=J.+Bentleyauthor=F.+T.+Boyleauthor=N.+J.+Curtinauthor=T.+G.+Daviesauthor=J.+A.+Endicottauthor=B.+T.+Goldingauthor=S.+Grantauthor=R.+J.+Griffinauthor=P.+Jewsburyauthor=L.+N.+Johnsonauthor=V.+Mesguicheauthor=D.+R.+Newellauthor=M.+E.+Nobleauthor=J.+A.+Tuckerauthor=H.+J.+Whitfield&title=Probing+the+ATP+ribose-binding+domain+of+cyclin-dependent+kinases+1+and+2+with+O%286%29-substituted+guanine+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38a&amp;dbid=16384&amp;doi=10.1021%2Fjm020056z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020056z%26sid%3Dliteratum%253Aachs%26aulast%3DGibson%26aufirst%3DA.%2BE.%26aulast%3DArris%26aufirst%3DC.%2BE.%26aulast%3DBentley%26aufirst%3DJ.%26aulast%3DBoyle%26aufirst%3DF.%2BT.%26aulast%3DCurtin%26aufirst%3DN.%2BJ.%26aulast%3DDavies%26aufirst%3DT.%2BG.%26aulast%3DEndicott%26aufirst%3DJ.%2BA.%26aulast%3DGolding%26aufirst%3DB.%2BT.%26aulast%3DGrant%26aufirst%3DS.%26aulast%3DGriffin%26aufirst%3DR.%2BJ.%26aulast%3DJewsbury%26aufirst%3DP.%26aulast%3DJohnson%26aufirst%3DL.%2BN.%26aulast%3DMesguiche%26aufirst%3DV.%26aulast%3DNewell%26aufirst%3DD.%2BR.%26aulast%3DNoble%26aufirst%3DM.%2BE.%26aulast%3DTucker%26aufirst%3DJ.%2BA.%26aulast%3DWhitfield%26aufirst%3DH.%2BJ.%26atitle%3DProbing%2520the%2520ATP%2520ribose-binding%2520domain%2520of%2520cyclin-dependent%2520kinases%25201%2520and%25202%2520with%2520O%25286%2529-substituted%2520guanine%2520derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D3381%26epage%3D3393" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit38b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hardcastle, I. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arris, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bentley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyle, F. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curtin, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endicott, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golding, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jewsbury, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menyerol, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mesguiche, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newell, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noble, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pratt, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitfield, H. J.</span><span> </span><span class="NLM_article-title">N2-substituted O6-cyclohexylmethylguanine derivatives: potent inhibitors of cyclin-dependent kinases 1 and 2</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">3710</span><span class="NLM_x">–</span> <span class="NLM_lpage">3722</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0311442" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=3710-3722&author=I.+R.+Hardcastleauthor=C.+E.+Arrisauthor=J.+Bentleyauthor=F.+T.+Boyleauthor=Y.+Chenauthor=N.+J.+Curtinauthor=J.+A.+Endicottauthor=A.+E.+Gibsonauthor=B.+T.+Goldingauthor=R.+J.+Griffinauthor=P.+Jewsburyauthor=J.+Menyerolauthor=V.+Mesguicheauthor=D.+R.+Newellauthor=M.+E.+Nobleauthor=D.+J.+Prattauthor=L.+Z.+Wangauthor=H.+J.+Whitfield&title=N2-substituted+O6-cyclohexylmethylguanine+derivatives%3A+potent+inhibitors+of+cyclin-dependent+kinases+1+and+2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38b&amp;dbid=16384&amp;doi=10.1021%2Fjm0311442&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0311442%26sid%3Dliteratum%253Aachs%26aulast%3DHardcastle%26aufirst%3DI.%2BR.%26aulast%3DArris%26aufirst%3DC.%2BE.%26aulast%3DBentley%26aufirst%3DJ.%26aulast%3DBoyle%26aufirst%3DF.%2BT.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DCurtin%26aufirst%3DN.%2BJ.%26aulast%3DEndicott%26aufirst%3DJ.%2BA.%26aulast%3DGibson%26aufirst%3DA.%2BE.%26aulast%3DGolding%26aufirst%3DB.%2BT.%26aulast%3DGriffin%26aufirst%3DR.%2BJ.%26aulast%3DJewsbury%26aufirst%3DP.%26aulast%3DMenyerol%26aufirst%3DJ.%26aulast%3DMesguiche%26aufirst%3DV.%26aulast%3DNewell%26aufirst%3DD.%2BR.%26aulast%3DNoble%26aufirst%3DM.%2BE.%26aulast%3DPratt%26aufirst%3DD.%2BJ.%26aulast%3DWang%26aufirst%3DL.%2BZ.%26aulast%3DWhitfield%26aufirst%3DH.%2BJ.%26atitle%3DN2-substituted%2520O6-cyclohexylmethylguanine%2520derivatives%253A%2520potent%2520inhibitors%2520of%2520cyclin-dependent%2520kinases%25201%2520and%25202%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D3710%26epage%3D3722" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Donald, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHardy, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowlands, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyle, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aherne, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrett, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, I.</span><span> </span><span class="NLM_article-title">Rapid evolution of 6-phenylpurine inhibitors of protein kinase B through structure-based design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">2289</span><span class="NLM_x">–</span> <span class="NLM_lpage">2293</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0700924" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=2289-2293&author=A.+Donaldauthor=T.+McHardyauthor=M.+G.+Rowlandsauthor=L.+K.+Hunterauthor=T.+G.+Daviesauthor=R.+G.+Boyleauthor=G.+W.+Aherneauthor=M.+D.+Garrettauthor=I.+Collins&title=Rapid+evolution+of+6-phenylpurine+inhibitors+of+protein+kinase+B+through+structure-based+design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39a&amp;dbid=16384&amp;doi=10.1021%2Fjm0700924&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0700924%26sid%3Dliteratum%253Aachs%26aulast%3DDonald%26aufirst%3DA.%26aulast%3DMcHardy%26aufirst%3DT.%26aulast%3DRowlands%26aufirst%3DM.%2BG.%26aulast%3DHunter%26aufirst%3DL.%2BK.%26aulast%3DDavies%26aufirst%3DT.%2BG.%26aulast%3DBoyle%26aufirst%3DR.%2BG.%26aulast%3DAherne%26aufirst%3DG.%2BW.%26aulast%3DGarrett%26aufirst%3DM.%2BD.%26aulast%3DCollins%26aufirst%3DI.%26atitle%3DRapid%2520evolution%2520of%25206-phenylpurine%2520inhibitors%2520of%2520protein%2520kinase%2520B%2520through%2520structure-based%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D2289%26epage%3D2293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit39b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Caldwell, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donald, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHardy, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowlands, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aherne, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruddle, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynaud, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verdonk, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrett, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, I.</span><span> </span><span class="NLM_article-title">Identification of 4-(4-aminopiperidin-1-yl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidines as selective inhibitors of protein kinase B through fragment elaboration</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">2147</span><span class="NLM_x">–</span> <span class="NLM_lpage">2157</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm701437d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=2147-2157&author=J.+J.+Caldwellauthor=T.+G.+Daviesauthor=A.+Donaldauthor=T.+McHardyauthor=M.+G.+Rowlandsauthor=G.+W.+Aherneauthor=L.+K.+Hunterauthor=K.+Taylorauthor=R.+Ruddleauthor=F.+I.+Raynaudauthor=M.+Verdonkauthor=P.+Workmanauthor=M.+D.+Garrettauthor=I.+Collins&title=Identification+of+4-%284-aminopiperidin-1-yl%29-7H-pyrrolo%5B2%2C3-d%5Dpyrimidines+as+selective+inhibitors+of+protein+kinase+B+through+fragment+elaboration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39b&amp;dbid=16384&amp;doi=10.1021%2Fjm701437d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701437d%26sid%3Dliteratum%253Aachs%26aulast%3DCaldwell%26aufirst%3DJ.%2BJ.%26aulast%3DDavies%26aufirst%3DT.%2BG.%26aulast%3DDonald%26aufirst%3DA.%26aulast%3DMcHardy%26aufirst%3DT.%26aulast%3DRowlands%26aufirst%3DM.%2BG.%26aulast%3DAherne%26aufirst%3DG.%2BW.%26aulast%3DHunter%26aufirst%3DL.%2BK.%26aulast%3DTaylor%26aufirst%3DK.%26aulast%3DRuddle%26aufirst%3DR.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DVerdonk%26aufirst%3DM.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DGarrett%26aufirst%3DM.%2BD.%26aulast%3DCollins%26aufirst%3DI.%26atitle%3DIdentification%2520of%25204-%25284-aminopiperidin-1-yl%2529-7H-pyrrolo%255B2%252C3-d%255Dpyrimidines%2520as%2520selective%2520inhibitors%2520of%2520protein%2520kinase%2520B%2520through%2520fragment%2520elaboration%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D2147%26epage%3D2157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Shapiro, G. I.</span><span> </span><span class="NLM_article-title">Cyclin-dependent kinase pathways as targets for cancer treatment</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">1770</span><span class="NLM_x">–</span> <span class="NLM_lpage">1783</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm900314j&amp;key=10.1200%2FJCO.2005.03.7689" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Fjm900314j&amp;key=16603719" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm900314j&amp;key=1%3ACAS%3A528%3ADC%252BD28XksVKgtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2006&pages=1770-1783&author=G.+I.+Shapiro&title=Cyclin-dependent+kinase+pathways+as+targets+for+cancer+treatment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclin-dependent kinase pathways as targets for cancer treatment</span></div><div class="casAuthors">Shapiro, Geoffrey I.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1770-1783</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">A review.  Cyclin-dependent kinases (cdks) are crit. regulators of cell cycle progression and RNA transcription.  A variety of genetic and epigenetic events cause universal overactivity of the cell cycle cdks in human cancer, and their inhibition can lead to both cell cycle arrest and apoptosis.  However, built-in redundancy may limit the effects of highly selective cdk inhibition.  Cdk4/6 inhibition has been shown to induce potent G1 arrest in vitro and tumor regression in vivo; cdk2/1 inhibition has the most potent effects during the S and G2 phases and induces E2F transcription factor-dependent cell death.  Modulation of cdk2 and cdk1 activities also affects survival checkpoint responses after exposure to DNA-damaging and microtubule-stabilizing agents.  The transcriptional cdks phosphorylate the carboxy-terminal domain of RNA polymerase II, facilitating efficient transcriptional initiation and elongation.  Inhibition of these cdks primarily affects the accumulation of transcripts with short half-lives, including those encoding antiapoptosis family members, cell cycle regulators, as well as p53 and nuclear factor-kappa B-responsive gene targets.  These effects may account for apoptosis induced by cdk9 inhibitors, esp. in malignant hematopoietic cells, and may also potentiate cytotoxicity mediated by disruption of a variety of pathways in many transformed cell types.  Current work is focusing on overcoming pharmacokinetic barriers that hindered development of flavopiridol, a pan-cdk inhibitor, as well as assessing novel classes of compds. potently targeting groups of cell cycle cdks (cdk4/6 or cdk2/1) with variable effects on the transcriptional cdks 7 and 9.  These efforts will establish whether the strategy of cdk inhibition is able to produce therapeutic benefit in the majority of human tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYfmCpSfvpTbVg90H21EOLACvtfcHk0li8yxvpaS3MDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XksVKgtbg%253D&md5=420a31b47f6600625f7d499a4b8a5fc9</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1200%2FJCO.2005.03.7689&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2005.03.7689%26sid%3Dliteratum%253Aachs%26aulast%3DShapiro%26aufirst%3DG.%2BI.%26atitle%3DCyclin-dependent%2520kinase%2520pathways%2520as%2520targets%2520for%2520cancer%2520treatment%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2006%26volume%3D24%26spage%3D1770%26epage%3D1783" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Xiao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xue, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, W.-Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bui, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tao, Z.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, N.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sowin, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span> </span><span class="NLM_article-title">Cyclin B1 is an efficacy-predicting biomarker for Chk1 inhibitors</span> <span class="citation_source-journal">Biomarkers</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">579</span><span class="NLM_x">–</span> <span class="NLM_lpage">596</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2008&pages=579-596&author=Z.+Xiaoauthor=J.+Xueauthor=W.-Z.+Guauthor=M.+Buiauthor=G.+Liauthor=Z.-F.+Taoauthor=N.-H.+Linauthor=T.+J.+Sowinauthor=H.+Zhang&title=Cyclin+B1+is+an+efficacy-predicting+biomarker+for+Chk1+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXiao%26aufirst%3DZ.%26aulast%3DXue%26aufirst%3DJ.%26aulast%3DGu%26aufirst%3DW.-Z.%26aulast%3DBui%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DTao%26aufirst%3DZ.-F.%26aulast%3DLin%26aufirst%3DN.-H.%26aulast%3DSowin%26aufirst%3DT.%2BJ.%26aulast%3DZhang%26aufirst%3DH.%26atitle%3DCyclin%2520B1%2520is%2520an%2520efficacy-predicting%2520biomarker%2520for%2520Chk1%2520inhibitors%26jtitle%3DBiomarkers%26date%3D2008%26volume%3D13%26spage%3D579%26epage%3D596" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Hoehn, H.; Denzel, T.</span><span> </span><span class="NLM_article-title">1<i>H</i>-Pyrazolo[3,4-<i>b</i>]pyridines</span>. Patent Appl. DE2301268,<span class="NLM_x"> </span><span class="NLM_year">1973</span><span class="NLM_x">, </span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1973&author=H.+Hoehn&author=T.+Denzel&title=1H-Pyrazolo%5B3%2C4-b%5Dpyridines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHoehn%26aufirst%3DH.%26atitle%3D1H-Pyrazolo%255B3%252C4-b%255Dpyridines%26date%3D1973" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="ref42_2"><span>;  <span class="citation_source-journal">Chem. Abs.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1973</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">115578</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=%3B+Chem.+Abs.+1973%2C+79%2C+115578."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=ref42_2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26jtitle%3DChem.%2520Abs.%26date%3D1973%26volume%3D79%26spage%3D115578" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Misra, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, H.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rawlins, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kellar, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulheron, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sack, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tokarski, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimball, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webster, K. R.</span><span> </span><span class="NLM_article-title">1<i>H</i>-Pyrazolo[3,4-<i>b</i>]pyridine inhibitors of cyclin-dependent kinases: highly potent 2,6-difluorophenacyl analogues</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">2405</span><span class="NLM_x">–</span> <span class="NLM_lpage">2408</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=2405-2408&author=R.+N.+Misraauthor=H.-Y.+Xiaoauthor=D.+B.+Rawlinsauthor=W.+Shanauthor=K.+A.+Kellarauthor=J.+G.+Mulheronauthor=J.+S.+Sackauthor=J.+S.+Tokarskiauthor=S.+D.+Kimballauthor=K.+R.+Webster&title=1H-Pyrazolo%5B3%2C4-b%5Dpyridine+inhibitors+of+cyclin-dependent+kinases%3A+highly+potent+2%2C6-difluorophenacyl+analogues"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMisra%26aufirst%3DR.%2BN.%26aulast%3DXiao%26aufirst%3DH.-Y.%26aulast%3DRawlins%26aufirst%3DD.%2BB.%26aulast%3DShan%26aufirst%3DW.%26aulast%3DKellar%26aufirst%3DK.%2BA.%26aulast%3DMulheron%26aufirst%3DJ.%2BG.%26aulast%3DSack%26aufirst%3DJ.%2BS.%26aulast%3DTokarski%26aufirst%3DJ.%2BS.%26aulast%3DKimball%26aufirst%3DS.%2BD.%26aulast%3DWebster%26aufirst%3DK.%2BR.%26atitle%3D1H-Pyrazolo%255B3%252C4-b%255Dpyridine%2520inhibitors%2520of%2520cyclin-dependent%2520kinases%253A%2520highly%2520potent%25202%252C6-difluorophenacyl%2520analogues%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D2405%26epage%3D2408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Brenner, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baldwin, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamagnan, G.</span><span> </span><span class="NLM_article-title">Asymmetric synthesis of (+)-(<i>S</i>,<i>S</i>)-reboxetine via a new (<i>S</i>)-2-(hydroxymethyl)morpholine preparation</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">937</span><span class="NLM_x">–</span> <span class="NLM_lpage">939</span></span><div class="citationLinks">[<a href="/doi/10.1021/ol050059g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2005&pages=937-939&author=E.+Brennerauthor=R.+M.+Baldwinauthor=G.+Tamagnan&title=Asymmetric+synthesis+of+%28%2B%29-%28S%2CS%29-reboxetine+via+a+new+%28S%29-2-%28hydroxymethyl%29morpholine+preparation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fol050059g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol050059g%26sid%3Dliteratum%253Aachs%26aulast%3DBrenner%26aufirst%3DE.%26aulast%3DBaldwin%26aufirst%3DR.%2BM.%26aulast%3DTamagnan%26aufirst%3DG.%26atitle%3DAsymmetric%2520synthesis%2520of%2520%2528%252B%2529-%2528S%252CS%2529-reboxetine%2520via%2520a%2520new%2520%2528S%2529-2-%2528hydroxymethyl%2529morpholine%2520preparation%26jtitle%3DOrg.%2520Lett.%26date%3D2005%26volume%3D7%26spage%3D937%26epage%3D939" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Parry, D.; Shanahan, F.; Davis, N.; Wiswell, D.; Seghezzi, W.; Pierce, R.; Hsieh, Y.; Paruch, K.; Guzi, T.</span><span> </span><span class="NLM_article-title">Targeting the replication checkpoint with a potent and selective CHK1 inhibitor SCH 900776</span>. <span class="NLM_conf-name">Abstracts of the 100th AACR Annual Meeting</span>, <span class="NLM_conf-loc">Denver, CO</span>, <span class="NLM_conf-date">April 18−29, 2009</span>, paper 2490.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Parry%2C+D.%3B+Shanahan%2C+F.%3B+Davis%2C+N.%3B+Wiswell%2C+D.%3B+Seghezzi%2C+W.%3B+Pierce%2C+R.%3B+Hsieh%2C+Y.%3B+Paruch%2C+K.%3B+Guzi%2C+T.+Targeting+the+replication+checkpoint+with+a+potent+and+selective+CHK1+inhibitor+SCH+900776.+Abstracts+of+the+100th+AACR+Annual+Meeting%2C+Denver%2C+CO%2C+April+18%E2%88%9229%2C+2009%2C+paper+2490."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DParry%26aufirst%3DD.%26atitle%3DTargeting%2520the%2520replication%2520checkpoint%2520with%2520a%2520potent%2520and%2520selective%2520CHK1%2520inhibitor%2520SCH%2520900776" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Schirok, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kast, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Figueroa-Perez, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennabi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gnoth, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feurer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heckroth, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thutewohl, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paulsen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knorr, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huetter, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lobell, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muenter, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geiss, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ehmke, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radtke, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mittendorf, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stasch, J.</span><span> </span><span class="NLM_article-title">Design and synthesis of potent and selective azaindole-based Rho kinase (ROCK) inhibitors</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1893</span><span class="NLM_x">–</span> <span class="NLM_lpage">1904</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=1893-1904&author=H.+Schirokauthor=R.+Kastauthor=S.+Figueroa-Perezauthor=S.+Bennabiauthor=M.+J.+Gnothauthor=A.+Feurerauthor=H.+Heckrothauthor=M.+Thutewohlauthor=H.+Paulsenauthor=A.+Knorrauthor=J.+Huetterauthor=M.+Lobellauthor=K.+Muenterauthor=V.+Geissauthor=H.+Ehmkeauthor=D.+Langauthor=M.+Radtkeauthor=J.+Mittendorfauthor=J.+Stasch&title=Design+and+synthesis+of+potent+and+selective+azaindole-based+Rho+kinase+%28ROCK%29+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchirok%26aufirst%3DH.%26aulast%3DKast%26aufirst%3DR.%26aulast%3DFigueroa-Perez%26aufirst%3DS.%26aulast%3DBennabi%26aufirst%3DS.%26aulast%3DGnoth%26aufirst%3DM.%2BJ.%26aulast%3DFeurer%26aufirst%3DA.%26aulast%3DHeckroth%26aufirst%3DH.%26aulast%3DThutewohl%26aufirst%3DM.%26aulast%3DPaulsen%26aufirst%3DH.%26aulast%3DKnorr%26aufirst%3DA.%26aulast%3DHuetter%26aufirst%3DJ.%26aulast%3DLobell%26aufirst%3DM.%26aulast%3DMuenter%26aufirst%3DK.%26aulast%3DGeiss%26aufirst%3DV.%26aulast%3DEhmke%26aufirst%3DH.%26aulast%3DLang%26aufirst%3DD.%26aulast%3DRadtke%26aufirst%3DM.%26aulast%3DMittendorf%26aufirst%3DJ.%26aulast%3DStasch%26aufirst%3DJ.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520potent%2520and%2520selective%2520azaindole-based%2520Rho%2520kinase%2520%2528ROCK%2529%2520inhibitors%26jtitle%3DChemMedChem%26date%3D2008%26volume%3D3%26spage%3D1893%26epage%3D1904" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit46b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Dai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartandi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soni, N. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pease, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reuter, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osterling, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doktor, S. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albert, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouska, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glaser, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcotte, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidsen, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michaelides, M. R.</span><span> </span><span class="NLM_article-title">Identification of aminopyrazolopyridine ureas as potent VEGFR/PDGFR multitargeted kinase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">386</span><span class="NLM_x">–</span> <span class="NLM_lpage">390</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=386-390&author=Y.+Daiauthor=K.+Hartandiauthor=N.+B.+Soniauthor=L.+J.+Peaseauthor=D.+R.+Reuterauthor=A.+M.+Olsonauthor=D.+J.+Osterlingauthor=S.+Z.+Doktorauthor=D.+H.+Albertauthor=J.+J.+Bouskaauthor=K.+B.+Glaserauthor=P.+A.+Marcotteauthor=K.+D.+Stewartauthor=S.+K.+Davidsenauthor=M.+R.+Michaelides&title=Identification+of+aminopyrazolopyridine+ureas+as+potent+VEGFR%2FPDGFR+multitargeted+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDai%26aufirst%3DY.%26aulast%3DHartandi%26aufirst%3DK.%26aulast%3DSoni%26aufirst%3DN.%2BB.%26aulast%3DPease%26aufirst%3DL.%2BJ.%26aulast%3DReuter%26aufirst%3DD.%2BR.%26aulast%3DOlson%26aufirst%3DA.%2BM.%26aulast%3DOsterling%26aufirst%3DD.%2BJ.%26aulast%3DDoktor%26aufirst%3DS.%2BZ.%26aulast%3DAlbert%26aufirst%3DD.%2BH.%26aulast%3DBouska%26aufirst%3DJ.%2BJ.%26aulast%3DGlaser%26aufirst%3DK.%2BB.%26aulast%3DMarcotte%26aufirst%3DP.%2BA.%26aulast%3DStewart%26aufirst%3DK.%2BD.%26aulast%3DDavidsen%26aufirst%3DS.%2BK.%26aulast%3DMichaelides%26aufirst%3DM.%2BR.%26atitle%3DIdentification%2520of%2520aminopyrazolopyridine%2520ureas%2520as%2520potent%2520VEGFR%252FPDGFR%2520multitargeted%2520kinase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D386%26epage%3D390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit46c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Lin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connolly, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emanuel, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middleton, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gruninger, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuentes-Pesquera, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenberger, L. M.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of pyrazolo[3,4-<i>b</i>]pyridine CDK1 inhibitors as antitumor agents</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">4297</span><span class="NLM_x">–</span> <span class="NLM_lpage">4302</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=4297-4302&author=R.+Linauthor=P.+J.+Connollyauthor=Y.+Luauthor=G.+Chiuauthor=S.+Liauthor=Y.+Yuauthor=S.+Huangauthor=X.+Liauthor=S.+L.+Emanuelauthor=S.+A.+Middletonauthor=R.+H.+Gruningerauthor=M.+Adamsauthor=A.+R.+Fuentes-Pesqueraauthor=L.+M.+Greenberger&title=Synthesis+and+evaluation+of+pyrazolo%5B3%2C4-b%5Dpyridine+CDK1+inhibitors+as+antitumor+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DR.%26aulast%3DConnolly%26aufirst%3DP.%2BJ.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DChiu%26aufirst%3DG.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DYu%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DEmanuel%26aufirst%3DS.%2BL.%26aulast%3DMiddleton%26aufirst%3DS.%2BA.%26aulast%3DGruninger%26aufirst%3DR.%2BH.%26aulast%3DAdams%26aufirst%3DM.%26aulast%3DFuentes-Pesquera%26aufirst%3DA.%2BR.%26aulast%3DGreenberger%26aufirst%3DL.%2BM.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520pyrazolo%255B3%252C4-b%255Dpyridine%2520CDK1%2520inhibitors%2520as%2520antitumor%2520agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D4297%26epage%3D4302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit46d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Witherington, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bordas, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaiba, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garton, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naylor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rawlings, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slingsby, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takle, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, R. W.</span><span> </span><span class="NLM_article-title">6-Aryl-pyrazolo[3,4-<i>b</i>]pyridines: potent inhibitors of glycogen synthase kinase-3 (GSK-3)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">3055</span><span class="NLM_x">–</span> <span class="NLM_lpage">3057</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=3055-3057&author=J.+Witheringtonauthor=V.+Bordasauthor=A.+Gaibaauthor=N.+S.+Gartonauthor=A.+Naylorauthor=A.+D.+Rawlingsauthor=B.+P.+Slingsbyauthor=D.+G.+Smithauthor=A.+K.+Takleauthor=R.+W.+Ward&title=6-Aryl-pyrazolo%5B3%2C4-b%5Dpyridines%3A+potent+inhibitors+of+glycogen+synthase+kinase-3+%28GSK-3%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWitherington%26aufirst%3DJ.%26aulast%3DBordas%26aufirst%3DV.%26aulast%3DGaiba%26aufirst%3DA.%26aulast%3DGarton%26aufirst%3DN.%2BS.%26aulast%3DNaylor%26aufirst%3DA.%26aulast%3DRawlings%26aufirst%3DA.%2BD.%26aulast%3DSlingsby%26aufirst%3DB.%2BP.%26aulast%3DSmith%26aufirst%3DD.%2BG.%26aulast%3DTakle%26aufirst%3DA.%2BK.%26aulast%3DWard%26aufirst%3DR.%2BW.%26atitle%3D6-Aryl-pyrazolo%255B3%252C4-b%255Dpyridines%253A%2520potent%2520inhibitors%2520of%2520glycogen%2520synthase%2520kinase-3%2520%2528GSK-3%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D3055%26epage%3D3057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit46e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Witherington, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bordas, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garland, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickey, D. M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ife, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liddle, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saunders, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, R. W.</span><span> </span><span class="NLM_article-title">5-Aryl-pyrazolo[3,4-<i>b</i>]pyridines: potent inhibitors of glycogen synthase kinase-3 (GSK-3)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1577</span><span class="NLM_x">–</span> <span class="NLM_lpage">1580</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=1577-1580&author=J.+Witheringtonauthor=V.+Bordasauthor=S.+L.+Garlandauthor=D.+M.+B.+Hickeyauthor=R.+J.+Ifeauthor=J.+Liddleauthor=M.+Saundersauthor=D.+G.+Smithauthor=R.+W.+Ward&title=5-Aryl-pyrazolo%5B3%2C4-b%5Dpyridines%3A+potent+inhibitors+of+glycogen+synthase+kinase-3+%28GSK-3%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWitherington%26aufirst%3DJ.%26aulast%3DBordas%26aufirst%3DV.%26aulast%3DGarland%26aufirst%3DS.%2BL.%26aulast%3DHickey%26aufirst%3DD.%2BM.%2BB.%26aulast%3DIfe%26aufirst%3DR.%2BJ.%26aulast%3DLiddle%26aufirst%3DJ.%26aulast%3DSaunders%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DD.%2BG.%26aulast%3DWard%26aufirst%3DR.%2BW.%26atitle%3D5-Aryl-pyrazolo%255B3%252C4-b%255Dpyridines%253A%2520potent%2520inhibitors%2520of%2520glycogen%2520synthase%2520kinase-3%2520%2528GSK-3%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D1577%26epage%3D1580" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit46f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Misra, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rawlins, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bursuker, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kellar, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulheron, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sack, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tokarski, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimball, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webster, K. R.</span><span> </span><span class="NLM_article-title">1<i>H</i>-Pyrazolo[3,4-<i>b</i>]pyridine inhibitors of cyclin-dependent kinases</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1133</span><span class="NLM_x">–</span> <span class="NLM_lpage">1136</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=1133-1136&author=R.+N.+Misraauthor=D.+B.+Rawlinsauthor=H.+Xiaoauthor=W.+Shanauthor=I.+Bursukerauthor=K.+A.+Kellarauthor=J.+G.+Mulheronauthor=J.+S.+Sackauthor=J.+S.+Tokarskiauthor=S.+D.+Kimballauthor=K.+R.+Webster&title=1H-Pyrazolo%5B3%2C4-b%5Dpyridine+inhibitors+of+cyclin-dependent+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMisra%26aufirst%3DR.%2BN.%26aulast%3DRawlins%26aufirst%3DD.%2BB.%26aulast%3DXiao%26aufirst%3DH.%26aulast%3DShan%26aufirst%3DW.%26aulast%3DBursuker%26aufirst%3DI.%26aulast%3DKellar%26aufirst%3DK.%2BA.%26aulast%3DMulheron%26aufirst%3DJ.%2BG.%26aulast%3DSack%26aufirst%3DJ.%2BS.%26aulast%3DTokarski%26aufirst%3DJ.%2BS.%26aulast%3DKimball%26aufirst%3DS.%2BD.%26aulast%3DWebster%26aufirst%3DK.%2BR.%26atitle%3D1H-Pyrazolo%255B3%252C4-b%255Dpyridine%2520inhibitors%2520of%2520cyclin-dependent%2520kinases%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D1133%26epage%3D1136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Collins, I.; Reader, J. C.; Cheung, K. M.; Matthews, T. P.; Proisy, N.; Klair, S. S.</span> Patent Appl. WO2008075007,<span class="NLM_x"> </span><span class="NLM_year">2008</span><span class="NLM_x">; </span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Collins%2C+I.%3B+Reader%2C+J.+C.%3B+Cheung%2C+K.+M.%3B+Matthews%2C+T.+P.%3B+Proisy%2C+N.%3B+Klair%2C+S.+S.+Patent+Appl.+WO2008075007%2C+2008%3B+"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCollins%26aufirst%3DI.%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="ref47_2"><span> <span class="citation_source-journal">Chem. Abstr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">149</span><span class="NLM_x">, </span> <span class="NLM_fpage">104737</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Chem.+Abstr.+2008%2C+149%2C+104737."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=ref47_2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26jtitle%3DChem.%2520Abstr.%26date%3D2008%26volume%3D149%26spage%3D104737" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15a','cit15b','cit15c'],'ref16':['cit16a','cit16b'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38a','cit38b'],'ref39':['cit39a','cit39b'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42','ref42_2'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46a','cit46b','cit46c','cit46d','cit46e','cit46f'],'ref47':['cit47','ref47_2']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 32 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="NLM_string-name hlFld-ContribAuthor">Matthew D. Lloyd</span>. </span><span class="cited-content_cbyCitation_article-title">High-Throughput Screening for the Discovery of Enzyme Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (19)
                                     , 10742-10772. <a href="https://doi.org/10.1021/acs.jmedchem.0c00523" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00523</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00523&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00523%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DHigh-Throughput%252BScreening%252Bfor%252Bthe%252BDiscovery%252Bof%252BEnzyme%252BInhibitors%26aulast%3DLloyd%26aufirst%3DMatthew%2BD.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D30032020%26date%3D10062020%26date%3D20052020%26volume%3D63%26issue%3D19%26spage%3D10742%26epage%3D10772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Oscar  Méndez-Lucio</span>, <span class="hlFld-ContribAuthor ">Albert J.  Kooistra</span>, <span class="hlFld-ContribAuthor ">Chris de  Graaf</span>, <span class="hlFld-ContribAuthor ">Andreas  Bender</span>, and <span class="hlFld-ContribAuthor ">José L.  Medina-Franco</span>  . </span><span class="cited-content_cbyCitation_article-title">Analyzing Multitarget Activity Landscapes Using Protein–Ligand Interaction Fingerprints: Interaction Cliffs. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2015,</strong> <em>55 </em>
                                    (2)
                                     , 251-262. <a href="https://doi.org/10.1021/ci500721x" title="DOI URL">https://doi.org/10.1021/ci500721x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ci500721x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fci500721x%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DAnalyzing%252BMultitarget%252BActivity%252BLandscapes%252BUsing%252BProtein%2525E2%252580%252593Ligand%252BInteraction%252BFingerprints%25253A%252BInteraction%252BCliffs%26aulast%3DM%25C3%25A9ndez-Lucio%26aufirst%3DOscar%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D04122014%26date%3D06022015%26date%3D23022015%26date%3D23012015%26volume%3D55%26issue%3D2%26spage%3D251%26epage%3D262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ernst  Schonbrunn</span>, <span class="hlFld-ContribAuthor ">Stephane  Betzi</span>, <span class="hlFld-ContribAuthor ">Riazul  Alam</span>, <span class="hlFld-ContribAuthor ">Mathew P.  Martin</span>, <span class="hlFld-ContribAuthor ">Andreas  Becker</span>, <span class="hlFld-ContribAuthor ">Huijong  Han</span>, <span class="hlFld-ContribAuthor ">Rawle  Francis</span>, <span class="hlFld-ContribAuthor ">Ramappa  Chakrasali</span>, <span class="hlFld-ContribAuthor ">Sudhakar  Jakkaraj</span>, <span class="hlFld-ContribAuthor ">Aslamuzzaman  Kazi</span>, <span class="hlFld-ContribAuthor ">Said M.  Sebti</span>, <span class="hlFld-ContribAuthor ">Christopher L.  Cubitt</span>, <span class="hlFld-ContribAuthor ">Anthony W.  Gebhard</span>, <span class="hlFld-ContribAuthor ">Lori A.  Hazlehurst</span>, <span class="hlFld-ContribAuthor ">Joseph S.  Tash</span>, and <span class="hlFld-ContribAuthor ">Gunda I.  Georg</span>  . </span><span class="cited-content_cbyCitation_article-title">Development of Highly Potent and Selective Diaminothiazole Inhibitors of Cyclin-Dependent Kinases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (10)
                                     , 3768-3782. <a href="https://doi.org/10.1021/jm301234k" title="DOI URL">https://doi.org/10.1021/jm301234k</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm301234k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm301234k%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDevelopment%252Bof%252BHighly%252BPotent%252Band%252BSelective%252BDiaminothiazole%252BInhibitors%252Bof%252BCyclin-Dependent%252BKinases%26aulast%3DSchonbrunn%26aufirst%3DErnst%26date%3D2013%26date%3D2013%26date%3D2012%26date%3D27082012%26date%3D06052013%26date%3D23052013%26date%3D19042013%26volume%3D56%26issue%3D10%26spage%3D3768%26epage%3D3782" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael  Lainchbury</span>, <span class="hlFld-ContribAuthor ">Thomas P.  Matthews</span>, <span class="hlFld-ContribAuthor ">Tatiana  McHardy</span>, <span class="hlFld-ContribAuthor ">Kathy J.  Boxall</span>, <span class="hlFld-ContribAuthor ">Michael I.  Walton</span>, <span class="hlFld-ContribAuthor ">Paul D.  Eve</span>, <span class="hlFld-ContribAuthor ">Angela  Hayes</span>, <span class="hlFld-ContribAuthor ">Melanie R.  Valenti</span>, <span class="hlFld-ContribAuthor ">Alexis K.  de Haven Brandon</span>, <span class="hlFld-ContribAuthor ">Gary  Box</span>, <span class="hlFld-ContribAuthor ">G. Wynne  Aherne</span>, <span class="hlFld-ContribAuthor ">John C.  Reader</span>, <span class="hlFld-ContribAuthor ">Florence I.  Raynaud</span>, <span class="hlFld-ContribAuthor ">Suzanne A.  Eccles</span>, <span class="hlFld-ContribAuthor ">Michelle D.  Garrett</span>, and <span class="hlFld-ContribAuthor ">Ian  Collins</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of 3-Alkoxyamino-5-(pyridin-2-ylamino)pyrazine-2-carbonitriles as Selective, Orally Bioavailable CHK1 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (22)
                                     , 10229-10240. <a href="https://doi.org/10.1021/jm3012933" title="DOI URL">https://doi.org/10.1021/jm3012933</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm3012933&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm3012933%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B3-Alkoxyamino-5-%252528pyridin-2-ylamino%252529pyrazine-2-carbonitriles%252Bas%252BSelective%25252C%252BOrally%252BBioavailable%252BCHK1%252BInhibitors%26aulast%3DLainchbury%26aufirst%3DMichael%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D07092012%26date%3D19102012%26date%3D26112012%26volume%3D55%26issue%3D22%26spage%3D10229%26epage%3D10240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rongshi  Li</span>, <span class="hlFld-ContribAuthor ">Mathew P.  Martin</span>, <span class="hlFld-ContribAuthor ">Yan  Liu</span>, <span class="hlFld-ContribAuthor ">Binglin  Wang</span>, <span class="hlFld-ContribAuthor ">Ronil A.  Patel</span>, <span class="hlFld-ContribAuthor ">Jin-Yi  Zhu</span>, <span class="hlFld-ContribAuthor ">Nan  Sun</span>, <span class="hlFld-ContribAuthor ">Roberta  Pireddu</span>, <span class="hlFld-ContribAuthor ">Nicholas J.  Lawrence</span>, <span class="hlFld-ContribAuthor ">Jiannong  Li</span>, <span class="hlFld-ContribAuthor ">Eric B.  Haura</span>, <span class="hlFld-ContribAuthor ">Shen-Shu  Sung</span>, <span class="hlFld-ContribAuthor ">Wayne C.  Guida</span>, <span class="hlFld-ContribAuthor ">Ernst  Schonbrunn</span>, and <span class="hlFld-ContribAuthor ">Said M.  Sebti</span>  . </span><span class="cited-content_cbyCitation_article-title">Fragment-Based and Structure-Guided Discovery and Optimization of Rho Kinase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (5)
                                     , 2474-2478. <a href="https://doi.org/10.1021/jm201289r" title="DOI URL">https://doi.org/10.1021/jm201289r</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm201289r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm201289r%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFragment-Based%252Band%252BStructure-Guided%252BDiscovery%252Band%252BOptimization%252Bof%252BRho%252BKinase%252BInhibitors%26aulast%3DLi%26aufirst%3DRongshi%26date%3D2012%26date%3D2012%26date%3D2011%26date%3D29092011%26date%3D15022012%26date%3D08032012%26date%3D24012012%26volume%3D55%26issue%3D5%26spage%3D2474%26epage%3D2478" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">John C.  Reader</span>, <span class="hlFld-ContribAuthor ">Thomas P.  Matthews</span>, <span class="hlFld-ContribAuthor ">Suki  Klair</span>, <span class="hlFld-ContribAuthor ">Kwai-Ming J.  Cheung</span>, <span class="hlFld-ContribAuthor ">Jane  Scanlon</span>, <span class="hlFld-ContribAuthor ">Nicolas  Proisy</span>, <span class="hlFld-ContribAuthor ">Glynn  Addison</span>, <span class="hlFld-ContribAuthor ">John  Ellard</span>, <span class="hlFld-ContribAuthor ">Nelly  Piton</span>, <span class="hlFld-ContribAuthor ">Suzanne  Taylor</span>, <span class="hlFld-ContribAuthor ">Michael  Cherry</span>, <span class="hlFld-ContribAuthor ">Martin  Fisher</span>, <span class="hlFld-ContribAuthor ">Kathy  Boxall</span>, <span class="hlFld-ContribAuthor ">Samantha  Burns</span>, <span class="hlFld-ContribAuthor ">Michael I.  Walton</span>, <span class="hlFld-ContribAuthor ">Isaac M.  Westwood</span>, <span class="hlFld-ContribAuthor ">Angela  Hayes</span>, <span class="hlFld-ContribAuthor ">Paul  Eve</span>, <span class="hlFld-ContribAuthor ">Melanie  Valenti</span>, <span class="hlFld-ContribAuthor ">Alexis  de Haven Brandon</span>, <span class="hlFld-ContribAuthor ">Gary  Box</span>, <span class="hlFld-ContribAuthor ">Rob L. M.  van Montfort</span>, <span class="hlFld-ContribAuthor ">David H.  Williams</span>, <span class="hlFld-ContribAuthor ">G. Wynne  Aherne</span>, <span class="hlFld-ContribAuthor ">Florence I.  Raynaud</span>, <span class="hlFld-ContribAuthor ">Suzanne A.  Eccles</span>, <span class="hlFld-ContribAuthor ">Michelle D.  Garrett</span>, and <span class="hlFld-ContribAuthor ">Ian  Collins</span>  . </span><span class="cited-content_cbyCitation_article-title">Structure-Guided Evolution of Potent and Selective CHK1 Inhibitors through Scaffold Morphing. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>54 </em>
                                    (24)
                                     , 8328-8342. <a href="https://doi.org/10.1021/jm2007326" title="DOI URL">https://doi.org/10.1021/jm2007326</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm2007326&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm2007326%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-Guided%252BEvolution%252Bof%252BPotent%252Band%252BSelective%252BCHK1%252BInhibitors%252Bthrough%252BScaffold%252BMorphing%26aulast%3DReader%26aufirst%3DJohn%2BC.%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D08062011%26date%3D23112011%26date%3D22122011%26volume%3D54%26issue%3D24%26spage%3D8328%26epage%3D8342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yan  Li</span>, <span class="hlFld-ContribAuthor ">Dong Joon  Kim</span>, <span class="hlFld-ContribAuthor ">Weiya  Ma</span>, <span class="hlFld-ContribAuthor ">Ronald A.  Lubet</span>, <span class="hlFld-ContribAuthor ">Ann M.  Bode</span>, and <span class="hlFld-ContribAuthor ">Zigang  Dong</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Novel Checkpoint Kinase 1 Inhibitors by Virtual Screening Based on Multiple Crystal Structures. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2011,</strong> <em>51 </em>
                                    (11)
                                     , 2904-2914. <a href="https://doi.org/10.1021/ci200257b" title="DOI URL">https://doi.org/10.1021/ci200257b</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ci200257b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fci200257b%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DDiscovery%252Bof%252BNovel%252BCheckpoint%252BKinase%252B1%252BInhibitors%252Bby%252BVirtual%252BScreening%252BBased%252Bon%252BMultiple%252BCrystal%252BStructures%26aulast%3DLi%26aufirst%3DYan%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D10062011%26date%3D12102011%26date%3D28112011%26date%3D28092011%26volume%3D51%26issue%3D11%26spage%3D2904%26epage%3D2914" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paul  Bamborough</span>, <span class="hlFld-ContribAuthor ">Murray J.  Brown</span>, <span class="hlFld-ContribAuthor ">John A.  Christopher</span>, <span class="hlFld-ContribAuthor ">Chun-wa  Chung</span>, and <span class="hlFld-ContribAuthor ">Geoff W.  Mellor</span>  . </span><span class="cited-content_cbyCitation_article-title">Selectivity of Kinase Inhibitor Fragments. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>54 </em>
                                    (14)
                                     , 5131-5143. <a href="https://doi.org/10.1021/jm200349b" title="DOI URL">https://doi.org/10.1021/jm200349b</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm200349b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm200349b%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSelectivity%252Bof%252BKinase%252BInhibitor%252BFragments%26aulast%3DBamborough%26aufirst%3DPaul%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D25032011%26date%3D23062011%26date%3D28072011%26volume%3D54%26issue%3D14%26spage%3D5131%26epage%3D5143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tatiana  McHardy</span>, <span class="hlFld-ContribAuthor ">John J.  Caldwell</span>, <span class="hlFld-ContribAuthor ">Kwai-Ming  Cheung</span>, <span class="hlFld-ContribAuthor ">Lisa J.  Hunter</span>, <span class="hlFld-ContribAuthor ">Kevin  Taylor</span>, <span class="hlFld-ContribAuthor ">Martin  Rowlands</span>, <span class="hlFld-ContribAuthor ">Ruth  Ruddle</span>, <span class="hlFld-ContribAuthor ">Alan  Henley</span>, <span class="hlFld-ContribAuthor ">Alexis  de Haven Brandon</span>, <span class="hlFld-ContribAuthor ">Melanie  Valenti</span>, <span class="hlFld-ContribAuthor ">Thomas G.  Davies</span>, <span class="hlFld-ContribAuthor ">Lynsey  Fazal</span>, <span class="hlFld-ContribAuthor ">Lisa  Seavers</span>, <span class="hlFld-ContribAuthor ">Florence I.  Raynaud</span>, <span class="hlFld-ContribAuthor ">Suzanne A.  Eccles</span>, <span class="hlFld-ContribAuthor ">G. Wynne  Aherne</span>, <span class="hlFld-ContribAuthor ">Michelle D.  Garrett</span> and <span class="hlFld-ContribAuthor ">Ian  Collins</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of 4-Amino-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamides As Selective, Orally Active Inhibitors of Protein Kinase B (Akt). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2010,</strong> <em>53 </em>
                                    (5)
                                     , 2239-2249. <a href="https://doi.org/10.1021/jm901788j" title="DOI URL">https://doi.org/10.1021/jm901788j</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm901788j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm901788j%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B4-Amino-1-%2525287H-pyrrolo%25255B2%25252C3-d%25255Dpyrimidin-4-yl%252529piperidine-4-carboxamides%252BAs%252BSelective%25252C%252BOrally%252BActive%252BInhibitors%252Bof%252BProtein%252BKinase%252BB%252B%252528Akt%252529%26aulast%3DMcHardy%26aufirst%3DTatiana%26date%3D2010%26date%3D2010%26date%3D2009%26date%3D02122009%26date%3D12022010%26date%3D11032010%26volume%3D53%26issue%3D5%26spage%3D2239%26epage%3D2249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthew L. H.  Chu</span>, <span class="hlFld-ContribAuthor ">Zhaolei  Lang</span>, <span class="hlFld-ContribAuthor ">Leonard M. G.  Chavas</span>, <span class="hlFld-ContribAuthor ">João  Neres</span>, <span class="hlFld-ContribAuthor ">Olga S.  Fedorova</span>, <span class="hlFld-ContribAuthor ">Lydia  Tabernero</span>, <span class="hlFld-ContribAuthor ">Mike  Cherry</span>, <span class="hlFld-ContribAuthor ">David H.  Williams</span>, <span class="hlFld-ContribAuthor ">Kenneth T.  Douglas</span> and <span class="hlFld-ContribAuthor ">Patrick A.  Eyers</span>  . </span><span class="cited-content_cbyCitation_article-title">Biophysical and X-ray Crystallographic Analysis of Mps1 Kinase Inhibitor Complexes,. </span><span class="cited-content_cbyCitation_journal-name">Biochemistry</span><span> <strong>2010,</strong> <em>49 </em>
                                    (8)
                                     , 1689-1701. <a href="https://doi.org/10.1021/bi901970c" title="DOI URL">https://doi.org/10.1021/bi901970c</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/bi901970c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fbi901970c%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemistry%26atitle%3DBiophysical%252Band%252BX-ray%252BCrystallographic%252BAnalysis%252Bof%252BMps1%252BKinase%252BInhibitor%252BComplexes%25252C%26aulast%3DChu%26aufirst%3DMatthew%2BL.%2BH.%26date%3D2010%26date%3D2010%26date%3D2009%26date%3D2010%26date%3D15112009%26date%3D25012010%26date%3D04022010%26date%3D02032010%26date%3D25012010%26volume%3D49%26issue%3D8%26spage%3D1689%26epage%3D1701" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rahul  Singh</span>, <span class="hlFld-ContribAuthor ">Vijay Kumar  Bhardwaj</span>, <span class="hlFld-ContribAuthor ">Jatin  Sharma</span>, <span class="hlFld-ContribAuthor ">Pralay  Das</span>, <span class="hlFld-ContribAuthor ">Rituraj  Purohit</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and in silico evaluation of aminoarylbenzosuberene molecules as novel checkpoint kinase 1 inhibitor determinants. </span><span class="cited-content_cbyCitation_journal-name">Genomics</span><span> <strong>2021,</strong> <em>113 </em>
                                    (1)
                                     , 707-715. <a href="https://doi.org/10.1016/j.ygeno.2020.10.001" title="DOI URL">https://doi.org/10.1016/j.ygeno.2020.10.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ygeno.2020.10.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ygeno.2020.10.001%26sid%3Dliteratum%253Aachs%26jtitle%3DGenomics%26atitle%3DDiscovery%252Band%252Bin%252Bsilico%252Bevaluation%252Bof%252Baminoarylbenzosuberene%252Bmolecules%252Bas%252Bnovel%252Bcheckpoint%252Bkinase%252B1%252Binhibitor%252Bdeterminants%26aulast%3DSingh%26aufirst%3DRahul%26date%3D2021%26volume%3D113%26issue%3D1%26spage%3D707%26epage%3D715" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kornelia  Czaja</span>, <span class="hlFld-ContribAuthor ">Jacek  Kujawski</span>, <span class="hlFld-ContribAuthor ">Karol  Kamel</span>, <span class="hlFld-ContribAuthor ">Marek K.  Bernard</span>. </span><span class="cited-content_cbyCitation_article-title">Selected arylsulphonyl pyrazole derivatives as potential Chk1 kinase ligands—computational investigations. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Modeling</span><span> <strong>2020,</strong> <em>26 </em>
                                    (6)
                                     <a href="https://doi.org/10.1007/s00894-020-04407-3" title="DOI URL">https://doi.org/10.1007/s00894-020-04407-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00894-020-04407-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00894-020-04407-3%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Modeling%26atitle%3DSelected%252Barylsulphonyl%252Bpyrazole%252Bderivatives%252Bas%252Bpotential%252BChk1%252Bkinase%252Bligands%2525E2%252580%252594computational%252Binvestigations%26aulast%3DCzaja%26aufirst%3DKornelia%26date%3D2020%26date%3D2020%26volume%3D26%26issue%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Janos  Sapi</span>, <span class="hlFld-ContribAuthor ">Stéphane  Gérard</span>. </span><span class="cited-content_cbyCitation_article-title">Bicyclic 5-6 Systems: Three Heteroatoms 2:1. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,<a href="https://doi.org/10.1016/B978-0-12-818655-8.00021-4" title="DOI URL">https://doi.org/10.1016/B978-0-12-818655-8.00021-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-818655-8.00021-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-818655-8.00021-4%26sid%3Dliteratum%253Aachs%26atitle%3DBicyclic%252B5-6%252BSystems%25253A%252BThree%252BHeteroatoms%252B2%25253A1%26aulast%3DSapi%26aufirst%3DJanos%26date%3D2020%26pub%3DElsevier%26atitle%3DReference%252BModule%252Bin%252BChemistry%25252C%252BMolecular%252BSciences%252Band%252BChemical%252BEngineering%26date%3D2020%26volume%3Dvol.%252010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chao  Tian</span>, <span class="hlFld-ContribAuthor ">Zifei  Han</span>, <span class="hlFld-ContribAuthor ">Yuanxin  Li</span>, <span class="hlFld-ContribAuthor ">Meng  Wang</span>, <span class="hlFld-ContribAuthor ">Jiajia  Yang</span>, <span class="hlFld-ContribAuthor ">Xiaowei  Wang</span>, <span class="hlFld-ContribAuthor ">Zhili  Zhang</span>, <span class="hlFld-ContribAuthor ">Junyi  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of 2,6-disubstituted-9H-purine, 2,4-disubstitued-thieno[3,2-d]pyrimidine and -7H-pyrrolo[2,3-d]pyrimidine analogues as novel CHK1 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>151 </em>, 836-848. <a href="https://doi.org/10.1016/j.ejmech.2018.03.075" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.03.075</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.03.075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.03.075%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252B2%25252C6-disubstituted-9H-purine%25252C%252B2%25252C4-disubstitued-thieno%25255B3%25252C2-d%25255Dpyrimidine%252Band%252B-7H-pyrrolo%25255B2%25252C3-d%25255Dpyrimidine%252Banalogues%252Bas%252Bnovel%252BCHK1%252Binhibitors%26aulast%3DTian%26aufirst%3DChao%26date%3D2018%26volume%3D151%26spage%3D836%26epage%3D848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">D.  Dube</span>, <span class="hlFld-ContribAuthor ">P.  Tiwari</span>, <span class="hlFld-ContribAuthor ">P.  Kaur</span>. </span><span class="cited-content_cbyCitation_article-title">The hunt for antimitotic agents: an overview of structure-based design strategies. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2016,</strong> <em>11 </em>
                                    (6)
                                     , 579-597. <a href="https://doi.org/10.1080/17460441.2016.1174689" title="DOI URL">https://doi.org/10.1080/17460441.2016.1174689</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17460441.2016.1174689&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17460441.2016.1174689%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DThe%252Bhunt%252Bfor%252Bantimitotic%252Bagents%25253A%252Ban%252Boverview%252Bof%252Bstructure-based%252Bdesign%252Bstrategies%26aulast%3DDube%26aufirst%3DD.%26date%3D2016%26date%3D2016%26volume%3D11%26issue%3D6%26spage%3D579%26epage%3D597" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jon A.  Erickson</span>. </span><span class="cited-content_cbyCitation_article-title">Fragment-Based Design of Kinase Inhibitors: A Practical Guide. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2015,</strong>,, 157-183. <a href="https://doi.org/10.1007/978-1-4939-2486-8_13" title="DOI URL">https://doi.org/10.1007/978-1-4939-2486-8_13</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-1-4939-2486-8_13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-1-4939-2486-8_13%26sid%3Dliteratum%253Aachs%26atitle%3DFragment-Based%252BDesign%252Bof%252BKinase%252BInhibitors%25253A%252BA%252BPractical%252BGuide%26aulast%3DErickson%26aufirst%3DJon%2BA.%26date%3D2015%26date%3D2015%26spage%3D157%26epage%3D183%26pub%3DSpringer%2520New%2520York%26atitle%3DFragment-Based%252BMethods%252Bin%252BDrug%252BDiscovery%26aulast%3DKlon%26aufirst%3DAnthony%2BE.%26date%3D2015%26volume%3D1289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Homayon J.  Arabshahi</span>, <span class="hlFld-ContribAuthor ">Michelle  van Rensburg</span>, <span class="hlFld-ContribAuthor ">Lisa I.  Pilkington</span>, <span class="hlFld-ContribAuthor ">Chae Yeon  Jeon</span>, <span class="hlFld-ContribAuthor ">Mirae  Song</span>, <span class="hlFld-ContribAuthor ">Ling-Mey  Gridel</span>, <span class="hlFld-ContribAuthor ">Euphemia  Leung</span>, <span class="hlFld-ContribAuthor ">David  Barker</span>, <span class="hlFld-ContribAuthor ">Milena  Vuica-Ross</span>, <span class="hlFld-ContribAuthor ">Konstantin P.  Volcho</span>, <span class="hlFld-ContribAuthor ">Alexandra L.  Zakharenko</span>, <span class="hlFld-ContribAuthor ">Olga I.  Lavrik</span>, <span class="hlFld-ContribAuthor ">Jóhannes  Reynisson</span>. </span><span class="cited-content_cbyCitation_article-title">A synthesis, in silico, in vitro and in vivo study of thieno[2,3-b]pyridine anticancer analogues. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2015,</strong> <em>6 </em>
                                    (11)
                                     , 1987-1997. <a href="https://doi.org/10.1039/C5MD00245A" title="DOI URL">https://doi.org/10.1039/C5MD00245A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5MD00245A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5MD00245A%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DA%252Bsynthesis%25252C%252Bin%252Bsilico%25252C%252Bin%252Bvitro%252Band%252Bin%252Bvivo%252Bstudy%252Bof%252Bthieno%25255B2%25252C3-b%25255Dpyridine%252Banticancer%252Banalogues%26aulast%3DArabshahi%26aufirst%3DHomayon%2BJ.%26date%3D2015%26date%3D2015%26volume%3D6%26issue%3D11%26spage%3D1987%26epage%3D1997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paul N.  Mortenson</span>, <span class="hlFld-ContribAuthor ">Valerio  Berdini</span>, <span class="hlFld-ContribAuthor ">Marc  O’Reilly</span>. </span><span class="cited-content_cbyCitation_article-title">Fragment-Based Approaches to the Discovery of Kinase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 69-92. <a href="https://doi.org/10.1016/B978-0-12-397918-6.00003-3" title="DOI URL">https://doi.org/10.1016/B978-0-12-397918-6.00003-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-397918-6.00003-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-397918-6.00003-3%26sid%3Dliteratum%253Aachs%26atitle%3DFragment-Based%252BApproaches%252Bto%252Bthe%252BDiscovery%252Bof%252BKinase%252BInhibitors%26aulast%3DMortenson%26aufirst%3DPaul%2BN.%26date%3D2014%26spage%3D69%26epage%3D92%26pub%3DElsevier%26atitle%3DProtein%252BKinase%252BInhibitors%252Bin%252BResearch%252Band%252BMedicine%26date%3D2014%26volume%3D548" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Charlotte E.  Allen</span>, <span class="hlFld-ContribAuthor ">Amanda J.  Welford</span>, <span class="hlFld-ContribAuthor ">Thomas P.  Matthews</span>, <span class="hlFld-ContribAuthor ">John J.  Caldwell</span>, <span class="hlFld-ContribAuthor ">Ian  Collins</span>. </span><span class="cited-content_cbyCitation_article-title">Fragment growing to retain or alter the selectivity of anchored kinase hinge-binding fragments. </span><span class="cited-content_cbyCitation_journal-name">Med. Chem. Commun.</span><span> <strong>2014,</strong> <em>5 </em>
                                    (2)
                                     , 180-185. <a href="https://doi.org/10.1039/C3MD00308F" title="DOI URL">https://doi.org/10.1039/C3MD00308F</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C3MD00308F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC3MD00308F%26sid%3Dliteratum%253Aachs%26jtitle%3DMed.%2520Chem.%2520Commun.%26atitle%3DFragment%252Bgrowing%252Bto%252Bretain%252Bor%252Balter%252Bthe%252Bselectivity%252Bof%252Banchored%252Bkinase%252Bhinge-binding%252Bfragments%26aulast%3DAllen%26aufirst%3DCharlotte%2BE.%26date%3D2014%26date%3D2014%26volume%3D5%26issue%3D2%26spage%3D180%26epage%3D185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thomas P  Matthews</span>, <span class="hlFld-ContribAuthor ">Alan M  Jones</span>, <span class="hlFld-ContribAuthor ">Ian  Collins</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-based design, discovery and development of checkpoint kinase inhibitors as potential anticancer therapies. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2013,</strong> <em>8 </em>
                                    (6)
                                     , 621-640. <a href="https://doi.org/10.1517/17460441.2013.788496" title="DOI URL">https://doi.org/10.1517/17460441.2013.788496</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/17460441.2013.788496&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F17460441.2013.788496%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DStructure-based%252Bdesign%25252C%252Bdiscovery%252Band%252Bdevelopment%252Bof%252Bcheckpoint%252Bkinase%252Binhibitors%252Bas%252Bpotential%252Banticancer%252Btherapies%26aulast%3DMatthews%26aufirst%3DThomas%2BP%26date%3D2013%26date%3D2013%26volume%3D8%26issue%3D6%26spage%3D621%26epage%3D640" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">M. Cris  Silva-Santisteban</span>, <span class="hlFld-ContribAuthor ">Isaac M.  Westwood</span>, <span class="hlFld-ContribAuthor ">Kathy  Boxall</span>, <span class="hlFld-ContribAuthor ">Nathan  Brown</span>, <span class="hlFld-ContribAuthor ">Sam  Peacock</span>, <span class="hlFld-ContribAuthor ">Craig  McAndrew</span>, <span class="hlFld-ContribAuthor ">Elaine  Barrie</span>, <span class="hlFld-ContribAuthor ">Meirion  Richards</span>, <span class="hlFld-ContribAuthor ">Amin  Mirza</span>, <span class="hlFld-ContribAuthor ">Antony W.  Oliver</span>, <span class="hlFld-ContribAuthor ">Rosemary  Burke</span>, <span class="hlFld-ContribAuthor ">Swen  Hoelder</span>, <span class="hlFld-ContribAuthor ">Keith  Jones</span>, <span class="hlFld-ContribAuthor ">G. Wynne  Aherne</span>, <span class="hlFld-ContribAuthor ">Julian  Blagg</span>, <span class="hlFld-ContribAuthor ">Ian  Collins</span>, <span class="hlFld-ContribAuthor ">Michelle D.  Garrett</span>, <span class="hlFld-ContribAuthor ">Rob L. M.  van Montfort</span>, . </span><span class="cited-content_cbyCitation_article-title">Fragment-Based Screening Maps Inhibitor Interactions in the ATP-Binding Site of Checkpoint Kinase 2. </span><span class="cited-content_cbyCitation_journal-name">PLoS ONE</span><span> <strong>2013,</strong> <em>8 </em>
                                    (6)
                                     , e65689. <a href="https://doi.org/10.1371/journal.pone.0065689" title="DOI URL">https://doi.org/10.1371/journal.pone.0065689</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0065689&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0065689%26sid%3Dliteratum%253Aachs%26jtitle%3DPLoS%2520ONE%26atitle%3DFragment-Based%252BScreening%252BMaps%252BInhibitor%252BInteractions%252Bin%252Bthe%252BATP-Binding%252BSite%252Bof%252BCheckpoint%252BKinase%252B2%26aulast%3DSilva-Santisteban%26aufirst%3DM.%2BCris%26date%3D2013%26date%3D2013%26volume%3D8%26issue%3D6%26spage%3De65689" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Steve  Wenglowsky</span>. </span><span class="cited-content_cbyCitation_article-title">Pyrazolo[3,4-
              b
              ]pyridine kinase inhibitors: a patent review (2008 – present). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2013,</strong> <em>23 </em>
                                    (3)
                                     , 281-298. <a href="https://doi.org/10.1517/13543776.2013.749861" title="DOI URL">https://doi.org/10.1517/13543776.2013.749861</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543776.2013.749861&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543776.2013.749861%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DPyrazolo%25255B3%25252C4-%252Bb%252B%25255Dpyridine%252Bkinase%252Binhibitors%25253A%252Ba%252Bpatent%252Breview%252B%2525282008%252B%2525E2%252580%252593%252Bpresent%252529%26aulast%3DWenglowsky%26aufirst%3DSteve%26date%3D2013%26date%3D2013%26volume%3D23%26issue%3D3%26spage%3D281%26epage%3D298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Susan M.  Boyd</span>, <span class="hlFld-ContribAuthor ">Andrew P.  Turnbull</span>, <span class="hlFld-ContribAuthor ">Björn  Walse</span>. </span><span class="cited-content_cbyCitation_article-title">Fragment library design considerations. </span><span class="cited-content_cbyCitation_journal-name">Wiley Interdisciplinary Reviews: Computational Molecular Science</span><span> <strong>2012,</strong> <em>2 </em>
                                    (6)
                                     , 868-885. <a href="https://doi.org/10.1002/wcms.1098" title="DOI URL">https://doi.org/10.1002/wcms.1098</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/wcms.1098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fwcms.1098%26sid%3Dliteratum%253Aachs%26jtitle%3DWiley%2520Interdisciplinary%2520Reviews%253A%2520Computational%2520Molecular%2520Science%26atitle%3DFragment%252Blibrary%252Bdesign%252Bconsiderations%26aulast%3DBoyd%26aufirst%3DSusan%2BM.%26date%3D2012%26date%3D2012%26volume%3D2%26issue%3D6%26spage%3D868%26epage%3D885" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Julio  Caballero</span>, <span class="hlFld-ContribAuthor ">Szymon  Zilocchi</span>, <span class="hlFld-ContribAuthor ">William  Tiznado</span>, <span class="hlFld-ContribAuthor ">Simona  Collina</span>. </span><span class="cited-content_cbyCitation_article-title">Docking and quantitative structure–activity relationship studies for imidazo[1,2-a]pyrazines as inhibitors of checkpoint kinase-1. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2012,</strong> <em>21 </em>
                                    (8)
                                     , 1912-1920. <a href="https://doi.org/10.1007/s00044-011-9714-1" title="DOI URL">https://doi.org/10.1007/s00044-011-9714-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-011-9714-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-011-9714-1%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DDocking%252Band%252Bquantitative%252Bstructure%2525E2%252580%252593activity%252Brelationship%252Bstudies%252Bfor%252Bimidazo%25255B1%25252C2-a%25255Dpyrazines%252Bas%252Binhibitors%252Bof%252Bcheckpoint%252Bkinase-1%26aulast%3DCaballero%26aufirst%3DJulio%26date%3D2012%26date%3D2011%26volume%3D21%26issue%3D8%26spage%3D1912%26epage%3D1920" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Premlata K.  Ambre</span>, <span class="hlFld-ContribAuthor ">Raghuvir R. S.  Pissurlenkar</span>, <span class="hlFld-ContribAuthor ">Evans C.  Coutinho</span>, <span class="hlFld-ContribAuthor ">Radhakrishnan P.  Iyer</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of new checkpoint kinase-1 (Chk1) inhibitors by docking, 3D-QSAR, and pharmacophore-modeling methods. </span><span class="cited-content_cbyCitation_journal-name">Canadian Journal of Chemistry</span><span> <strong>2012,</strong> <em>90 </em>
                                    (8)
                                     , 675-692. <a href="https://doi.org/10.1139/v2012-047" title="DOI URL">https://doi.org/10.1139/v2012-047</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1139/v2012-047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1139%2Fv2012-047%26sid%3Dliteratum%253Aachs%26jtitle%3DCanadian%2520Journal%2520of%2520Chemistry%26atitle%3DIdentification%252Bof%252Bnew%252Bcheckpoint%252Bkinase-1%252B%252528Chk1%252529%252Binhibitors%252Bby%252Bdocking%25252C%252B3D-QSAR%25252C%252Band%252Bpharmacophore-modeling%252Bmethods%26aulast%3DAmbre%26aufirst%3DPremlata%2BK.%26date%3D2012%26volume%3D90%26issue%3D8%26spage%3D675%26epage%3D692" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael  Lainchbury</span>, <span class="hlFld-ContribAuthor ">Ian  Collins</span>. </span><span class="cited-content_cbyCitation_article-title">Checkpoint kinase inhibitors: a patent review (2009 – 2010). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2011,</strong> <em>21 </em>
                                    (8)
                                     , 1191-1210. <a href="https://doi.org/10.1517/13543776.2011.586632" title="DOI URL">https://doi.org/10.1517/13543776.2011.586632</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543776.2011.586632&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543776.2011.586632%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DCheckpoint%252Bkinase%252Binhibitors%25253A%252Ba%252Bpatent%252Breview%252B%2525282009%252B%2525E2%252580%252593%252B2010%252529%26aulast%3DLainchbury%26aufirst%3DMichael%26date%3D2011%26date%3D2011%26volume%3D21%26issue%3D8%26spage%3D1191%26epage%3D1210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael P.  Dwyer</span>, <span class="hlFld-ContribAuthor ">Kamil  Paruch</span>, <span class="hlFld-ContribAuthor ">Marc  Labroli</span>, <span class="hlFld-ContribAuthor ">Carmen  Alvarez</span>, <span class="hlFld-ContribAuthor ">Kerry M.  Keertikar</span>, <span class="hlFld-ContribAuthor ">Cory  Poker</span>, <span class="hlFld-ContribAuthor ">Randall  Rossman</span>, <span class="hlFld-ContribAuthor ">Thierry O.  Fischmann</span>, <span class="hlFld-ContribAuthor ">Jose S.  Duca</span>, <span class="hlFld-ContribAuthor ">Vincent  Madison</span>, <span class="hlFld-ContribAuthor ">David  Parry</span>, <span class="hlFld-ContribAuthor ">Nicole  Davis</span>, <span class="hlFld-ContribAuthor ">Wolfgang  Seghezzi</span>, <span class="hlFld-ContribAuthor ">Derek  Wiswell</span>, <span class="hlFld-ContribAuthor ">Timothy J.  Guzi</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of pyrazolo[1,5-a]pyrimidine-based CHK1 inhibitors: A template-based approach—Part 1. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2011,</strong> <em>21 </em>
                                    (1)
                                     , 467-470. <a href="https://doi.org/10.1016/j.bmcl.2010.10.113" title="DOI URL">https://doi.org/10.1016/j.bmcl.2010.10.113</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2010.10.113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2010.10.113%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Bpyrazolo%25255B1%25252C5-a%25255Dpyrimidine-based%252BCHK1%252Binhibitors%25253A%252BA%252Btemplate-based%252Bapproach%2525E2%252580%252594Part%252B1%26aulast%3DDwyer%26aufirst%3DMichael%2BP.%26date%3D2011%26volume%3D21%26issue%3D1%26spage%3D467%26epage%3D470" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marc  Labroli</span>, <span class="hlFld-ContribAuthor ">Kamil  Paruch</span>, <span class="hlFld-ContribAuthor ">Michael P.  Dwyer</span>, <span class="hlFld-ContribAuthor ">Carmen  Alvarez</span>, <span class="hlFld-ContribAuthor ">Kartik  Keertikar</span>, <span class="hlFld-ContribAuthor ">Cory  Poker</span>, <span class="hlFld-ContribAuthor ">Randall  Rossman</span>, <span class="hlFld-ContribAuthor ">Jose S.  Duca</span>, <span class="hlFld-ContribAuthor ">Thierry O.  Fischmann</span>, <span class="hlFld-ContribAuthor ">Vincent  Madison</span>, <span class="hlFld-ContribAuthor ">David  Parry</span>, <span class="hlFld-ContribAuthor ">Nicole  Davis</span>, <span class="hlFld-ContribAuthor ">Wolfgang  Seghezzi</span>, <span class="hlFld-ContribAuthor ">Derek  Wiswell</span>, <span class="hlFld-ContribAuthor ">Timothy J.  Guzi</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of pyrazolo[1,5-a]pyrimidine-based CHK1 inhibitors: A template-based approach—Part 2. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2011,</strong> <em>21 </em>
                                    (1)
                                     , 471-474. <a href="https://doi.org/10.1016/j.bmcl.2010.10.114" title="DOI URL">https://doi.org/10.1016/j.bmcl.2010.10.114</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2010.10.114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2010.10.114%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Bpyrazolo%25255B1%25252C5-a%25255Dpyrimidine-based%252BCHK1%252Binhibitors%25253A%252BA%252Btemplate-based%252Bapproach%2525E2%252580%252594Part%252B2%26aulast%3DLabroli%26aufirst%3DMarc%26date%3D2011%26volume%3D21%26issue%3D1%26spage%3D471%26epage%3D474" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zenon D  Konteatis</span>. </span><span class="cited-content_cbyCitation_article-title">In silico
              fragment-based drug design. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2010,</strong> <em>5 </em>
                                    (11)
                                     , 1047-1065. <a href="https://doi.org/10.1517/17460441.2010.523697" title="DOI URL">https://doi.org/10.1517/17460441.2010.523697</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/17460441.2010.523697&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F17460441.2010.523697%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DIn%252Bsilico%252Bfragment-based%252Bdrug%252Bdesign%26aulast%3DKonteatis%26aufirst%3DZenon%2BD%26date%3D2010%26date%3D2010%26volume%3D5%26issue%3D11%26spage%3D1047%26epage%3D1065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christopher W  Murray</span>, <span class="hlFld-ContribAuthor ">Tom L  Blundell</span>. </span><span class="cited-content_cbyCitation_article-title">Structural biology in fragment-based drug design. </span><span class="cited-content_cbyCitation_journal-name">Current Opinion in Structural Biology</span><span> <strong>2010,</strong> <em>20 </em>
                                    (4)
                                     , 497-507. <a href="https://doi.org/10.1016/j.sbi.2010.04.003" title="DOI URL">https://doi.org/10.1016/j.sbi.2010.04.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.sbi.2010.04.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.sbi.2010.04.003%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Opinion%2520in%2520Structural%2520Biology%26atitle%3DStructural%252Bbiology%252Bin%252Bfragment-based%252Bdrug%252Bdesign%26aulast%3DMurray%26aufirst%3DChristopher%2BW%26date%3D2010%26volume%3D20%26issue%3D4%26spage%3D497%26epage%3D507" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thomas P.  Matthews</span>, <span class="hlFld-ContribAuthor ">Tatiana  McHardy</span>, <span class="hlFld-ContribAuthor ">Suki  Klair</span>, <span class="hlFld-ContribAuthor ">Kathy  Boxall</span>, <span class="hlFld-ContribAuthor ">Martin  Fisher</span>, <span class="hlFld-ContribAuthor ">Michael  Cherry</span>, <span class="hlFld-ContribAuthor ">Charlotte E.  Allen</span>, <span class="hlFld-ContribAuthor ">Glynn J.  Addison</span>, <span class="hlFld-ContribAuthor ">John  Ellard</span>, <span class="hlFld-ContribAuthor ">G. Wynne  Aherne</span>, <span class="hlFld-ContribAuthor ">Isaac M.  Westwood</span>, <span class="hlFld-ContribAuthor ">Rob van  Montfort</span>, <span class="hlFld-ContribAuthor ">Michelle D.  Garrett</span>, <span class="hlFld-ContribAuthor ">John C.  Reader</span>, <span class="hlFld-ContribAuthor ">Ian  Collins</span>. </span><span class="cited-content_cbyCitation_article-title">Design and evaluation of 3,6-di(hetero)aryl imidazo[1,2-a]pyrazines as inhibitors of checkpoint and other kinases. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2010,</strong> <em>20 </em>
                                    (14)
                                     , 4045-4049. <a href="https://doi.org/10.1016/j.bmcl.2010.05.096" title="DOI URL">https://doi.org/10.1016/j.bmcl.2010.05.096</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2010.05.096&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2010.05.096%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%252Band%252Bevaluation%252Bof%252B3%25252C6-di%252528hetero%252529aryl%252Bimidazo%25255B1%25252C2-a%25255Dpyrazines%252Bas%252Binhibitors%252Bof%252Bcheckpoint%252Band%252Bother%252Bkinases%26aulast%3DMatthews%26aufirst%3DThomas%2BP.%26date%3D2010%26volume%3D20%26issue%3D14%26spage%3D4045%26epage%3D4049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael I.  Walton</span>, <span class="hlFld-ContribAuthor ">Paul D.  Eve</span>, <span class="hlFld-ContribAuthor ">Angela  Hayes</span>, <span class="hlFld-ContribAuthor ">Melanie  Valenti</span>, <span class="hlFld-ContribAuthor ">Alexis  De Haven Brandon</span>, <span class="hlFld-ContribAuthor ">Gary  Box</span>, <span class="hlFld-ContribAuthor ">Kathy J.  Boxall</span>, <span class="hlFld-ContribAuthor ">G. Wynne  Aherne</span>, <span class="hlFld-ContribAuthor ">Suzanne A.  Eccles</span>, <span class="hlFld-ContribAuthor ">Florence I.  Raynaud</span>, <span class="hlFld-ContribAuthor ">David H.  Williams</span>, <span class="hlFld-ContribAuthor ">John C.  Reader</span>, <span class="hlFld-ContribAuthor ">Ian  Collins</span>, <span class="hlFld-ContribAuthor ">Michelle D.  Garrett</span>. </span><span class="cited-content_cbyCitation_article-title">The Preclinical Pharmacology and Therapeutic Activity of the Novel CHK1 Inhibitor SAR-020106. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Therapeutics</span><span> <strong>2010,</strong> <em>9 </em>
                                    (1)
                                     , 89-100. <a href="https://doi.org/10.1158/1535-7163.MCT-09-0938" title="DOI URL">https://doi.org/10.1158/1535-7163.MCT-09-0938</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1535-7163.MCT-09-0938&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1535-7163.MCT-09-0938%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Therapeutics%26atitle%3DThe%252BPreclinical%252BPharmacology%252Band%252BTherapeutic%252BActivity%252Bof%252Bthe%252BNovel%252BCHK1%252BInhibitor%252BSAR-020106%26aulast%3DWalton%26aufirst%3DMichael%2BI.%26date%3D2010%26date%3D2010%26volume%3D9%26issue%3D1%26spage%3D89%26epage%3D100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900314j/production/images/medium/jm-2009-00314j_0010.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900314j/production/images/large/jm-2009-00314j_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900314j&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900314j/production/images/medium/jm-2009-00314j_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900314j/production/images/large/jm-2009-00314j_0004.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Structures of Selected Published Clinical Candidate CHK1 Inhibitors</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900314j/production/images/large/jm-2009-00314j_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900314j&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900314j/production/images/medium/jm-2009-00314j_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900314j/production/images/large/jm-2009-00314j_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. CHK1 ATP-binding site pharmacophore used for the virtual screen of commercially available templates.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900314j/production/images/large/jm-2009-00314j_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900314j&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Chart 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900314j/production/images/medium/jm-2009-00314j_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900314j/production/images/large/jm-2009-00314j_0005.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 2. Chemical Structures of the Nine Template Hits Validated by CHK1 Crystallography<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900314j/production/images/large/jm-2009-00314j_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900314j&amp;id=cht2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Chart a</span>Compounds <b>1</b> and <b>2</b> were lower confidence hits from the bioassay, which showed some nonspecific inhibition, while compounds <b>3</b>−<b>9</b> were high confidence hits that showed similar activity in the presence and absence of Triton X-100 detergent in the bioassay.</p></p></figure><figure data-id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900314j/production/images/medium/jm-2009-00314j_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900314j/production/images/large/jm-2009-00314j_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Summary of the template screening cascade and hit validation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900314j/production/images/large/jm-2009-00314j_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900314j&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900314j/production/images/medium/jm-2009-00314j_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900314j/production/images/large/jm-2009-00314j_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Crystal structures of hits <b>5</b> (A), <b>6</b> (B), <b>7</b> (C), <b>8</b> (D), and <b>9</b> (E) in the ATP binding pocket of CHK1. Panel F: Overlay of hits <b>5</b>−<b>9</b> relative to the hinge-region of CHK1, orange = <b>5</b>, gray = <b>6</b>, red = <b>7</b>, cyan = <b>8</b>, green = <b>9</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900314j/production/images/large/jm-2009-00314j_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900314j&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900314j/production/images/medium/jm-2009-00314j_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900314j/production/images/large/jm-2009-00314j_0009.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Details of the binding of <b>9</b> (A), <b>10</b> (B), <b>12</b> (C), and <b>14</b> (D) to CHK1 kinase domain. Residues and side chains not involved in binding are omitted for clarity. Water molecules detected in the interior pocket of CHK1 or hydrogen bonded to the inhibitors are shown as red spheres. Hydrogen bonds to the inhibitors are shown as dashed green lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900314j/production/images/large/jm-2009-00314j_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900314j&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900314j/production/images/medium/jm-2009-00314j_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900314j/production/images/large/jm-2009-00314j_0001.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900314j/production/images/large/jm-2009-00314j_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900314j&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) POCl<sub>3</sub>, 110°C; (ii) <i>tert</i>-butyl morpholin-2-ylmethylcarbamate, Et<sub>3</sub>N, <i>n</i>-BuOH, 100°C (53% over 2 steps); (iii) 4M HCl−dioxane, rt (8%); (iv) POCl<sub>3</sub>, 60°C (79%); (v) <i>tert</i>-butyl morpholin-2-ylmethylcarbamate, Et<sub>3</sub>N, <i>n</i>-BuOH, 100°C (49%); (vi) ArB(OH)<sub>2</sub>, Pd(dppf)Cl<sub>2</sub>, Na<sub>2</sub>CO<sub>3</sub>, H<sub>2</sub>O, MeCN, 140°C, microwave; (vii) CF<sub>3</sub>CO<sub>2</sub>H, 40°C (16−41% over 2 steps).</p></p></figure><figure data-id="sch2" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900314j/production/images/medium/jm-2009-00314j_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900314j/production/images/large/jm-2009-00314j_0002.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900314j/production/images/large/jm-2009-00314j_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900314j&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) TsCl, Et<sub>3</sub>N, DMAP, CH<sub>2</sub>Cl<sub>2</sub>, 0°C → rt (85%); (ii) NaN<sub>3</sub>, DMF, 80°C; (iii) NH<sub>4</sub><sup>+</sup>HCO<sub>2</sub><sup>−</sup>, Pd/C, MeOH, rt; (iv) Cbz-Cl, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, rt (42% over 3 steps); (v) 4M HCl-dioxane, 0°C → 5°C (83%); (vi) 5-bromo-4-chloro-1-(4-methoxybenzyl)-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine, Et<sub>3</sub>N, <i>n</i>-BuOH, 160°C, microwave (67%); (vii) PhB(OH)<sub>2</sub>, Pd(dppf)Cl<sub>2</sub>, Na<sub>2</sub>CO<sub>3</sub>, H<sub>2</sub>O, MeCN, 140°C, microwave (48%); (viii) CF<sub>3</sub>CO<sub>2</sub>H, 40°C (55%).</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i20">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74883" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74883" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 47 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Walworth, N.</span><span> </span><span class="NLM_article-title">Cell-cycle checkpoint kinases: checking in on the cell cycle</span> <span class="citation_source-journal">Curr. Opin. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">697</span><span class="NLM_x">–</span> <span class="NLM_lpage">704</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm900314j&amp;key=10.1016%2FS0955-0674%2800%2900154-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm900314j&amp;key=11063934" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm900314j&amp;key=1%3ACAS%3A528%3ADC%252BD3cXovVagsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2000&pages=697-704&author=N.+Walworth&title=Cell-cycle+checkpoint+kinases%3A+checking+in+on+the+cell+cycle"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Cell-cycle checkpoint kinases: checking in on the cell cycle</span></div><div class="casAuthors">Walworth, Nancy C.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Cell Biology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">697-704</span>CODEN:
                <span class="NLM_cas:coden">COCBE3</span>;
        ISSN:<span class="NLM_cas:issn">0955-0674</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review, with 80 refs.  In response to DNA damage, cell-cycle checkpoints integrate cell-cycle control with DNA repair.  The idea that checkpoint controls are an integral component of normal cell-cycle progression has arisen as a result of studies in Drosophila and mice.  In addn., an appreciation that DNA damage arises as a natural consequence of cellular metab., including DNA replication itself, has influenced thinking regarding the nature of checkpoint pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-rtR1VBU73rVg90H21EOLACvtfcHk0lhOZ4nbMT0gIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXovVagsLo%253D&md5=457f90681ab2c930480d3b3228502036</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2FS0955-0674%2800%2900154-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0955-0674%252800%252900154-X%26sid%3Dliteratum%253Aachs%26aulast%3DWalworth%26aufirst%3DN.%26atitle%3DCell-cycle%2520checkpoint%2520kinases%253A%2520checking%2520in%2520on%2520the%2520cell%2520cycle%26jtitle%3DCurr.%2520Opin.%2520Cell%2520Biol.%26date%3D2000%26volume%3D12%26spage%3D697%26epage%3D704" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Bartek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukas, J.</span><span> </span><span class="NLM_article-title">Chk1 and Chk2 kinases in checkpoint control and cancer</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">421</span><span class="NLM_x">–</span> <span class="NLM_lpage">429</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=421-429&author=J.+Bartekauthor=J.+Lukas&title=Chk1+and+Chk2+kinases+in+checkpoint+control+and+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBartek%26aufirst%3DJ.%26aulast%3DLukas%26aufirst%3DJ.%26atitle%3DChk1%2520and%2520Chk2%2520kinases%2520in%2520checkpoint%2520control%2520and%2520cancer%26jtitle%3DCancer%2520Cell%26date%3D2003%26volume%3D3%26spage%3D421%26epage%3D429" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leverson, J. D.</span><span> </span><span class="NLM_article-title">New opportunities in chemosensitization and radiosensitization: modulating the DNA-damage response</span> <span class="citation_source-journal">Expert Rev. Anticancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">333</span><span class="NLM_x">–</span> <span class="NLM_lpage">342</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm900314j&amp;key=10.1586%2F14737140.5.2.333" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm900314j&amp;key=15877529" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm900314j&amp;key=1%3ACAS%3A528%3ADC%252BD2MXktlajt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=333-342&author=Y.+Luoauthor=J.+D.+Leverson&title=New+opportunities+in+chemosensitization+and+radiosensitization%3A+modulating+the+DNA-damage+response"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">New opportunities in chemosensitization and radiosensitization: Modulating the DNA-damage response</span></div><div class="casAuthors">Luo, Yan; Leverson, Joel D.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Anticancer Therapy</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">333-342</span>CODEN:
                <span class="NLM_cas:coden">ERATBJ</span>;
        ISSN:<span class="NLM_cas:issn">1473-7140</span>.
    
            (<span class="NLM_cas:orgname">Future Drugs Ltd.</span>)
        </div><div class="casAbstract">A review.  Many current cancer treatments, including certain classes of chemotherapeutics and radiation, induce cytotoxicity by damaging DNA.  However, many cancers are resistant to these therapies, which represents a significant challenge in the clinic.  Thus, modulating DNA-damage responses to selectively enhance the sensitivity of cancer cells to these therapies is highly desirable.  When DNA damage is detected, DNA checkpoint mechanisms are activated to halt cells at various phases of the cell cycle.  Simultaneously, DNA-damage sensors transduce signals to activate DNA-repair mechanisms via de novo expression or post-translational modification of enzymes required for DNA repair.  P53 is the major player in a checkpoint that arrests cells at the G1/S boundary, while checkpoint kinase (Chk)1 is crit. for the G2/M checkpoint and also the S checkpoint that prevents cell cycle progression after replication defects (intra-S-phase checkpoint) or S/M uncoupling (S/M checkpoint).  Poly(ADP-ribose) polymerase is involved in sensing DNA single-strand breaks and inducing DNA repair via poly(ADP-ribosyl)ating various DNA-binding and DNA-repair proteins.  In this review, strategies for implementing small-mol. inhibitors of poly(ADP-ribose) polymerase and Chk1, which are emerging as potential adjuncts to current therapies, are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzQYSJtb4VSrVg90H21EOLACvtfcHk0lhOZ4nbMT0gIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXktlajt7w%253D&md5=0bd7912a0cf8b8cc4ecbdb96b8672782</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1586%2F14737140.5.2.333&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252F14737140.5.2.333%26sid%3Dliteratum%253Aachs%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DLeverson%26aufirst%3DJ.%2BD.%26atitle%3DNew%2520opportunities%2520in%2520chemosensitization%2520and%2520radiosensitization%253A%2520modulating%2520the%2520DNA-damage%2520response%26jtitle%3DExpert%2520Rev.%2520Anticancer%2520Ther.%26date%3D2005%26volume%3D5%26spage%3D333%26epage%3D342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Bourdon, J.-C.</span><span> </span><span class="NLM_article-title">p53 and its isoforms in cancer</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">277</span><span class="NLM_x">–</span> <span class="NLM_lpage">282</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm900314j&amp;key=10.1038%2Fsj.bjc.6603886" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm900314j&amp;key=17637683" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm900314j&amp;key=1%3ACAS%3A528%3ADC%252BD2sXotlSgt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2007&pages=277-282&author=J.-C.+Bourdon&title=p53+and+its+isoforms+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">p53 and its isoforms in cancer</span></div><div class="casAuthors">Bourdon, J.-C.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">277-282</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  P53, p63 and p73 are members of the p53 gene family involved in development, differentiation and response to cellular stress. p53 gene is a transcription factor essential for the prevention of cancer formation.  The p53 pathway is ubiquitously lost in human cancer either by p53 gene mutation (60% of cancers) or by lost of cell signalling upstream and downstream of p53 in the remaining cancers expressing WTp53 gene.  As p53 pathway inactivation is a common denominator to all cancers, the understanding of p53 tumor suppressor activity is likely to bring us closer to cancer therapy.  However, despite all the exptl. evidences showing the importance of p53 in preventing carcinogenesis, it is difficult in clin. studies to link p53 status to cancer treatment and clin. outcome.  The recent discovery that p53 gene encodes for nine different p53 proteins (isoforms) may have a profound impact on our understanding of p53 tumor suppressor activity.  Studies in several tumor types have shown that the nine different p53 isoforms are abnormally expressed in tumor tissues compared to normal cells. p53 protein isoforms modulate p53 transcriptional activity and cell fate outcome in response to stress.  Regulation of p53 function in normal and tumor tissues in man is likely to be more complex than has been hitherto appreciated.  Therefore, the tumor p53 status needs to be detd. more accurately by integrating p53 isoform expression, functional p53 mutation anal. and a panel of antibodies specific of p53 and of its target genes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqf6wgB9kOGm7Vg90H21EOLACvtfcHk0ljKR9aBK1FTPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXotlSgt78%253D&md5=939a18836ca7ea948adfaf2c4bbd0dcb</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6603886&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6603886%26sid%3Dliteratum%253Aachs%26aulast%3DBourdon%26aufirst%3DJ.-C.%26atitle%3Dp53%2520and%2520its%2520isoforms%2520in%2520cancer%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2007%26volume%3D97%26spage%3D277%26epage%3D282" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sowin, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sham, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fesik, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span> </span><span class="NLM_article-title">Human Chk1 expression is dispensable for somatic cell death and critical for sustaining G2 DNA damage checkpoint</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">543</span><span class="NLM_x">–</span> <span class="NLM_lpage">548</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm900314j&amp;key=10.4161%2Fcbt.2.5.454" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm900314j&amp;key=12813133" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm900314j&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlslWkt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2003&pages=543-548&author=Z.+Chenauthor=Z.+Xiaoauthor=J.+Chenauthor=S.+C.+Ngauthor=T.+Sowinauthor=H.+Shamauthor=S.+Rosenbergauthor=S.+Fesikauthor=H.+Zhang&title=Human+Chk1+expression+is+dispensable+for+somatic+cell+death+and+critical+for+sustaining+G2+DNA+damage+checkpoint"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Human Chk1 expression is dispensable for somatic cell death and critical for sustaining G2 DNA damage checkpoint</span></div><div class="casAuthors">Chen, Zehan; Xiao, Zhan; Chen, Jun; Ng, Shi-Chung; Sowin, Thomas; Sham, Hing; Rosenberg, Saul; Fesik, Steve; Zhang, Haiying</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">543-548</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Mammalian Chk1 is an essential kinase for embryonic development and plays an important role in the cellular response to DNA damage.  However, it remains unclear whether inhibition of Chk1 induces apoptosis in somatic cells.  The uncertainty has become a crit. issue for rationale design of Chk1 mechanism-based anticancer drugs.  Here we show that Chk1 small interfering RNA (siRNA) effectively eliminates Chk1 protein expression without altering the cell cycle profile or inducing apoptosis in various human cancer cell lines under normal conditions.  In the presence of DNA-damaging agents, however, Chk1 siRNA alone is sufficient to abrogate the DNA damage-induced G2 checkpoint and significantly enhance apoptosis.  Cell cycle kinetic profiles show that abrogation of G2 arrest is mediated through shortening of the checkpoint.  We also demonstrate that Chk1 siRNA enhances DNA damage-induced apoptosis in p53-deficient cancer cell lines and augments the growth inhibition conferred by DNA-damaging agents.  These findings imply that Chk1 inhibitors will have low cytotoxicity on their own and can enhance the efficacy of DNA-damaging drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpD0X4IEJ-mh7Vg90H21EOLACvtfcHk0ljKR9aBK1FTPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlslWkt7k%253D&md5=13351c9321140baebd0728fd0f7f36a9</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.4161%2Fcbt.2.5.454&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcbt.2.5.454%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DXiao%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DNg%26aufirst%3DS.%2BC.%26aulast%3DSowin%26aufirst%3DT.%26aulast%3DSham%26aufirst%3DH.%26aulast%3DRosenberg%26aufirst%3DS.%26aulast%3DFesik%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DH.%26atitle%3DHuman%2520Chk1%2520expression%2520is%2520dispensable%2520for%2520somatic%2520cell%2520death%2520and%2520critical%2520for%2520sustaining%2520G2%2520DNA%2520damage%2520checkpoint%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2003%26volume%3D2%26spage%3D543%26epage%3D548" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Bucher, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Britten, C. D.</span><span> </span><span class="NLM_article-title">G2 checkpoint abrogation and checkpoint kinase-1 targeting in the treatment of cancer</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">523</span><span class="NLM_x">–</span> <span class="NLM_lpage">528</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm900314j&amp;key=10.1038%2Fsj.bjc.6604208" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm900314j&amp;key=18231106" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm900314j&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhs1KrsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2008&pages=523-528&author=N.+Bucherauthor=C.+D.+Britten&title=G2+checkpoint+abrogation+and+checkpoint+kinase-1+targeting+in+the+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">G2 checkpoint abrogation and checkpoint kinase-1 targeting in the treatment of cancer</span></div><div class="casAuthors">Bucher, N.; Britten, C. D.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">523-528</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Rigorous quality control steps, termed checkpoints, tightly regulate progression through the cell cycle.  DNA-damaging chemotherapy and radiation activate functional cellular checkpoints.  These checkpoints can facilitate DNA repair and promote cell death in unrepaired cells.  There are at least three DNA damage checkpoints - at G1/S, S, and G2/M - as well as a mitotic spindle checkpoint.  Most cancer cells harbor mutations in tumor suppressors and/or oncogenes, which impair certain cell checkpoints.  Inhibiting the remaining cell checkpoints - particularly after exposure of cancer cells to chemotherapy and/or radiation - allows cell death, a strategy now being employed in cancer therapeutics.  With our increasing knowledge of cell cycle regulation, many compds. have been developed to inhibit specific checkpoint components, particularly at the G2/M transition.  One such target is checkpoint kinase-1 (Chk1).  We review here the mol. framework of the cell cycle, the rationale for targeting Chk1, the preclin. concepts related to the development of Chk1 inhibitors, and the efficacy and safety results from Chk1 inhibitors now in phase I/II trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKqRg9PDH1B7Vg90H21EOLACvtfcHk0lhasyBXTnCgbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhs1KrsLc%253D&md5=607123f2a15cbe76fbd2aba55da7d289</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6604208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6604208%26sid%3Dliteratum%253Aachs%26aulast%3DBucher%26aufirst%3DN.%26aulast%3DBritten%26aufirst%3DC.%2BD.%26atitle%3DG2%2520checkpoint%2520abrogation%2520and%2520checkpoint%2520kinase-1%2520targeting%2520in%2520the%2520treatment%2520of%2520cancer%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2008%26volume%3D98%26spage%3D523%26epage%3D528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xue, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bui, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kovar, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tao, Z.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, N.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sham, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J. Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sowin, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span> </span><span class="NLM_article-title">Selective Chk1 inhibitors differentially sensitize p53-deficient cells to cancer therapeutics</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">119</span><span class="NLM_x">, </span> <span class="NLM_fpage">2784</span><span class="NLM_x">–</span> <span class="NLM_lpage">2794</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm900314j&amp;key=10.1002%2Fijc.22198" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm900314j&amp;key=17019715" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm900314j&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1yqt7vK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2006&pages=2784-2794&author=Z.+Chenauthor=X.+Xiaoauthor=W.+Guauthor=J.+Xueauthor=M.+H.+Buiauthor=P.+Kovarauthor=G.+Liauthor=G.+Wangauthor=Z.-F.+Taoauthor=Y.+Tongauthor=N.-H.+Linauthor=H.+L.+Shamauthor=J.+Y.+J.+Wangauthor=T.+J.+Sowinauthor=S.+H.+Rosenbergauthor=H.+Zhang&title=Selective+Chk1+inhibitors+differentially+sensitize+p53-deficient+cells+to+cancer+therapeutics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Selective Chk1 inhibitors differentially sensitize p53-deficient cancer cells to cancer therapeutics</span></div><div class="casAuthors">Chen, Zehan; Xiao, Zhan; Gu, Wen-zhen; Xue, John; Bui, Mai H.; Kovar, Peter; Li, Gaoquan; Wang, Gary; Tao, Zhi-Fu; Tong, Yunsong; Lin, Nan-Horng; Sham, Hing L.; Wang, Jean Y. J.; Sowin, Thomas J.; Rosenberg, Saul H.; Zhang, Haiying</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2784-2794</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">The majority of cancer therapeutics induces DNA damage to kill cells.  Normal proliferating cells undergo cell cycle arrest in response to DNA damage, thus allowing DNA repair to protect the genome.  DNA damage induced cell cycle arrest depends on an evolutionarily conserved signal transduction network in which the Chk1 kinase plays a crit. role.  In mammalian cells, the p53 and RB pathways further augment the cell cycle arrest response to prevent catastrophic cell death.  Given the fact that most tumor cells suffer defects in the p53 and RB pathways, it is likely that tumor cells would depend more on the Chk1 kinase to maintain cell cycle arrest than would normal cells.  Therefore Chk1 inhibition could be used to specifically sensitize tumor cells to DNA-damaging agents.  We have previously shown that siRNA-mediated Chk1 knockdown abrogates DNA damage-induced checkpoints and potentiates the cytotoxicity of several DNA-damaging agents in p53-deficient cell lines.  In this study, we have developed 2 potent and selective Chk1 inhibitors, A-690002 and A-641397, and shown that these compds. abrogate cell cycle checkpoints and potentiate the cytotoxicity of topoisomerase inhibitors and γ-radiation in p53-deficient but not in p53-proficient cells of different tissue origins.  These results indicate that it is feasible to achieve a therapeutic window with 1 or more Chk1 inhibitors in potentiation of cancer therapy based on the status of the p53 pathway in a wide spectrum of tumor types.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWCzPiGB4dXbVg90H21EOLACvtfcHk0lhasyBXTnCgbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1yqt7vK&md5=5b9574d46444ba16210e96de0f8f8f3c</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1002%2Fijc.22198&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.22198%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DXiao%26aufirst%3DX.%26aulast%3DGu%26aufirst%3DW.%26aulast%3DXue%26aufirst%3DJ.%26aulast%3DBui%26aufirst%3DM.%2BH.%26aulast%3DKovar%26aufirst%3DP.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DTao%26aufirst%3DZ.-F.%26aulast%3DTong%26aufirst%3DY.%26aulast%3DLin%26aufirst%3DN.-H.%26aulast%3DSham%26aufirst%3DH.%2BL.%26aulast%3DWang%26aufirst%3DJ.%2BY.%2BJ.%26aulast%3DSowin%26aufirst%3DT.%2BJ.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DZhang%26aufirst%3DH.%26atitle%3DSelective%2520Chk1%2520inhibitors%2520differentially%2520sensitize%2520p53-deficient%2520cells%2520to%2520cancer%2520therapeutics%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2006%26volume%3D119%26spage%3D2784%26epage%3D2794" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Zhou, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartek, J.</span><span> </span><span class="NLM_article-title">Targeting the checkpoint kinases: chemosensitization versus chemoprotection</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">216</span><span class="NLM_x">–</span> <span class="NLM_lpage">225</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm900314j&amp;key=10.1038%2Fnrc1296" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm900314j&amp;key=14993903" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm900314j&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhs1Ggsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=216-225&author=B.+B.+Zhouauthor=J.+Bartek&title=Targeting+the+checkpoint+kinases%3A+chemosensitization+versus+chemoprotection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the checkpoint kinases: chemosensitization versus chemoprotection</span></div><div class="casAuthors">Zhou, Bin-Bing S.; Bartek, Jiri</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">216-225</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  An important part of the cellular response to DNA damage is checkpoint activation - checkpoint kinases CHK1 and CHK2 phosphorylate key proteins to elicit cell-cycle blocks.  Inhibiting these kinases was believed to sensitize tumor cells to cancer treatments that damage DNA, because in the absence of checkpoints and efficient DNA repair, the response would switch to cell death or senescence.  Recent discoveries have, however, highlighted different and expanded roles for CHK1 and CHK2, so should the therapeutic hypothesis that is concerned with targeting so-called checkpoint kinases be modified.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxA1I9VXUZd7Vg90H21EOLACvtfcHk0ligTnecxoP6mA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhs1Ggsr4%253D&md5=c68980da8189320521ead28482259eb8</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnrc1296&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1296%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DB.%2BB.%26aulast%3DBartek%26aufirst%3DJ.%26atitle%3DTargeting%2520the%2520checkpoint%2520kinases%253A%2520chemosensitization%2520versus%2520chemoprotection%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2004%26volume%3D4%26spage%3D216%26epage%3D225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Tse, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carvajal, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scwartz, G. K.</span><span> </span><span class="NLM_article-title">Targeting checkpoint kinase 1 in cancer therapeutics</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1955</span><span class="NLM_x">–</span> <span class="NLM_lpage">1960</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm900314j&amp;key=10.1158%2F1078-0432.CCR-06-2793" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm900314j&amp;key=17404075" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm900314j&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjs12rsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=1955-1960&author=A.+N.+Tseauthor=R.+Carvajalauthor=G.+K.+Scwartz&title=Targeting+checkpoint+kinase+1+in+cancer+therapeutics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Checkpoint Kinase 1 in Cancer Therapeutics</span></div><div class="casAuthors">Tse, Archie N.; Carvajal, Richard; Schwartz, Gary K.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1955-1960</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Progression through the cell cycle is monitored by surveillance mechanisms known as cell cycle checkpoints.  Our knowledge of the biochem. nature of checkpoint regulation during an unperturbed cell cycle and following DNA damage has expanded tremendously over the past decade.  We now know that dysfunction in cell cycle checkpoints leads to genomic instability and contributes to tumor progression, and most agents used for cancer therapy, such as cytotoxic chemotherapy and ionizing radiation, also activate cell cycle checkpoints.  Understanding how checkpoints are regulated is therefore important from the points of view of both tumorigenesis and cancer treatment.  In this review, we present an overview of the mol. hierarchy of the checkpoint signaling network and the emerging role of checkpoint targets, esp. checkpoint kinase 1, in cancer therapy.  Further, we discuss the results of recent clin. trials involving the nonspecific checkpoint kinase 1 inhibitor, UCN-01, and the challenges we face with this new therapeutic approach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqU0LSEvsvnJLVg90H21EOLACvtfcHk0ligTnecxoP6mA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjs12rsbs%253D&md5=9b8666c39ab028672501c655c34c4fb0</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-06-2793&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-06-2793%26sid%3Dliteratum%253Aachs%26aulast%3DTse%26aufirst%3DA.%2BN.%26aulast%3DCarvajal%26aufirst%3DR.%26aulast%3DScwartz%26aufirst%3DG.%2BK.%26atitle%3DTargeting%2520checkpoint%2520kinase%25201%2520in%2520cancer%2520therapeutics%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2007%26volume%3D13%26spage%3D1955%26epage%3D1960" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Lam, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, J. M.</span><span> </span><span class="NLM_article-title">Chk1 versus Cdc25: chking one's levels of cellular proliferation</span> <span class="citation_source-journal">Cell Cycle</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1355</span><span class="NLM_x">–</span> <span class="NLM_lpage">1357</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=1355-1357&author=M.+H.+Lamauthor=J.+M.+Rosen&title=Chk1+versus+Cdc25%3A+chking+one%27s+levels+of+cellular+proliferation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLam%26aufirst%3DM.%2BH.%26aulast%3DRosen%26aufirst%3DJ.%2BM.%26atitle%3DChk1%2520versus%2520Cdc25%253A%2520chking%2520one%2527s%2520levels%2520of%2520cellular%2520proliferation%26jtitle%3DCell%2520Cycle%26date%3D2004%26volume%3D3%26spage%3D1355%26epage%3D1357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Xiao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xue, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sowin, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span> </span><span class="NLM_article-title">Differential roles of checkpoint kinase 1, checkpoint kinase 2, and mitogen-activated protein kinase-activated protein kinase 2 in mediating DNA damage-induced cell cycle arrest: implications for cancer therapy</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1935</span><span class="NLM_x">–</span> <span class="NLM_lpage">1943</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm900314j&amp;key=10.1158%2F1535-7163.MCT-06-0077" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm900314j&amp;key=16928813" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm900314j&amp;key=1%3ACAS%3A528%3ADC%252BD28XosVans7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=1935-1943&author=Z.+Xiaoauthor=J.+Xueauthor=T.+J.+Sowinauthor=H.+Zhang&title=Differential+roles+of+checkpoint+kinase+1%2C+checkpoint+kinase+2%2C+and+mitogen-activated+protein+kinase-activated+protein+kinase+2+in+mediating+DNA+damage-induced+cell+cycle+arrest%3A+implications+for+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Differential roles of checkpoint kinase 1, checkpoint kinase 2, and mitogen-activated protein kinase-activated protein kinase 2 in mediating DNA damage-induced cell cycle arrest: implications for cancer therapy</span></div><div class="casAuthors">Xiao, Zhan; Xue, John; Sowin, Thomas J.; Zhang, Haiying</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1935-1943</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Mammalian cells initiate cell cycle arrest at different phases of the cell cycle in response to various forms of genotoxic stress to allow time for DNA repair, and thus preserving their genomic integrity.  The protein kinases checkpoint kinase 1 (Chk1), checkpoint kinase 2 (Chk2), and mitogen-activated protein kinase-activated protein kinase 2 (MK2) have all been shown to be involved in cell cycle checkpoint control.  Recently, cell cycle checkpoint abrogation has been proposed as one way to sensitize cancer cells to DNA-damaging agents due to the expected induction of mitotic catastrophe.  Due to their overlapping substrate spectra and redundant functions, it is still not clear which kinase is mainly responsible for the cell cycle arrests conferred by clin. relevant chemotherapeutics.  Thus, the issue remains about which kinase is the most therapeutically relevant target and, more importantly, whether multiple kinases might need to be targeted to achieve the best efficacy in light of recent studies showing superior efficacy for pan-receptor tyrosine kinase inhibitors.  To clarify this issue, we investigated the roles of the three kinases in response to different genotoxic stresses through small interfering RNA-mediated specific target knockdowns.  Our result showed that only the down-regulation of Chk1, but not of Chk2 or MK2, abrogated camptothecin- or 5-fluorouracil-induced S-phase arrest or doxorubicin-induced G2-phase arrest.  This was followed by mitotic catastrophe and apoptosis.  Moreover, double inhibition of Chk1 and Chk2 failed to achieve better efficacy than Chk1 inhibition alone; surprisingly, inhibition of MK2, in addn. to Chk1 suppression, partially reversed the checkpoint abrogation and negated mitotic catastrophe.  We further showed that this is due to the fact that in MK2-deficient cells, Cdc25A protein, which is critically required for the mitotic progression following checkpoint abrogation, becomes greatly depleted.  In summary, our findings show that Chk1 is the only relevant checkpoint kinase as a cancer drug target and inhibition of other checkpoint kinases in addn. to Chk1 would be nonproductive.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-Au13f9gHdLVg90H21EOLACvtfcHk0lhVPCdOLDUflg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XosVans7o%253D&md5=2144e703cacac5049bc937e35fca8713</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-06-0077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-06-0077%26sid%3Dliteratum%253Aachs%26aulast%3DXiao%26aufirst%3DZ.%26aulast%3DXue%26aufirst%3DJ.%26aulast%3DSowin%26aufirst%3DT.%2BJ.%26aulast%3DZhang%26aufirst%3DH.%26atitle%3DDifferential%2520roles%2520of%2520checkpoint%2520kinase%25201%252C%2520checkpoint%2520kinase%25202%252C%2520and%2520mitogen-activated%2520protein%2520kinase-activated%2520protein%2520kinase%25202%2520in%2520mediating%2520DNA%2520damage-induced%2520cell%2520cycle%2520arrest%253A%2520implications%2520for%2520cancer%2520therapy%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2006%26volume%3D5%26spage%3D1935%26epage%3D1943" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Ganzeinelli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrassa, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crippa, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tavecchio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broggini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damia, G.</span><span> </span><span class="NLM_article-title">Checkpoint kinase 1 down-regulation by an inducible small interfering RNA expression system sensitized in vivo tumours to treatment with 5-fluorouracil</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">5131</span><span class="NLM_x">–</span> <span class="NLM_lpage">5141</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm900314j&amp;key=10.1158%2F1078-0432.CCR-08-0304" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm900314j&amp;key=18698031" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=5131-5141&author=M.+Ganzeinelliauthor=L.+Carrassaauthor=F.+Crippaauthor=M.+Tavecchioauthor=M.+Brogginiauthor=G.+Damia&title=Checkpoint+kinase+1+down-regulation+by+an+inducible+small+interfering+RNA+expression+system+sensitized+in+vivo+tumours+to+treatment+with+5-fluorouracil"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-08-0304&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-08-0304%26sid%3Dliteratum%253Aachs%26aulast%3DGanzeinelli%26aufirst%3DM.%26aulast%3DCarrassa%26aufirst%3DL.%26aulast%3DCrippa%26aufirst%3DF.%26aulast%3DTavecchio%26aufirst%3DM.%26aulast%3DBroggini%26aufirst%3DM.%26aulast%3DDamia%26aufirst%3DG.%26atitle%3DCheckpoint%2520kinase%25201%2520down-regulation%2520by%2520an%2520inducible%2520small%2520interfering%2520RNA%2520expression%2520system%2520sensitized%2520in%2520vivo%2520tumours%2520to%2520treatment%2520with%25205-fluorouracil%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2008%26volume%3D14%26spage%3D5131%26epage%3D5141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Collins, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrett, M.</span><span> </span><span class="NLM_article-title">Inhibitors of the cell cycle</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">366</span><span class="NLM_x">–</span> <span class="NLM_lpage">373</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm900314j&amp;key=10.1016%2Fj.coph.2005.04.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm900314j&amp;key=15964238" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm900314j&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlvFKlsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=366-373&author=I.+Collinsauthor=M.+Garrett&title=Inhibitors+of+the+cell+cycle"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the cell division cycle in cancer: CDK and cell cycle checkpoint kinase inhibitors</span></div><div class="casAuthors">Collins, Ian; Garrett, Michelle D.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">366-373</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The cyclin-dependent kinase (CDK) family of serine/threonine kinases regulate progression through each stage of the cell division cycle and as such are major targets for deregulation in cancer.  This has led to the development of several small-mol. inhibitors of CDKs as potential therapeutic agents for the treatment of this disease.  Progression through the cell cycle is also monitored at several positions known as cell cycle checkpoints, 2 of which occur during G1 and G2 in response to DNA damage.  These are often defective in cancer, leading to the suggestion that inhibition of one or both of the cell cycle checkpoint kinases CHK1 and CHK2 may drive a cancer cell that already has defects in its cell cycle checkpoints towards death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlqcFxaO9gh7Vg90H21EOLACvtfcHk0lg8DgbD9v04fg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlvFKlsL0%253D&md5=40607fa37e866766581683b322829a13</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2005.04.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2005.04.009%26sid%3Dliteratum%253Aachs%26aulast%3DCollins%26aufirst%3DI.%26aulast%3DGarrett%26aufirst%3DM.%26atitle%3DInhibitors%2520of%2520the%2520cell%2520cycle%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2005%26volume%3D5%26spage%3D366%26epage%3D373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Tao, Z.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, N.-H.</span><span> </span><span class="NLM_article-title">Chk1 inhibitors for novel cancer treatment</span> <span class="citation_source-journal">Anticancer Agents Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">377</span><span class="NLM_x">–</span> <span class="NLM_lpage">388</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm900314j&amp;key=10.2174%2F187152006777698132" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm900314j&amp;key=16842237" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm900314j&amp;key=1%3ACAS%3A528%3ADC%252BD28Xms1WksLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=377-388&author=Z.-F.+Taoauthor=N.-H.+Lin&title=Chk1+inhibitors+for+novel+cancer+treatment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Chk1 inhibitors for novel cancer treatment</span></div><div class="casAuthors">Tao, Zhi-Fu; Lin, Nan-Horng</div><div class="citationInfo"><span class="NLM_cas:title">Anti-Cancer Agents in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">377-388</span>CODEN:
                <span class="NLM_cas:coden">AAMCE4</span>;
        ISSN:<span class="NLM_cas:issn">1871-5206</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Chemo- and radiotherapies that target DNA are the mainstay of cancer treatment.  In response to DNA damage, cells are arrested in multiple checkpoints in the cell cycle to allow the damaged DNA to be repaired before progressing into mitosis.  Normal cells are arrested in the G1 phase mediated by the p53 tumor suppressor, and p53-deficient cancer cells are arrested in the S or G2 phase.  Checkpoint kinase 1 (Chk 1) is a serine / threonine protein kinase and a key mediator in the DNA damage-induced checkpoint network.  When the G2 or S checkpoint is abrogated by the inhibition of Chk1, p53-deficient cancer cells undergo mitotic catastrophe and eventually apoptosis, whereas normal cells are still arrested in the G1 phase.  Thus, Chk1 inhibitors can preferentially potentiate the efficacy of DNA damaging agents in cancer cells, and Chk1 is an attractive therapeutic target for cancer treatment, esp. since approx. 50% of all human cancers are p53-deficient.  This review discusses the rationale of Chk1 as an anticancer target, the structural basis for designing Chk1 inhibitors, and recently disclosed Chk1 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqefhJeyP15drVg90H21EOLACvtfcHk0lg8DgbD9v04fg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xms1WksLg%253D&md5=e6d5be5846832b30d0c8125d036d8aa8</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.2174%2F187152006777698132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187152006777698132%26sid%3Dliteratum%253Aachs%26aulast%3DTao%26aufirst%3DZ.-F.%26aulast%3DLin%26aufirst%3DN.-H.%26atitle%3DChk1%2520inhibitors%2520for%2520novel%2520cancer%2520treatment%26jtitle%3DAnticancer%2520Agents%2520Med.%2520Chem.%26date%3D2006%26volume%3D6%26spage%3D377%26epage%3D388" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Wang, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mantei, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kovar, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sham, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sowin, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, N.-H.</span><span> </span><span class="NLM_article-title">1-(5-Chloro-2-alkoxyphenyl)-3-(5-cyanopyrazin-2-yl)ureas as potent and selective inhibitors of Chk1 kinase: synthesis, preliminary SAR, and biological activities</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">31118</span><span class="NLM_x">–</span> <span class="NLM_lpage">3121</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=31118-3121&author=G.+T.+Wangauthor=G.+Liauthor=R.+A.+Manteiauthor=Z.+Chenauthor=P.+Kovarauthor=W.+Guauthor=Z.+Xiaoauthor=H.+Zhangauthor=H.+L.+Shamauthor=T.+Sowinauthor=S.+H.+Rosenbergauthor=N.-H.+Lin&title=1-%285-Chloro-2-alkoxyphenyl%29-3-%285-cyanopyrazin-2-yl%29ureas+as+potent+and+selective+inhibitors+of+Chk1+kinase%3A+synthesis%2C+preliminary+SAR%2C+and+biological+activities"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DG.%2BT.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DMantei%26aufirst%3DR.%2BA.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DKovar%26aufirst%3DP.%26aulast%3DGu%26aufirst%3DW.%26aulast%3DXiao%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DSham%26aufirst%3DH.%2BL.%26aulast%3DSowin%26aufirst%3DT.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DLin%26aufirst%3DN.-H.%26atitle%3D1-%25285-Chloro-2-alkoxyphenyl%2529-3-%25285-cyanopyrazin-2-yl%2529ureas%2520as%2520potent%2520and%2520selective%2520inhibitors%2520of%2520Chk1%2520kinase%253A%2520synthesis%252C%2520preliminary%2520SAR%252C%2520and%2520biological%2520activities%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D31118%26epage%3D3121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit15b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Tong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claiborne, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kovar, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Credo, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, W.-Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gwaltney, S. L.,  II</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Judge, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sham, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sowin, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, N.</span><span> </span><span class="NLM_article-title">Discovery of 1,4-dihydroindeno[1,2-<i>c</i>]pyrazoles as a novel class of potent and selective checkpoint kinase 1 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">2759</span><span class="NLM_x">–</span> <span class="NLM_lpage">2767</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15b&amp;dbid=16&amp;doi=10.1021%2Fjm900314j&amp;key=10.1016%2Fj.bmc.2007.01.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15b&amp;dbid=8&amp;doi=10.1021%2Fjm900314j&amp;key=17287122" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15b&amp;dbid=32&amp;doi=10.1021%2Fjm900314j&amp;key=1%3ACAS%3A528%3ADC%252BD2sXivVagt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2007&pages=2759-2767&author=Y.+Tongauthor=A.+Claiborneauthor=K.+D.+Stewartauthor=C.+Parkauthor=P.+Kovarauthor=Z.+Chenauthor=R.+B.+Credoauthor=W.-Z.+Guauthor=S.+L.+Gwaltneyauthor=R.+A.+Judgeauthor=H.+Zhangauthor=S.+H.+Rosenbergauthor=H.+L.+Shamauthor=T.+J.+Sowinauthor=N.+Lin&title=Discovery+of+1%2C4-dihydroindeno%5B1%2C2-c%5Dpyrazoles+as+a+novel+class+of+potent+and+selective+checkpoint+kinase+1+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15bR"><div class="casContent"><span class="casTitleNuber">15b</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 1,4-dihydroindeno[1,2-c]pyrazoles as a novel class of potent and selective checkpoint kinase 1 inhibitors</span></div><div class="casAuthors">Tong, Yunsong; Claiborne, Akiyo; Stewart, Kent D.; Park, Chang; Kovar, Peter; Chen, Zehan; Credo, Robert B.; Gu, Wen-Zhen; Gwaltney, Stephen L.; Judge, Russell A.; Zhang, Haiying; Rosenberg, Saul H.; Sham, Hing L.; Sowin, Thomas J.; Lin, Nan-horng</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2759-2767</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A new class of checkpoint kinase 1 (CHK-1) inhibitors bearing a 1,4-dihydroindeno[1,2-c]pyrazole core was developed after initial hits from high throughput screening.  The efficient hit-to-lead process was facilitated by X-ray crystallog. and led to potent inhibitors (<10 nM) against CHK-1.  X-ray co-crystal structures of bound inhibitors demonstrated that two sub-series of this class of compds., exemplified by 21 and 41, exhibit distinctive hydrogen bonding patterns in the specificity pocket of the active site.  Two compds., 41 and 43, were capable of potentiating doxorubicin and camptothecin, both DNA-damaging agents, in cell proliferation assays (MTS and soft agar assays) and abrogating G2/M checkpoint in a mechanism-based FACS assay.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVp7DNSZaexbVg90H21EOLACvtfcHk0liYUm3PDC9blA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXivVagt7w%253D&md5=0966753ebf59128001db7601ca7d8cee</span></div><a href="/servlet/linkout?suffix=cit15b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2007.01.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2007.01.012%26sid%3Dliteratum%253Aachs%26aulast%3DTong%26aufirst%3DY.%26aulast%3DClaiborne%26aufirst%3DA.%26aulast%3DStewart%26aufirst%3DK.%2BD.%26aulast%3DPark%26aufirst%3DC.%26aulast%3DKovar%26aufirst%3DP.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DCredo%26aufirst%3DR.%2BB.%26aulast%3DGu%26aufirst%3DW.-Z.%26aulast%3DGwaltney%26aufirst%3DS.%2BL.%26aulast%3DJudge%26aufirst%3DR.%2BA.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DSham%26aufirst%3DH.%2BL.%26aulast%3DSowin%26aufirst%3DT.%2BJ.%26aulast%3DLin%26aufirst%3DN.%26atitle%3DDiscovery%2520of%25201%252C4-dihydroindeno%255B1%252C2-c%255Dpyrazoles%2520as%2520a%2520novel%2520class%2520of%2520potent%2520and%2520selective%2520checkpoint%2520kinase%25201%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2007%26volume%3D15%26spage%3D2759%26epage%3D2767" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit15c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sullivan, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hexamer, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasvold, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Przytulinska, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tao, Z.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, W.-Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xue, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bui, M.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merta, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kovar, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouska, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sham, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sowin, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, N.-H.</span><span> </span><span class="NLM_article-title">Design, synthesis and biological activity of 5,10-dihydro-dibenzo[<i>b</i>,<i>e</i>][1,4]diazepin-11-one-based potent and selective Chk-1 inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">4162</span><span class="NLM_x">–</span> <span class="NLM_lpage">4176</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070105d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=4162-4176&author=L.+Wangauthor=G.+M.+Sullivanauthor=L.+A.+Hexamerauthor=R.+T.+Hasvoldauthor=M.+Przytulinskaauthor=Z.-F.+Taoauthor=G.+Liauthor=Z.+Chenauthor=Z.+Xiaoauthor=W.-Z.+Guauthor=J.+Xueauthor=M.-H.+Buiauthor=P.+Mertaauthor=P.+Kovarauthor=J.+J.+Bouskaauthor=H.+Zhangauthor=C.+Parkauthor=K.+D.+Stewartauthor=H.+L.+Shamauthor=T.+J.+Sowinauthor=S.+H.+Rosenbergauthor=N.-H.+Lin&title=Design%2C+synthesis+and+biological+activity+of+5%2C10-dihydro-dibenzo%5Bb%2Ce%5D%5B1%2C4%5Ddiazepin-11-one-based+potent+and+selective+Chk-1+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15c&amp;dbid=16384&amp;doi=10.1021%2Fjm070105d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070105d%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DL.%26aulast%3DSullivan%26aufirst%3DG.%2BM.%26aulast%3DHexamer%26aufirst%3DL.%2BA.%26aulast%3DHasvold%26aufirst%3DR.%2BT.%26aulast%3DPrzytulinska%26aufirst%3DM.%26aulast%3DTao%26aufirst%3DZ.-F.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DXiao%26aufirst%3DZ.%26aulast%3DGu%26aufirst%3DW.-Z.%26aulast%3DXue%26aufirst%3DJ.%26aulast%3DBui%26aufirst%3DM.-H.%26aulast%3DMerta%26aufirst%3DP.%26aulast%3DKovar%26aufirst%3DP.%26aulast%3DBouska%26aufirst%3DJ.%2BJ.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DPark%26aufirst%3DC.%26aulast%3DStewart%26aufirst%3DK.%2BD.%26aulast%3DSham%26aufirst%3DH.%2BL.%26aulast%3DSowin%26aufirst%3DT.%2BJ.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DLin%26aufirst%3DN.-H.%26atitle%3DDesign%252C%2520synthesis%2520and%2520biological%2520activity%2520of%25205%252C10-dihydro-dibenzo%255Bb%252Ce%255D%255B1%252C4%255Ddiazepin-11-one-based%2520potent%2520and%2520selective%2520Chk-1%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D4162%26epage%3D4176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Huang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garbaccio, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraley, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kreatsoulas, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartmann, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stirdivant, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drakas, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rickert, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamilton, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buser, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardwick, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrams, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beck, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lobell, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sepp-Lorenzino, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikuta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sardana, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munshi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reilly, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahan, E.</span><span> </span><span class="NLM_article-title">Development of 6-substituted indolylquinolinones as potent Chek1 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">5907</span><span class="NLM_x">–</span> <span class="NLM_lpage">5912</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=5907-5912&author=S.+Huangauthor=R.+M.+Garbaccioauthor=M.+E.+Fraleyauthor=J.+Steenauthor=C.+Kreatsoulasauthor=G.+Hartmannauthor=S.+Stirdivantauthor=B.+Drakasauthor=K.+Rickertauthor=E.+Walshauthor=K.+Hamiltonauthor=C.+A.+Buserauthor=J.+Hardwickauthor=X.+Maoauthor=M.+Abramsauthor=S.+Beckauthor=W.+Taoauthor=R.+Lobellauthor=L.+Sepp-Lorenzinoauthor=Y.+Yanauthor=M.+Ikutaauthor=J.+Z.+Murphyauthor=V.+Sardanaauthor=S.+Munshiauthor=L.+Kuoauthor=M.+Reillyauthor=E.+Mahan&title=Development+of+6-substituted+indolylquinolinones+as+potent+Chek1+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DS.%26aulast%3DGarbaccio%26aufirst%3DR.%2BM.%26aulast%3DFraley%26aufirst%3DM.%2BE.%26aulast%3DSteen%26aufirst%3DJ.%26aulast%3DKreatsoulas%26aufirst%3DC.%26aulast%3DHartmann%26aufirst%3DG.%26aulast%3DStirdivant%26aufirst%3DS.%26aulast%3DDrakas%26aufirst%3DB.%26aulast%3DRickert%26aufirst%3DK.%26aulast%3DWalsh%26aufirst%3DE.%26aulast%3DHamilton%26aufirst%3DK.%26aulast%3DBuser%26aufirst%3DC.%2BA.%26aulast%3DHardwick%26aufirst%3DJ.%26aulast%3DMao%26aufirst%3DX.%26aulast%3DAbrams%26aufirst%3DM.%26aulast%3DBeck%26aufirst%3DS.%26aulast%3DTao%26aufirst%3DW.%26aulast%3DLobell%26aufirst%3DR.%26aulast%3DSepp-Lorenzino%26aufirst%3DL.%26aulast%3DYan%26aufirst%3DY.%26aulast%3DIkuta%26aufirst%3DM.%26aulast%3DMurphy%26aufirst%3DJ.%2BZ.%26aulast%3DSardana%26aufirst%3DV.%26aulast%3DMunshi%26aufirst%3DS.%26aulast%3DKuo%26aufirst%3DL.%26aulast%3DReilly%26aufirst%3DM.%26aulast%3DMahan%26aufirst%3DE.%26atitle%3DDevelopment%2520of%25206-substituted%2520indolylquinolinones%2520as%2520potent%2520Chek1%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D5907%26epage%3D5912" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Fraley, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steen, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brnardic, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrington, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spencer, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanney, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stirdivant, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drakas, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rickert, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamilton, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buser, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardwick, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beck, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lobell, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sepp-Lorenzino, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikuta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munshi, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kreatsoulas, C.</span><span> </span><span class="NLM_article-title">3-(Indol-2-yl)indazoles as Chek1 kinase inhibitors: Optimization of potency and selectivity via substitution at C6</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">6049</span><span class="NLM_x">–</span> <span class="NLM_lpage">6053</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=6049-6053&author=M.+E.+Fraleyauthor=J.+T.+Steenauthor=E.+J.+Brnardicauthor=K.+L.+Arringtonauthor=K.+L.+Spencerauthor=B.+A.+Hanneyauthor=Y.+Kimauthor=G.+D.+Hartmanauthor=S.+M.+Stirdivantauthor=B.+A.+Drakasauthor=K.+Rickertauthor=E.+S.+Walshauthor=K.+Hamiltonauthor=C.+A.+Buserauthor=J.+Hardwickauthor=W.+Taoauthor=S.+C.+Beckauthor=X.+Maoauthor=R.+B.+Lobellauthor=L.+Sepp-Lorenzinoauthor=Y.+Yanauthor=M.+Ikutaauthor=S.+K.+Munshiauthor=L.+C.+Kuoauthor=C.+Kreatsoulas&title=3-%28Indol-2-yl%29indazoles+as+Chek1+kinase+inhibitors%3A+Optimization+of+potency+and+selectivity+via+substitution+at+C6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFraley%26aufirst%3DM.%2BE.%26aulast%3DSteen%26aufirst%3DJ.%2BT.%26aulast%3DBrnardic%26aufirst%3DE.%2BJ.%26aulast%3DArrington%26aufirst%3DK.%2BL.%26aulast%3DSpencer%26aufirst%3DK.%2BL.%26aulast%3DHanney%26aufirst%3DB.%2BA.%26aulast%3DKim%26aufirst%3DY.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26aulast%3DStirdivant%26aufirst%3DS.%2BM.%26aulast%3DDrakas%26aufirst%3DB.%2BA.%26aulast%3DRickert%26aufirst%3DK.%26aulast%3DWalsh%26aufirst%3DE.%2BS.%26aulast%3DHamilton%26aufirst%3DK.%26aulast%3DBuser%26aufirst%3DC.%2BA.%26aulast%3DHardwick%26aufirst%3DJ.%26aulast%3DTao%26aufirst%3DW.%26aulast%3DBeck%26aufirst%3DS.%2BC.%26aulast%3DMao%26aufirst%3DX.%26aulast%3DLobell%26aufirst%3DR.%2BB.%26aulast%3DSepp-Lorenzino%26aufirst%3DL.%26aulast%3DYan%26aufirst%3DY.%26aulast%3DIkuta%26aufirst%3DM.%26aulast%3DMunshi%26aufirst%3DS.%2BK.%26aulast%3DKuo%26aufirst%3DL.%2BC.%26aulast%3DKreatsoulas%26aufirst%3DC.%26atitle%3D3-%2528Indol-2-yl%2529indazoles%2520as%2520Chek1%2520kinase%2520inhibitors%253A%2520Optimization%2520of%2520potency%2520and%2520selectivity%2520via%2520substitution%2520at%2520C6%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D6049%26epage%3D6053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Teng, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kornmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blasina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Register, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderes, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ninkovic, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grant, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundgren, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kania, R. S.</span><span> </span><span class="NLM_article-title">Structure-based design and synthesis of (5-arylamino-2<i>H</i>-pyrazol-3-yl)-biphenyl-2′,4′-diols as novel and potent human CHK1 inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">5253</span><span class="NLM_x">–</span> <span class="NLM_lpage">5256</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0704604" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=5253-5256&author=M.+Tengauthor=J.+Zhuauthor=M.+D.+Johnsonauthor=P.+Chenauthor=J.+Kornmannauthor=E.+Chenauthor=A.+Blasinaauthor=J.+Registerauthor=K.+Anderesauthor=C.+Rogersauthor=Y.+Dengauthor=S.+Ninkovicauthor=S.+Grantauthor=Q.+Huauthor=K.+Lundgrenauthor=Z.+Pengauthor=R.+S.+Kania&title=Structure-based+design+and+synthesis+of+%285-arylamino-2H-pyrazol-3-yl%29-biphenyl-2%E2%80%B2%2C4%E2%80%B2-diols+as+novel+and+potent+human+CHK1+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm0704604&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0704604%26sid%3Dliteratum%253Aachs%26aulast%3DTeng%26aufirst%3DM.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DJohnson%26aufirst%3DM.%2BD.%26aulast%3DChen%26aufirst%3DP.%26aulast%3DKornmann%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DE.%26aulast%3DBlasina%26aufirst%3DA.%26aulast%3DRegister%26aufirst%3DJ.%26aulast%3DAnderes%26aufirst%3DK.%26aulast%3DRogers%26aufirst%3DC.%26aulast%3DDeng%26aufirst%3DY.%26aulast%3DNinkovic%26aufirst%3DS.%26aulast%3DGrant%26aufirst%3DS.%26aulast%3DHu%26aufirst%3DQ.%26aulast%3DLundgren%26aufirst%3DK.%26aulast%3DPeng%26aufirst%3DZ.%26aulast%3DKania%26aufirst%3DR.%2BS.%26atitle%3DStructure-based%2520design%2520and%2520synthesis%2520of%2520%25285-arylamino-2H-pyrazol-3-yl%2529-biphenyl-2%25E2%2580%25B2%252C4%25E2%2580%25B2-diols%2520as%2520novel%2520and%2520potent%2520human%2520CHK1%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D5253%26epage%3D5256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Tse, A.; Rendahl, K. G.; Sheikh, T.; Cheema, H.; Aardalen, K.; Embry, M.; Ma, S.; Moler, E. J.; Nie, Z. J.; Lopas de Menezes, D. E.; Hibner, B.; Gesner, T. G.; Schwartz, G. K.</span><span> </span><span class="NLM_article-title">CHIR-124, a novel potent inhibitor of Chk1, potentiates the cytotoxicity of topoisomerase 1 poisons in vitro and in vivo</span>. Clin. Cancer Res.<span class="NLM_x"> </span><span class="NLM_year">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">591</span>− <span class="NLM_lpage">602</span>. </span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&pages=591-602&author=A.+Tse&author=K.+G.+Rendahl&author=T.+Sheikh&author=H.+Cheema&author=K.+Aardalen&author=M.+Embry&author=S.+Ma&author=E.+J.+Moler&author=Z.+J.+Nie&author=D.+E.+Lopas+de+Menezes&author=B.+Hibner&author=T.+G.+Gesner&author=G.+K.+Schwartz&title=CHIR-124%2C+a+novel+potent+inhibitor+of+Chk1%2C+potentiates+the+cytotoxicity+of+topoisomerase+1+poisons+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DTse%26aufirst%3DA.%26atitle%3DCHIR-124%252C%2520a%2520novel%2520potent%2520inhibitor%2520of%2520Chk1%252C%2520potentiates%2520the%2520cytotoxicity%2520of%2520topoisomerase%25201%2520poisons%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2007%26volume%3D13%26spage%3D591%26epage%3D602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Blasina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arango, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraynov, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Register, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gant, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ninkovic, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nichols, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderes, K.</span><span> </span><span class="NLM_article-title">Breaching the DNA damage checkpoint with PF-00477736, a novel small-molecule inhibitor of checkpoint kinase 1</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">2394</span><span class="NLM_x">–</span> <span class="NLM_lpage">2404</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm900314j&amp;key=10.1158%2F1535-7163.MCT-07-2391" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm900314j&amp;key=18723486" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm900314j&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVWksL%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=2394-2404&author=A.+Blasinaauthor=J.+Hallinauthor=E.+Chenauthor=M.+E.+Arangoauthor=E.+Kraynovauthor=J.+Registerauthor=S.+Gantauthor=S.+Ninkovicauthor=P.+Chenauthor=T.+Nicholsauthor=P.+O%E2%80%99Connorauthor=K.+Anderes&title=Breaching+the+DNA+damage+checkpoint+with+PF-00477736%2C+a+novel+small-molecule+inhibitor+of+checkpoint+kinase+1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Breaching the DNA damage checkpoint via PF-00477736, a novel small-molecule inhibitor of checkpoint kinase 1</span></div><div class="casAuthors">Blasina, Alessandra; Hallin, Jill; Chen, Enhong; Arango, Maria Elena; Kraynov, Eugenia; Register, James; Grant, Stephan; Ninkovic, Sacha; Chen, Ping; Nichols, Tim; O'Connor, Patrick; Anderes, Kenna</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2394-2404</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Checkpoints are present in all phases of the cell cycle and are regarded as the gatekeepers maintaining the integrity of the genome.  Many conventional agents used to treat cancer impart damage to the genome and activate cell cycle checkpoints.  Many tumors are defective in the tumor suppressor p53 and therefore lack a functional G1 checkpoint.  In these tumors, however, the S-G2 checkpoints remain intact and, in response to DNA damage, arrest cell cycle progression allowing time for DNA repair.  Checkpoint kinase 1 (Chk1) is a key element in the DNA damage response pathway and plays a crucial role in the S-G2-phase checkpoints.  Inhibiting Chk1 represents a therapeutic strategy for creating a "synthetic lethal" response by overriding the last checkpoint defense of tumor cells against the lethal damage induced by DNA-directed chemotherapeutic agents.  Chk1 inhibition is consistent with emerging targeted therapies aiming to exploit mol. differences between normal and cancer cells.  Adding a Chk1 inhibitor to DNA-damaging cytotoxic therapy selectively targets tumors with intrinsic checkpoint defects while minimizing toxicity in checkpoint-competent normal cells.  PF-00477736 was identified as a potent, selective ATP-competitive small-mol. inhibitor that inhibits Chk1 with a Ki of 0.49 nM.  PF-00477736 abrogates cell cycle arrest induced by DNA damage and enhances cytotoxicity of clin. important chemotherapeutic agents, including gemcitabine and carboplatin.  In xenografts, PF-00477736 enhanced the antitumor activity of gemcitabine in a dose-dependent manner.  PF-00477736 combinations were well tolerated with no exacerbation of side effects commonly assocd. with cytotoxic agents. [Mol Cancer Ther 2008;7(8):2394-404].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCAlkcnouhLrVg90H21EOLACvtfcHk0lgKlZs3TDLvxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVWksL%252FP&md5=fc3f9cf9121c207c6fa284b2090ed1c3</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-07-2391&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-07-2391%26sid%3Dliteratum%253Aachs%26aulast%3DBlasina%26aufirst%3DA.%26aulast%3DHallin%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DE.%26aulast%3DArango%26aufirst%3DM.%2BE.%26aulast%3DKraynov%26aufirst%3DE.%26aulast%3DRegister%26aufirst%3DJ.%26aulast%3DGant%26aufirst%3DS.%26aulast%3DNinkovic%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DP.%26aulast%3DNichols%26aufirst%3DT.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DP.%26aulast%3DAnderes%26aufirst%3DK.%26atitle%3DBreaching%2520the%2520DNA%2520damage%2520checkpoint%2520with%2520PF-00477736%252C%2520a%2520novel%2520small-molecule%2520inhibitor%2520of%2520checkpoint%2520kinase%25201%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2008%26volume%3D7%26spage%3D2394%26epage%3D2404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Zabludoff, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grondine, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheehy, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashwell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caleb, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haye, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horn, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janetka, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mouchet, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ready, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenthal, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Queva, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tse, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, A. M.</span><span> </span><span class="NLM_article-title">AZD7762, a novel checkpoint kinase inhibitor, drives checkpoint abrogation and potentiates DNA-targeted therapies</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">2955</span><span class="NLM_x">–</span> <span class="NLM_lpage">2966</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm900314j&amp;key=10.1158%2F1535-7163.MCT-08-0492" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm900314j&amp;key=18790776" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm900314j&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFSmsL7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=2955-2966&author=S.+D.+Zabludoffauthor=C.+Dengauthor=M.+R.+Grondineauthor=A.+M.+Sheehyauthor=S.+Ashwellauthor=B.+L.+Calebauthor=S.+Greenauthor=H.+R.+Hayeauthor=C.+L.+Hornauthor=J.+W.+Janetkaauthor=D.+Liuauthor=E.+Mouchetauthor=S.+Readyauthor=J.+L.+Rosenthalauthor=C.+Quevaauthor=G.+K.+Schwartzauthor=K.+J.+Taylorauthor=A.+N.+Tseauthor=G.+E.+Walkerauthor=A.+M.+White&title=AZD7762%2C+a+novel+checkpoint+kinase+inhibitor%2C+drives+checkpoint+abrogation+and+potentiates+DNA-targeted+therapies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">AZD7762, a novel checkpoint kinase inhibitor, drives checkpoint abrogation and potentiates DNA-targeted therapies</span></div><div class="casAuthors">Zabludoff, Sonya D.; Deng, Chun; Grondine, Michael R.; Sheehy, Adam M.; Ashwell, Susan; Caleb, Benjamin L.; Green, Stephen; Haye, Heather R.; Horn, Candice L.; Janetka, James W.; Liu, Dongfang; Mouchet, Elizabeth; Ready, Shannon; Rosenthal, Judith L.; Queva, Christophe; Schwartz, Gary K.; Taylor, Karen J.; Tse, Archie N.; Walker, Graeme E.; White, Anne M.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2955-2966</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Insights from cell cycle research have led to the hypothesis that tumors may be selectively sensitized to DNA-damaging agents resulting in improved antitumor activity and a wider therapeutic margin.  The theory relies on the observation that the majority of tumors are deficient in the G1-DNA damage checkpoint pathway resulting in reliance on S and G2 checkpoints for DNA repair and cell survival.  The S and G2 checkpoints are regulated by checkpoint kinase 1, a serine/threonine kinase that is activated in response to DNA damage; thus, inhibition of checkpoint kinase 1 signaling impairs DNA repair and increases tumor cell death.  Normal tissues, however, have a functioning G1 checkpoint signaling pathway allowing for DNA repair and cell survival.  Here, we describe the preclin. profile of AZD7762, a potent ATP-competitive checkpoint kinase inhibitor in clin. trials.  AZD7762 has been profiled extensively in vitro and in vivo in combination with DNA-damaging agents and has been shown to potentiate response in several different settings where inhibition of checkpoint kinase results in the abrogation of DNA damage-induced cell cycle arrest.  Dose-dependent potentiation of antitumor activity, when AZD7762 is administered in combination with DNA-damaging agents, has been obsd. in multiple xenograft models with several DNA-damaging agents, further supporting the potential of checkpoint kinase inhibitors to enhance the efficacy of both conventional chemotherapy and radiotherapy and increase patient response rates in a variety of settings. [Mol Cancer Ther 2008;7(9):2955-66].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTXvjs3OaUFrVg90H21EOLACvtfcHk0lgKlZs3TDLvxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFSmsL7O&md5=b33ff697c6592c9823e85c9bb265c02d</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-08-0492&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-08-0492%26sid%3Dliteratum%253Aachs%26aulast%3DZabludoff%26aufirst%3DS.%2BD.%26aulast%3DDeng%26aufirst%3DC.%26aulast%3DGrondine%26aufirst%3DM.%2BR.%26aulast%3DSheehy%26aufirst%3DA.%2BM.%26aulast%3DAshwell%26aufirst%3DS.%26aulast%3DCaleb%26aufirst%3DB.%2BL.%26aulast%3DGreen%26aufirst%3DS.%26aulast%3DHaye%26aufirst%3DH.%2BR.%26aulast%3DHorn%26aufirst%3DC.%2BL.%26aulast%3DJanetka%26aufirst%3DJ.%2BW.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DMouchet%26aufirst%3DE.%26aulast%3DReady%26aufirst%3DS.%26aulast%3DRosenthal%26aufirst%3DJ.%2BL.%26aulast%3DQueva%26aufirst%3DC.%26aulast%3DSchwartz%26aufirst%3DG.%2BK.%26aulast%3DTaylor%26aufirst%3DK.%2BJ.%26aulast%3DTse%26aufirst%3DA.%2BN.%26aulast%3DWalker%26aufirst%3DG.%2BE.%26aulast%3DWhite%26aufirst%3DA.%2BM.%26atitle%3DAZD7762%252C%2520a%2520novel%2520checkpoint%2520kinase%2520inhibitor%252C%2520drives%2520checkpoint%2520abrogation%2520and%2520potentiates%2520DNA-targeted%2520therapies%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2008%26volume%3D7%26spage%3D2955%26epage%3D2966" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Ashwell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zabludoff, S.</span><span> </span><span class="NLM_article-title">DNA damage detection and repair pathways−recent advances with inhibitors of checkpoint kinases in cancer therapy</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">4032</span><span class="NLM_x">–</span> <span class="NLM_lpage">4037</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm900314j&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnvFylur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=4032-4037&author=S.+Ashwellauthor=S.+Zabludoff&title=DNA+damage+detection+and+repair+pathways%E2%88%92recent+advances+with+inhibitors+of+checkpoint+kinases+in+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">DNA Damage Detection and Repair Pathways-Recent Advances with Inhibitors of Checkpoint Kinases in Cancer Therapy</span></div><div class="casAuthors">Ashwell, Susan; Zabludoff, Sonya</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4032-4037</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Insights from cell cycle research have led to the hypothesis that tumors may be selectivity sensitized to DNA-damaging agents, resulting in improved antitumor activity and a wider therapeutic margin.  The theory relies primarily on the observation that the majority of tumors are deficient in the G1-DNA damage checkpoint pathway, resulting in reliance on S and G2 phase checkpoints for DNA repair and cell survival.  The S and G2 phase checkpoints are predominantly regulated by checkpoint kinase 1; thus, inhibition of checkpoint kinase 1 signaling impairs DNA repair and increases tumor cell death.  Normal tissues, however, have a functioning G1 checkpoint signaling pathway that allows for DNA repair and cell survival.  There is now a large body of preclin. evidence showing that checkpoint kinase inhibitors do indeed enhance the efficacy of both conventional chemotherapy and radiotherapy, and several agents have recently entered clin. trials.  Excitingly, addnl. therapeutic opportunities for checkpoint kinase inhibitors continue to emerge as biol. outside their pivotal role in cell cycle arrest is further elucidated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9wY3TzSvx77Vg90H21EOLACvtfcHk0lg6H6iK8rV9jg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnvFylur4%253D&md5=0de4c1639ae26f12e3efaa82a08bfeec</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAshwell%26aufirst%3DS.%26aulast%3DZabludoff%26aufirst%3DS.%26atitle%3DDNA%2520damage%2520detection%2520and%2520repair%2520pathways%25E2%2588%2592recent%2520advances%2520with%2520inhibitors%2520of%2520checkpoint%2520kinases%2520in%2520cancer%2520therapy%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2008%26volume%3D14%26spage%3D4032%26epage%3D4037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Janetka, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashwell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zabludoff, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyne, P.</span><span> </span><span class="NLM_article-title">Inhibitors of checkpoint kinases: from discovery to the clinic</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">473</span><span class="NLM_x">–</span> <span class="NLM_lpage">486</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2007&pages=473-486&author=J.+W.+Janetkaauthor=S.+Ashwellauthor=S.+Zabludoffauthor=P.+Lyne&title=Inhibitors+of+checkpoint+kinases%3A+from+discovery+to+the+clinic"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJanetka%26aufirst%3DJ.%2BW.%26aulast%3DAshwell%26aufirst%3DS.%26aulast%3DZabludoff%26aufirst%3DS.%26aulast%3DLyne%26aufirst%3DP.%26atitle%3DInhibitors%2520of%2520checkpoint%2520kinases%253A%2520from%2520discovery%2520to%2520the%2520clinic%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2007%26volume%3D10%26spage%3D473%26epage%3D486" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Prudhomme, M.</span><span> </span><span class="NLM_article-title">Novel CHK1 inhibitors</span> <span class="citation_source-journal">Recent Pat. Anti-Cancer Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">55</span><span class="NLM_x">–</span> <span class="NLM_lpage">68</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2006&pages=55-68&author=M.+Prudhomme&title=Novel+CHK1+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPrudhomme%26aufirst%3DM.%26atitle%3DNovel%2520CHK1%2520inhibitors%26jtitle%3DRecent%2520Pat.%2520Anti-Cancer%2520Drug%2520Discovery%26date%3D2006%26volume%3D1%26spage%3D55%26epage%3D68" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Hénon, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conchon, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hugon, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Messaoudi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golsteyn, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prudhomme, M.</span><span> </span><span class="NLM_article-title">Pyrrolocarbazoles as checkpoint 1 kinase inhibitors</span> <span class="citation_source-journal">Anticancer Agents Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">577</span><span class="NLM_x">–</span> <span class="NLM_lpage">597</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm900314j&amp;key=18690823" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm900314j&amp;key=1%3ACAS%3A528%3ADC%252BD1cXps1Ohu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=577-597&author=H.+H%C3%A9nonauthor=E.+Conchonauthor=B.+Hugonauthor=S.+Messaoudiauthor=R.+M.+Golsteynauthor=M.+Prudhomme&title=Pyrrolocarbazoles+as+checkpoint+1+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Pyrrolocarbazoles as checkpoint 1 kinase inhibitors</span></div><div class="casAuthors">Henon, Helene; Conchon, Elisabeth; Hugon, Bernadette; Messaoudi, Samir; Golsteyn, Roy M.; Prudhomme, Michelle</div><div class="citationInfo"><span class="NLM_cas:title">Anti-Cancer Agents in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">577-597</span>CODEN:
                <span class="NLM_cas:coden">AAMCE4</span>;
        ISSN:<span class="NLM_cas:issn">1871-5206</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The carbazole framework is found in many natural compds. of biol. interest.  Indolocarbazoles such as rebeccamycin and staurosporine which are either a topoisomerase I inhibitor (rebeccamycin) or a non selective kinase inhibitor (staurosporine) are bacterial metabolites.  In the search for new antitumor agents, DNA damage checkpoint kinases, in particular Checkpoint kinase 1, have recently emerged as attractive targets for cancer therapy.  This review reports the synthesis and Chk1 inhibitory activities of pyrrolocarbazole compds. bearing four or five fused rings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZ1k6BiMZs7LVg90H21EOLACvtfcHk0lggIVb104z0VA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXps1Ohu7Y%253D&md5=e3bed62fe3f1ef68537ea202184090df</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DH%25C3%25A9non%26aufirst%3DH.%26aulast%3DConchon%26aufirst%3DE.%26aulast%3DHugon%26aufirst%3DB.%26aulast%3DMessaoudi%26aufirst%3DS.%26aulast%3DGolsteyn%26aufirst%3DR.%2BM.%26aulast%3DPrudhomme%26aufirst%3DM.%26atitle%3DPyrrolocarbazoles%2520as%2520checkpoint%25201%2520kinase%2520inhibitors%26jtitle%3DAnticancer%2520Agents%2520Med.%2520Chem.%26date%3D2008%26volume%3D8%26spage%3D577%26epage%3D597" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Lyne, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenny, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosgrove, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zabludoff, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wendeloski, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashwell, S.</span><span> </span><span class="NLM_article-title">Identification of compounds with nanomolar binding affinity for checkpoint kinase-1 using knowledge-based virtual screening</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">1962</span><span class="NLM_x">–</span> <span class="NLM_lpage">1968</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm030504i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1962-1968&author=P.+D.+Lyneauthor=P.+W.+Kennyauthor=D.+A.+Cosgroveauthor=C.+Dengauthor=S.+Zabludoffauthor=J.+J.+Wendeloskiauthor=S.+Ashwell&title=Identification+of+compounds+with+nanomolar+binding+affinity+for+checkpoint+kinase-1+using+knowledge-based+virtual+screening"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm030504i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030504i%26sid%3Dliteratum%253Aachs%26aulast%3DLyne%26aufirst%3DP.%2BD.%26aulast%3DKenny%26aufirst%3DP.%2BW.%26aulast%3DCosgrove%26aufirst%3DD.%2BA.%26aulast%3DDeng%26aufirst%3DC.%26aulast%3DZabludoff%26aufirst%3DS.%26aulast%3DWendeloski%26aufirst%3DJ.%2BJ.%26aulast%3DAshwell%26aufirst%3DS.%26atitle%3DIdentification%2520of%2520compounds%2520with%2520nanomolar%2520binding%2520affinity%2520for%2520checkpoint%2520kinase-1%2520using%2520knowledge-based%2520virtual%2520screening%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D1962%26epage%3D1968" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Foloppe, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, L .M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howes, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, A. G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surgenor, A. E.</span><span> </span><span class="NLM_article-title">Identification of chemically diverse Chk1 inhibitors by receptor-based virtual screening</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">4792</span><span class="NLM_x">–</span> <span class="NLM_lpage">4802</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=4792-4802&author=N.+Foloppeauthor=L+.M.+Fisherauthor=R.+Howesauthor=A.+Potterauthor=A.+G.+S.+Robertsonauthor=A.+E.+Surgenor&title=Identification+of+chemically+diverse+Chk1+inhibitors+by+receptor-based+virtual+screening"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFoloppe%26aufirst%3DN.%26aulast%3DFisher%26aufirst%3DL%2B.M.%26aulast%3DHowes%26aufirst%3DR.%26aulast%3DPotter%26aufirst%3DA.%26aulast%3DRobertson%26aufirst%3DA.%2BG.%2BS.%26aulast%3DSurgenor%26aufirst%3DA.%2BE.%26atitle%3DIdentification%2520of%2520chemically%2520diverse%2520Chk1%2520inhibitors%2520by%2520receptor-based%2520virtual%2520screening%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26spage%3D4792%26epage%3D4802" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Chen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Register, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Margosiak, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tempczyk-Russell, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myers, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundgren, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kan, C.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, P. M.</span><span> </span><span class="NLM_article-title">The 1.7 A crystal structure of human cell cycle checkpoint kinase Chk1: implications for Chk1 regulation</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">681</span><span class="NLM_x">–</span> <span class="NLM_lpage">692</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2000&pages=681-692&author=P.+Chenauthor=C.+Luoauthor=Y.+Dengauthor=K.+Ryanauthor=J.+Registerauthor=S.+Margosiakauthor=A.+Tempczyk-Russellauthor=B.+Nguyenauthor=P.+Myersauthor=K.+Lundgrenauthor=C.-C.+Kanauthor=P.+M.+O%E2%80%99Connor&title=The+1.7+A+crystal+structure+of+human+cell+cycle+checkpoint+kinase+Chk1%3A+implications+for+Chk1+regulation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DP.%26aulast%3DLuo%26aufirst%3DC.%26aulast%3DDeng%26aufirst%3DY.%26aulast%3DRyan%26aufirst%3DK.%26aulast%3DRegister%26aufirst%3DJ.%26aulast%3DMargosiak%26aufirst%3DS.%26aulast%3DTempczyk-Russell%26aufirst%3DA.%26aulast%3DNguyen%26aufirst%3DB.%26aulast%3DMyers%26aufirst%3DP.%26aulast%3DLundgren%26aufirst%3DK.%26aulast%3DKan%26aufirst%3DC.-C.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DP.%2BM.%26atitle%3DThe%25201.7%2520A%2520crystal%2520structure%2520of%2520human%2520cell%2520cycle%2520checkpoint%2520kinase%2520Chk1%253A%2520implications%2520for%2520Chk1%2520regulation%26jtitle%3DCell%26date%3D2000%26volume%3D100%26spage%3D681%26epage%3D692" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Jhoti, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cleasby, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verdonk, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, G.</span><span> </span><span class="NLM_article-title">Fragment-based screening using X-ray crystallography and NMR spectroscopy</span> <span class="citation_source-journal">Curr. Opin. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">485</span><span class="NLM_x">–</span> <span class="NLM_lpage">493</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm900314j&amp;key=10.1016%2Fj.cbpa.2007.07.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm900314j&amp;key=17851109" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm900314j&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtF2rsb3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2007&pages=485-493&author=H.+Jhotiauthor=A.+Cleasbyauthor=M.+Verdonkauthor=G.+Williams&title=Fragment-based+screening+using+X-ray+crystallography+and+NMR+spectroscopy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-based screening using X-ray crystallography and NMR spectroscopy</span></div><div class="casAuthors">Jhoti, Harren; Cleasby, Anne; Verdonk, Marcel; Williams, Glyn</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Chemical Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">485-493</span>CODEN:
                <span class="NLM_cas:coden">COCBF4</span>;
        ISSN:<span class="NLM_cas:issn">1367-5931</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Approaches which start from a study of the interaction of very simple mols. (fragments) with the protein target are proving to be valuable addns. to drug design.  Fragment-based screening allows the complementarity between a protein active site and drug-like mols. to be rapidly and effectively explored, using structural methods.  Recent improvements in the intensities of lab. x-ray sources permits the collection of greater amts. of high-quality diffraction data and were matched by developments in automation, crystn. and data anal.  Developments in NMR screening, including the use of cryogenically cooled NMR probes and 19F-contg. reporter mols. have expanded the scope of this technique, while increasing the availability of binding site and quant. affinity data for the fragments.  Application of these methods has led to a greater knowledge of the chem. variety, structural features and energetics of protein-fragment interactions.  While fragment-based screening has already been shown to reduce the timescales of the drug discovery process, a more detailed characterization of fragment screening hits can reveal unexpected similarities between fragment chemotypes and protein active sites leading to improved understanding of the pharmacophores and the re-use of this information against other protein targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFTfwnJaPUpLVg90H21EOLACvtfcHk0libpJmOGAbXHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtF2rsb3E&md5=5a4e431308fe3a8d435cea55960dc663</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.cbpa.2007.07.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbpa.2007.07.010%26sid%3Dliteratum%253Aachs%26aulast%3DJhoti%26aufirst%3DH.%26aulast%3DCleasby%26aufirst%3DA.%26aulast%3DVerdonk%26aufirst%3DM.%26aulast%3DWilliams%26aufirst%3DG.%26atitle%3DFragment-based%2520screening%2520using%2520X-ray%2520crystallography%2520and%2520NMR%2520spectroscopy%26jtitle%3DCurr.%2520Opin.%2520Chem.%2520Biol.%26date%3D2007%26volume%3D11%26spage%3D485%26epage%3D493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Hopkins, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groom, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alex, A.</span><span> </span><span class="NLM_article-title">Ligand efficiency: a useful metric for lead selection</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">430</span><span class="NLM_x">–</span> <span class="NLM_lpage">431</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm900314j&amp;key=10.1016%2FS1359-6446%2804%2903069-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm900314j&amp;key=15109945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm900314j&amp;key=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=430-431&author=A.+L.+Hopkinsauthor=C.+R.+Groomauthor=A.+Alex&title=Ligand+efficiency%3A+a+useful+metric+for+lead+selection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand efficiency: a useful metric for lead selection</span></div><div class="casAuthors">Hopkins Andrew L; Groom Colin R; Alex Alexander</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">430-1</span>
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSdMyKW_d6RPeIHSmpohpd0fW6udTcc2eb3R7iaWTWBpLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D&md5=eb19a1bca53247d0bd9adcb99d5817e6</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2804%2903069-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252804%252903069-7%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26aulast%3DGroom%26aufirst%3DC.%2BR.%26aulast%3DAlex%26aufirst%3DA.%26atitle%3DLigand%2520efficiency%253A%2520a%2520useful%2520metric%2520for%2520lead%2520selection%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2004%26volume%3D9%26spage%3D430%26epage%3D431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Card, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blasdel, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">England, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillette, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fong, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ibrahim, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Artis, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bollag, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milburn, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlessinger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, K. Y.</span><span> </span><span class="NLM_article-title">A family of phosphodiesterase inhibitors discovered by cocrystallography and scaffold-based drug design</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">184</span><span class="NLM_x">–</span> <span class="NLM_lpage">186</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2005&pages=184-186&author=G.+L.+Cardauthor=L.+Blasdelauthor=B.+P.+Englandauthor=C.+Zhangauthor=Y.+Suzukiauthor=S.+Gilletteauthor=D.+Fongauthor=P.+N.+Ibrahimauthor=D.+R.+Artisauthor=G.+Bollagauthor=M.+V.+Milburnauthor=S.+H.+Kimauthor=J.+Schlessingerauthor=K.+Y.+Zhang&title=A+family+of+phosphodiesterase+inhibitors+discovered+by+cocrystallography+and+scaffold-based+drug+design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCard%26aufirst%3DG.%2BL.%26aulast%3DBlasdel%26aufirst%3DL.%26aulast%3DEngland%26aufirst%3DB.%2BP.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DSuzuki%26aufirst%3DY.%26aulast%3DGillette%26aufirst%3DS.%26aulast%3DFong%26aufirst%3DD.%26aulast%3DIbrahim%26aufirst%3DP.%2BN.%26aulast%3DArtis%26aufirst%3DD.%2BR.%26aulast%3DBollag%26aufirst%3DG.%26aulast%3DMilburn%26aufirst%3DM.%2BV.%26aulast%3DKim%26aufirst%3DS.%2BH.%26aulast%3DSchlessinger%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DK.%2BY.%26atitle%3DA%2520family%2520of%2520phosphodiesterase%2520inhibitors%2520discovered%2520by%2520cocrystallography%2520and%2520scaffold-based%2520drug%2520design%26jtitle%3DNat.%2520Biotechnol.%26date%3D2005%26volume%3D23%26spage%3D184%26epage%3D186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Collins, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span> </span><span class="NLM_article-title">New approaches to molecular cancer therapeutics</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">689</span><span class="NLM_x">–</span> <span class="NLM_lpage">700</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm900314j&amp;key=10.1038%2Fnchembio840" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm900314j&amp;key=17108987" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm900314j&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1SrtLfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2006&pages=689-700&author=I.+Collinsauthor=P.+Workman&title=New+approaches+to+molecular+cancer+therapeutics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">New approaches to molecular cancer therapeutics</span></div><div class="casAuthors">Collins, Ian; Workman, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">689-700</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Cancer drug development is leading the way in exploiting mol. biol. and genetic information to develop 'personalized' medicine.  The new paradigm is to develop agents that target the precise mol. pathol. driving the progression of individual cancers.  Drug developers have benefited from decades of academic cancer research and from investment in genomics, genetics and automation; their success is exemplified by high-profile drugs such as Herceptin (trastuzumab), Gleevec (imatinib), Tarceva (erlotinib) and Avastin (bevacizumab).  However, only 5% of cancer drugs entering clin. trials reach marketing approval.  Cancer remains a high unmet medical need, and many potential cancer targets remain undrugged.  In this review we assess the status of the discovery and development of small-mol. cancer therapeutics.  We show how chem. biol. approaches offer techniques for interconnecting elements of the traditional linear progression from gene to drug, thereby providing a basis for increasing speed and success in cancer drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvuRrpAAZbbLVg90H21EOLACvtfcHk0lj_TRMZx2e26w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1SrtLfP&md5=f784ada9031f4f7508c5c58fa040de5b</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1038%2Fnchembio840&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio840%26sid%3Dliteratum%253Aachs%26aulast%3DCollins%26aufirst%3DI.%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DNew%2520approaches%2520to%2520molecular%2520cancer%2520therapeutics%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2006%26volume%3D2%26spage%3D689%26epage%3D700" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span>Chemical Computing Group; <a href="http://www.chemcomp.com" class="extLink">http://www.chemcomp.com</a>. Accessed on 24 June 2009.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Chemical+Computing+Group%3B+http%3A%2F%2Fwww.chemcomp.com.+Accessed+on+24+June+2009."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Computing%2520Group" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Von Leoprechting, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumpf, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menzel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reulle, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griebel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valler, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Büttner, F. H.</span><span> </span><span class="NLM_article-title">Miniaturization and validation of a high-throughput serine kinase assay using the AlphaScreen platform</span> <span class="citation_source-journal">J. Biomol. Screen.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">719</span><span class="NLM_x">–</span> <span class="NLM_lpage">725</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm900314j&amp;key=10.1177%2F1087057104268805" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm900314j&amp;key=15634799" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm900314j&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmsFOisg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=719-725&author=A.+Von+Leoprechtingauthor=R.+Kumpfauthor=S.+Menzelauthor=D.+Reulleauthor=R.+Griebelauthor=M.+J.+Vallerauthor=F.+H.+B%C3%BCttner&title=Miniaturization+and+validation+of+a+high-throughput+serine+kinase+assay+using+the+AlphaScreen+platform"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Miniaturization and validation of a high-throughput serine kinase assay using the AlphaScreen platform</span></div><div class="casAuthors">von Leoprechting, Achim; Kumpf, Renate; Menzel, Susanne; Reulle, Dominique; Griebel, Ralf; Valler, Martin J.; Buttner, Frank H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular Screening</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">719-725</span>CODEN:
                <span class="NLM_cas:coden">JBISF3</span>;
        ISSN:<span class="NLM_cas:issn">1087-0571</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">Reducing costs while maintaining the highest readout quality is a precept of modern high-throughput screening.  Given the trend toward nonradiometric screening platforms, this has been a big challenge for some kinase target classes.  Common issues include low sensitivity, susceptibility to nonspecific interference, or the need for costly reagents.  In this study, the authors describe the feasibility of miniaturization of a serine kinase assay using generic reagents in the AlphaScreen format.  They have validated the robustness of this assay in the course of miniaturization from a 35- to 4.375-μL final assay vol. in 384- and 1536-well formats.  Within this vol. range, they consistently obtained Z' values above 0.5 and have investigated the suitability of these assay formats for measuring compd. effects by testing a set of 25 previously identified active compds.  These active compds. were also reliably identified in the miniaturized assay formats.  The results presented here show that the AlphaScreen technol. permits robust and cost-efficient miniaturization of serine/threonine kinase assays.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomQCsTDO5pn7Vg90H21EOLACvtfcHk0lgbS9Rshm0EgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmsFOisg%253D%253D&md5=9d3a88967e965643be4924d3bf2656a8</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1177%2F1087057104268805&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057104268805%26sid%3Dliteratum%253Aachs%26aulast%3DVon%2BLeoprechting%26aufirst%3DA.%26aulast%3DKumpf%26aufirst%3DR.%26aulast%3DMenzel%26aufirst%3DS.%26aulast%3DReulle%26aufirst%3DD.%26aulast%3DGriebel%26aufirst%3DR.%26aulast%3DValler%26aufirst%3DM.%2BJ.%26aulast%3DB%25C3%25BCttner%26aufirst%3DF.%2BH.%26atitle%3DMiniaturization%2520and%2520validation%2520of%2520a%2520high-throughput%2520serine%2520kinase%2520assay%2520using%2520the%2520AlphaScreen%2520platform%26jtitle%3DJ.%2520Biomol.%2520Screen.%26date%3D2004%26volume%3D9%26spage%3D719%26epage%3D725" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Ryan, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowe, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, C. W.</span><span> </span><span class="NLM_article-title">Effect of detergent on “promiscuous” inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">3448</span><span class="NLM_x">–</span> <span class="NLM_lpage">3451</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0340896" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=3448-3451&author=A.+J.+Ryanauthor=N.+M.+Grayauthor=P.+N.+Loweauthor=C.+W.+Chung&title=Effect+of+detergent+on+%E2%80%9Cpromiscuous%E2%80%9D+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm0340896&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0340896%26sid%3Dliteratum%253Aachs%26aulast%3DRyan%26aufirst%3DA.%2BJ.%26aulast%3DGray%26aufirst%3DN.%2BM.%26aulast%3DLowe%26aufirst%3DP.%2BN.%26aulast%3DChung%26aufirst%3DC.%2BW.%26atitle%3DEffect%2520of%2520detergent%2520on%2520%25E2%2580%259Cpromiscuous%25E2%2580%259D%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D3448%26epage%3D3451" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Burns, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Travers, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowlands, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newbatt, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrett, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aherne, W.</span><span> </span><span class="NLM_article-title">Identification of small molecule inhibitors of protein kinase B (PKB) in an AlphaScreen high-throughput screen</span> <span class="citation_source-journal">J. Biomol. Screening</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">822</span><span class="NLM_x">–</span> <span class="NLM_lpage">827</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm900314j&amp;key=10.1177%2F1087057106290992" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm900314j&amp;key=16902245" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm900314j&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1SgsLzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2006&pages=822-827&author=S.+Burnsauthor=J.+Traversauthor=I.+Collinsauthor=M.+G.+Rowlandsauthor=Y.+Newbattauthor=N.+Thompsonauthor=M.+D.+Garrettauthor=P.+Workmanauthor=W.+Aherne&title=Identification+of+small+molecule+inhibitors+of+protein+kinase+B+%28PKB%29+in+an+AlphaScreen+high-throughput+screen"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of small-molecule inhibitors of protein kinase B (PKB/AKT) in an AlphaScreen high-throughput screen</span></div><div class="casAuthors">Burns, Samantha; Travers, Jonathan; Collins, Ian; Rowlands, Martin G.; Newbatt, Yvette; Thompson, Neil; Garrett, Michelle D.; Workman, Paul; Aherne, Wynne</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular Screening</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">822-827</span>CODEN:
                <span class="NLM_cas:coden">JBISF3</span>;
        ISSN:<span class="NLM_cas:issn">1087-0571</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">Protein kinase B (PKB/AKT) was identified as a promising cancer drug target downstream of PI3 kinase.  To find novel inhibitors of PKB/AKT kinase activity for progression as anticancer agents, the authors have used a high-throughput screen based on AlphaScreen technol.  A known kinase inhibitor, the isoquinoline H8, was used as a pos. control with mean inhibition in the screen of 43.4% ± 13.1%.  The performance of the screen was highly acceptable with Z' and Z factors of 0.83 ± 0.07 and 0.75 ± 0.04, resp.  A no. of confirmed hits (∼0.1% hit rate) were identified from 63,500 compds. screened.  Five compds. have previously been described as PKB inhibitors, demonstrating the ability of the assay to find authentic inhibitors of the enzyme.  Five hits had the potential to interfere with the assay signal and were deemed to be false positives.  Two compds. were nonspecific inhibitors of PKB as enzyme inhibition in a filter-based assay was markedly reduced in the presence of 0.01% Triton X100.  The authors now include an interference assay during hit confirmation procedures and check compd. activity in the presence of Triton X100 in an attempt to eliminate nonspecific aggregators at an early stage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaOwUuRayl-bVg90H21EOLACvtfcHk0lgQ_K3pbPYM0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1SgsLzJ&md5=329182ca4dd153c00cdbf7795b118518</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1177%2F1087057106290992&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057106290992%26sid%3Dliteratum%253Aachs%26aulast%3DBurns%26aufirst%3DS.%26aulast%3DTravers%26aufirst%3DJ.%26aulast%3DCollins%26aufirst%3DI.%26aulast%3DRowlands%26aufirst%3DM.%2BG.%26aulast%3DNewbatt%26aufirst%3DY.%26aulast%3DThompson%26aufirst%3DN.%26aulast%3DGarrett%26aufirst%3DM.%2BD.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DAherne%26aufirst%3DW.%26atitle%3DIdentification%2520of%2520small%2520molecule%2520inhibitors%2520of%2520protein%2520kinase%2520B%2520%2528PKB%2529%2520in%2520an%2520AlphaScreen%2520high-throughput%2520screen%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D2006%26volume%3D11%26spage%3D822%26epage%3D827" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Babaoglu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoichet, B. K.</span><span> </span><span class="NLM_article-title">Deconstructing fragment-based inhibitor discovery</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">658</span><span class="NLM_x">–</span> <span class="NLM_lpage">659</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm900314j&amp;key=10.1038%2Fnchembio831" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm900314j&amp;key=17108979" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2006&pages=658-659&author=K.+Babaogluauthor=B.+K.+Shoichet&title=Deconstructing+fragment-based+inhibitor+discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1038%2Fnchembio831&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio831%26sid%3Dliteratum%253Aachs%26aulast%3DBabaoglu%26aufirst%3DK.%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26atitle%3DDeconstructing%2520fragment-based%2520inhibitor%2520discovery%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2006%26volume%3D2%26spage%3D658%26epage%3D659" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Foloppe, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howes, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kierstan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, A.</span><span> </span><span class="NLM_article-title">Identification of a buried pocket for potent and selective inhibition of CHk1: Prediction and verification</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1792</span><span class="NLM_x">–</span> <span class="NLM_lpage">1804</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=1792-1804&author=N.+Foloppeauthor=L.+M.+Fisherauthor=G.+Francisauthor=R.+Howesauthor=P.+Kierstanauthor=A.+Potter&title=Identification+of+a+buried+pocket+for+potent+and+selective+inhibition+of+CHk1%3A+Prediction+and+verification"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFoloppe%26aufirst%3DN.%26aulast%3DFisher%26aufirst%3DL.%2BM.%26aulast%3DFrancis%26aufirst%3DG.%26aulast%3DHowes%26aufirst%3DR.%26aulast%3DKierstan%26aufirst%3DP.%26aulast%3DPotter%26aufirst%3DA.%26atitle%3DIdentification%2520of%2520a%2520buried%2520pocket%2520for%2520potent%2520and%2520selective%2520inhibition%2520of%2520CHk1%253A%2520Prediction%2520and%2520verification%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26spage%3D1792%26epage%3D1804" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Gibson, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arris, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bentley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyle, F. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curtin, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endicott, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golding, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grant, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jewsbury, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, L. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mesguiche, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newell, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noble, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tucker, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitfield, H. J.</span><span> </span><span class="NLM_article-title">Probing the ATP ribose-binding domain of cyclin-dependent kinases 1 and 2 with O(6)-substituted guanine derivatives</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">3381</span><span class="NLM_x">–</span> <span class="NLM_lpage">3393</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm020056z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=3381-3393&author=A.+E.+Gibsonauthor=C.+E.+Arrisauthor=J.+Bentleyauthor=F.+T.+Boyleauthor=N.+J.+Curtinauthor=T.+G.+Daviesauthor=J.+A.+Endicottauthor=B.+T.+Goldingauthor=S.+Grantauthor=R.+J.+Griffinauthor=P.+Jewsburyauthor=L.+N.+Johnsonauthor=V.+Mesguicheauthor=D.+R.+Newellauthor=M.+E.+Nobleauthor=J.+A.+Tuckerauthor=H.+J.+Whitfield&title=Probing+the+ATP+ribose-binding+domain+of+cyclin-dependent+kinases+1+and+2+with+O%286%29-substituted+guanine+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38a&amp;dbid=16384&amp;doi=10.1021%2Fjm020056z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020056z%26sid%3Dliteratum%253Aachs%26aulast%3DGibson%26aufirst%3DA.%2BE.%26aulast%3DArris%26aufirst%3DC.%2BE.%26aulast%3DBentley%26aufirst%3DJ.%26aulast%3DBoyle%26aufirst%3DF.%2BT.%26aulast%3DCurtin%26aufirst%3DN.%2BJ.%26aulast%3DDavies%26aufirst%3DT.%2BG.%26aulast%3DEndicott%26aufirst%3DJ.%2BA.%26aulast%3DGolding%26aufirst%3DB.%2BT.%26aulast%3DGrant%26aufirst%3DS.%26aulast%3DGriffin%26aufirst%3DR.%2BJ.%26aulast%3DJewsbury%26aufirst%3DP.%26aulast%3DJohnson%26aufirst%3DL.%2BN.%26aulast%3DMesguiche%26aufirst%3DV.%26aulast%3DNewell%26aufirst%3DD.%2BR.%26aulast%3DNoble%26aufirst%3DM.%2BE.%26aulast%3DTucker%26aufirst%3DJ.%2BA.%26aulast%3DWhitfield%26aufirst%3DH.%2BJ.%26atitle%3DProbing%2520the%2520ATP%2520ribose-binding%2520domain%2520of%2520cyclin-dependent%2520kinases%25201%2520and%25202%2520with%2520O%25286%2529-substituted%2520guanine%2520derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D3381%26epage%3D3393" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit38b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hardcastle, I. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arris, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bentley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyle, F. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curtin, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endicott, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golding, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jewsbury, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menyerol, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mesguiche, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newell, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noble, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pratt, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitfield, H. J.</span><span> </span><span class="NLM_article-title">N2-substituted O6-cyclohexylmethylguanine derivatives: potent inhibitors of cyclin-dependent kinases 1 and 2</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">3710</span><span class="NLM_x">–</span> <span class="NLM_lpage">3722</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0311442" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=3710-3722&author=I.+R.+Hardcastleauthor=C.+E.+Arrisauthor=J.+Bentleyauthor=F.+T.+Boyleauthor=Y.+Chenauthor=N.+J.+Curtinauthor=J.+A.+Endicottauthor=A.+E.+Gibsonauthor=B.+T.+Goldingauthor=R.+J.+Griffinauthor=P.+Jewsburyauthor=J.+Menyerolauthor=V.+Mesguicheauthor=D.+R.+Newellauthor=M.+E.+Nobleauthor=D.+J.+Prattauthor=L.+Z.+Wangauthor=H.+J.+Whitfield&title=N2-substituted+O6-cyclohexylmethylguanine+derivatives%3A+potent+inhibitors+of+cyclin-dependent+kinases+1+and+2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38b&amp;dbid=16384&amp;doi=10.1021%2Fjm0311442&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0311442%26sid%3Dliteratum%253Aachs%26aulast%3DHardcastle%26aufirst%3DI.%2BR.%26aulast%3DArris%26aufirst%3DC.%2BE.%26aulast%3DBentley%26aufirst%3DJ.%26aulast%3DBoyle%26aufirst%3DF.%2BT.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DCurtin%26aufirst%3DN.%2BJ.%26aulast%3DEndicott%26aufirst%3DJ.%2BA.%26aulast%3DGibson%26aufirst%3DA.%2BE.%26aulast%3DGolding%26aufirst%3DB.%2BT.%26aulast%3DGriffin%26aufirst%3DR.%2BJ.%26aulast%3DJewsbury%26aufirst%3DP.%26aulast%3DMenyerol%26aufirst%3DJ.%26aulast%3DMesguiche%26aufirst%3DV.%26aulast%3DNewell%26aufirst%3DD.%2BR.%26aulast%3DNoble%26aufirst%3DM.%2BE.%26aulast%3DPratt%26aufirst%3DD.%2BJ.%26aulast%3DWang%26aufirst%3DL.%2BZ.%26aulast%3DWhitfield%26aufirst%3DH.%2BJ.%26atitle%3DN2-substituted%2520O6-cyclohexylmethylguanine%2520derivatives%253A%2520potent%2520inhibitors%2520of%2520cyclin-dependent%2520kinases%25201%2520and%25202%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D3710%26epage%3D3722" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Donald, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHardy, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowlands, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyle, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aherne, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrett, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, I.</span><span> </span><span class="NLM_article-title">Rapid evolution of 6-phenylpurine inhibitors of protein kinase B through structure-based design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">2289</span><span class="NLM_x">–</span> <span class="NLM_lpage">2293</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0700924" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=2289-2293&author=A.+Donaldauthor=T.+McHardyauthor=M.+G.+Rowlandsauthor=L.+K.+Hunterauthor=T.+G.+Daviesauthor=R.+G.+Boyleauthor=G.+W.+Aherneauthor=M.+D.+Garrettauthor=I.+Collins&title=Rapid+evolution+of+6-phenylpurine+inhibitors+of+protein+kinase+B+through+structure-based+design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39a&amp;dbid=16384&amp;doi=10.1021%2Fjm0700924&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0700924%26sid%3Dliteratum%253Aachs%26aulast%3DDonald%26aufirst%3DA.%26aulast%3DMcHardy%26aufirst%3DT.%26aulast%3DRowlands%26aufirst%3DM.%2BG.%26aulast%3DHunter%26aufirst%3DL.%2BK.%26aulast%3DDavies%26aufirst%3DT.%2BG.%26aulast%3DBoyle%26aufirst%3DR.%2BG.%26aulast%3DAherne%26aufirst%3DG.%2BW.%26aulast%3DGarrett%26aufirst%3DM.%2BD.%26aulast%3DCollins%26aufirst%3DI.%26atitle%3DRapid%2520evolution%2520of%25206-phenylpurine%2520inhibitors%2520of%2520protein%2520kinase%2520B%2520through%2520structure-based%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D2289%26epage%3D2293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit39b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Caldwell, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donald, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHardy, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowlands, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aherne, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruddle, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynaud, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verdonk, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrett, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, I.</span><span> </span><span class="NLM_article-title">Identification of 4-(4-aminopiperidin-1-yl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidines as selective inhibitors of protein kinase B through fragment elaboration</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">2147</span><span class="NLM_x">–</span> <span class="NLM_lpage">2157</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm701437d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=2147-2157&author=J.+J.+Caldwellauthor=T.+G.+Daviesauthor=A.+Donaldauthor=T.+McHardyauthor=M.+G.+Rowlandsauthor=G.+W.+Aherneauthor=L.+K.+Hunterauthor=K.+Taylorauthor=R.+Ruddleauthor=F.+I.+Raynaudauthor=M.+Verdonkauthor=P.+Workmanauthor=M.+D.+Garrettauthor=I.+Collins&title=Identification+of+4-%284-aminopiperidin-1-yl%29-7H-pyrrolo%5B2%2C3-d%5Dpyrimidines+as+selective+inhibitors+of+protein+kinase+B+through+fragment+elaboration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39b&amp;dbid=16384&amp;doi=10.1021%2Fjm701437d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701437d%26sid%3Dliteratum%253Aachs%26aulast%3DCaldwell%26aufirst%3DJ.%2BJ.%26aulast%3DDavies%26aufirst%3DT.%2BG.%26aulast%3DDonald%26aufirst%3DA.%26aulast%3DMcHardy%26aufirst%3DT.%26aulast%3DRowlands%26aufirst%3DM.%2BG.%26aulast%3DAherne%26aufirst%3DG.%2BW.%26aulast%3DHunter%26aufirst%3DL.%2BK.%26aulast%3DTaylor%26aufirst%3DK.%26aulast%3DRuddle%26aufirst%3DR.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DVerdonk%26aufirst%3DM.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DGarrett%26aufirst%3DM.%2BD.%26aulast%3DCollins%26aufirst%3DI.%26atitle%3DIdentification%2520of%25204-%25284-aminopiperidin-1-yl%2529-7H-pyrrolo%255B2%252C3-d%255Dpyrimidines%2520as%2520selective%2520inhibitors%2520of%2520protein%2520kinase%2520B%2520through%2520fragment%2520elaboration%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D2147%26epage%3D2157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Shapiro, G. I.</span><span> </span><span class="NLM_article-title">Cyclin-dependent kinase pathways as targets for cancer treatment</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">1770</span><span class="NLM_x">–</span> <span class="NLM_lpage">1783</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm900314j&amp;key=10.1200%2FJCO.2005.03.7689" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Fjm900314j&amp;key=16603719" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm900314j&amp;key=1%3ACAS%3A528%3ADC%252BD28XksVKgtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2006&pages=1770-1783&author=G.+I.+Shapiro&title=Cyclin-dependent+kinase+pathways+as+targets+for+cancer+treatment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclin-dependent kinase pathways as targets for cancer treatment</span></div><div class="casAuthors">Shapiro, Geoffrey I.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1770-1783</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">A review.  Cyclin-dependent kinases (cdks) are crit. regulators of cell cycle progression and RNA transcription.  A variety of genetic and epigenetic events cause universal overactivity of the cell cycle cdks in human cancer, and their inhibition can lead to both cell cycle arrest and apoptosis.  However, built-in redundancy may limit the effects of highly selective cdk inhibition.  Cdk4/6 inhibition has been shown to induce potent G1 arrest in vitro and tumor regression in vivo; cdk2/1 inhibition has the most potent effects during the S and G2 phases and induces E2F transcription factor-dependent cell death.  Modulation of cdk2 and cdk1 activities also affects survival checkpoint responses after exposure to DNA-damaging and microtubule-stabilizing agents.  The transcriptional cdks phosphorylate the carboxy-terminal domain of RNA polymerase II, facilitating efficient transcriptional initiation and elongation.  Inhibition of these cdks primarily affects the accumulation of transcripts with short half-lives, including those encoding antiapoptosis family members, cell cycle regulators, as well as p53 and nuclear factor-kappa B-responsive gene targets.  These effects may account for apoptosis induced by cdk9 inhibitors, esp. in malignant hematopoietic cells, and may also potentiate cytotoxicity mediated by disruption of a variety of pathways in many transformed cell types.  Current work is focusing on overcoming pharmacokinetic barriers that hindered development of flavopiridol, a pan-cdk inhibitor, as well as assessing novel classes of compds. potently targeting groups of cell cycle cdks (cdk4/6 or cdk2/1) with variable effects on the transcriptional cdks 7 and 9.  These efforts will establish whether the strategy of cdk inhibition is able to produce therapeutic benefit in the majority of human tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYfmCpSfvpTbVg90H21EOLACvtfcHk0lgKA7SgWd2Vdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XksVKgtbg%253D&md5=420a31b47f6600625f7d499a4b8a5fc9</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1200%2FJCO.2005.03.7689&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2005.03.7689%26sid%3Dliteratum%253Aachs%26aulast%3DShapiro%26aufirst%3DG.%2BI.%26atitle%3DCyclin-dependent%2520kinase%2520pathways%2520as%2520targets%2520for%2520cancer%2520treatment%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2006%26volume%3D24%26spage%3D1770%26epage%3D1783" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Xiao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xue, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, W.-Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bui, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tao, Z.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, N.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sowin, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span> </span><span class="NLM_article-title">Cyclin B1 is an efficacy-predicting biomarker for Chk1 inhibitors</span> <span class="citation_source-journal">Biomarkers</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">579</span><span class="NLM_x">–</span> <span class="NLM_lpage">596</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2008&pages=579-596&author=Z.+Xiaoauthor=J.+Xueauthor=W.-Z.+Guauthor=M.+Buiauthor=G.+Liauthor=Z.-F.+Taoauthor=N.-H.+Linauthor=T.+J.+Sowinauthor=H.+Zhang&title=Cyclin+B1+is+an+efficacy-predicting+biomarker+for+Chk1+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXiao%26aufirst%3DZ.%26aulast%3DXue%26aufirst%3DJ.%26aulast%3DGu%26aufirst%3DW.-Z.%26aulast%3DBui%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DTao%26aufirst%3DZ.-F.%26aulast%3DLin%26aufirst%3DN.-H.%26aulast%3DSowin%26aufirst%3DT.%2BJ.%26aulast%3DZhang%26aufirst%3DH.%26atitle%3DCyclin%2520B1%2520is%2520an%2520efficacy-predicting%2520biomarker%2520for%2520Chk1%2520inhibitors%26jtitle%3DBiomarkers%26date%3D2008%26volume%3D13%26spage%3D579%26epage%3D596" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Hoehn, H.; Denzel, T.</span><span> </span><span class="NLM_article-title">1<i>H</i>-Pyrazolo[3,4-<i>b</i>]pyridines</span>. Patent Appl. DE2301268,<span class="NLM_x"> </span><span class="NLM_year">1973</span><span class="NLM_x">, </span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1973&author=H.+Hoehn&author=T.+Denzel&title=1H-Pyrazolo%5B3%2C4-b%5Dpyridines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHoehn%26aufirst%3DH.%26atitle%3D1H-Pyrazolo%255B3%252C4-b%255Dpyridines%26date%3D1973" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-ref42_2"><span>;  <span class="citation_source-journal">Chem. Abs.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1973</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">115578</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=%3B+Chem.+Abs.+1973%2C+79%2C+115578."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=ref42_2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26jtitle%3DChem.%2520Abs.%26date%3D1973%26volume%3D79%26spage%3D115578" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Misra, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, H.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rawlins, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kellar, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulheron, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sack, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tokarski, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimball, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webster, K. R.</span><span> </span><span class="NLM_article-title">1<i>H</i>-Pyrazolo[3,4-<i>b</i>]pyridine inhibitors of cyclin-dependent kinases: highly potent 2,6-difluorophenacyl analogues</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">2405</span><span class="NLM_x">–</span> <span class="NLM_lpage">2408</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=2405-2408&author=R.+N.+Misraauthor=H.-Y.+Xiaoauthor=D.+B.+Rawlinsauthor=W.+Shanauthor=K.+A.+Kellarauthor=J.+G.+Mulheronauthor=J.+S.+Sackauthor=J.+S.+Tokarskiauthor=S.+D.+Kimballauthor=K.+R.+Webster&title=1H-Pyrazolo%5B3%2C4-b%5Dpyridine+inhibitors+of+cyclin-dependent+kinases%3A+highly+potent+2%2C6-difluorophenacyl+analogues"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMisra%26aufirst%3DR.%2BN.%26aulast%3DXiao%26aufirst%3DH.-Y.%26aulast%3DRawlins%26aufirst%3DD.%2BB.%26aulast%3DShan%26aufirst%3DW.%26aulast%3DKellar%26aufirst%3DK.%2BA.%26aulast%3DMulheron%26aufirst%3DJ.%2BG.%26aulast%3DSack%26aufirst%3DJ.%2BS.%26aulast%3DTokarski%26aufirst%3DJ.%2BS.%26aulast%3DKimball%26aufirst%3DS.%2BD.%26aulast%3DWebster%26aufirst%3DK.%2BR.%26atitle%3D1H-Pyrazolo%255B3%252C4-b%255Dpyridine%2520inhibitors%2520of%2520cyclin-dependent%2520kinases%253A%2520highly%2520potent%25202%252C6-difluorophenacyl%2520analogues%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D2405%26epage%3D2408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Brenner, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baldwin, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamagnan, G.</span><span> </span><span class="NLM_article-title">Asymmetric synthesis of (+)-(<i>S</i>,<i>S</i>)-reboxetine via a new (<i>S</i>)-2-(hydroxymethyl)morpholine preparation</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">937</span><span class="NLM_x">–</span> <span class="NLM_lpage">939</span></span><div class="citationLinks">[<a href="/doi/10.1021/ol050059g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2005&pages=937-939&author=E.+Brennerauthor=R.+M.+Baldwinauthor=G.+Tamagnan&title=Asymmetric+synthesis+of+%28%2B%29-%28S%2CS%29-reboxetine+via+a+new+%28S%29-2-%28hydroxymethyl%29morpholine+preparation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fol050059g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol050059g%26sid%3Dliteratum%253Aachs%26aulast%3DBrenner%26aufirst%3DE.%26aulast%3DBaldwin%26aufirst%3DR.%2BM.%26aulast%3DTamagnan%26aufirst%3DG.%26atitle%3DAsymmetric%2520synthesis%2520of%2520%2528%252B%2529-%2528S%252CS%2529-reboxetine%2520via%2520a%2520new%2520%2528S%2529-2-%2528hydroxymethyl%2529morpholine%2520preparation%26jtitle%3DOrg.%2520Lett.%26date%3D2005%26volume%3D7%26spage%3D937%26epage%3D939" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Parry, D.; Shanahan, F.; Davis, N.; Wiswell, D.; Seghezzi, W.; Pierce, R.; Hsieh, Y.; Paruch, K.; Guzi, T.</span><span> </span><span class="NLM_article-title">Targeting the replication checkpoint with a potent and selective CHK1 inhibitor SCH 900776</span>. <span class="NLM_conf-name">Abstracts of the 100th AACR Annual Meeting</span>, <span class="NLM_conf-loc">Denver, CO</span>, <span class="NLM_conf-date">April 18−29, 2009</span>, paper 2490.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Parry%2C+D.%3B+Shanahan%2C+F.%3B+Davis%2C+N.%3B+Wiswell%2C+D.%3B+Seghezzi%2C+W.%3B+Pierce%2C+R.%3B+Hsieh%2C+Y.%3B+Paruch%2C+K.%3B+Guzi%2C+T.+Targeting+the+replication+checkpoint+with+a+potent+and+selective+CHK1+inhibitor+SCH+900776.+Abstracts+of+the+100th+AACR+Annual+Meeting%2C+Denver%2C+CO%2C+April+18%E2%88%9229%2C+2009%2C+paper+2490."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DParry%26aufirst%3DD.%26atitle%3DTargeting%2520the%2520replication%2520checkpoint%2520with%2520a%2520potent%2520and%2520selective%2520CHK1%2520inhibitor%2520SCH%2520900776" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Schirok, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kast, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Figueroa-Perez, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennabi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gnoth, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feurer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heckroth, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thutewohl, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paulsen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knorr, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huetter, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lobell, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muenter, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geiss, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ehmke, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radtke, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mittendorf, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stasch, J.</span><span> </span><span class="NLM_article-title">Design and synthesis of potent and selective azaindole-based Rho kinase (ROCK) inhibitors</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1893</span><span class="NLM_x">–</span> <span class="NLM_lpage">1904</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=1893-1904&author=H.+Schirokauthor=R.+Kastauthor=S.+Figueroa-Perezauthor=S.+Bennabiauthor=M.+J.+Gnothauthor=A.+Feurerauthor=H.+Heckrothauthor=M.+Thutewohlauthor=H.+Paulsenauthor=A.+Knorrauthor=J.+Huetterauthor=M.+Lobellauthor=K.+Muenterauthor=V.+Geissauthor=H.+Ehmkeauthor=D.+Langauthor=M.+Radtkeauthor=J.+Mittendorfauthor=J.+Stasch&title=Design+and+synthesis+of+potent+and+selective+azaindole-based+Rho+kinase+%28ROCK%29+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchirok%26aufirst%3DH.%26aulast%3DKast%26aufirst%3DR.%26aulast%3DFigueroa-Perez%26aufirst%3DS.%26aulast%3DBennabi%26aufirst%3DS.%26aulast%3DGnoth%26aufirst%3DM.%2BJ.%26aulast%3DFeurer%26aufirst%3DA.%26aulast%3DHeckroth%26aufirst%3DH.%26aulast%3DThutewohl%26aufirst%3DM.%26aulast%3DPaulsen%26aufirst%3DH.%26aulast%3DKnorr%26aufirst%3DA.%26aulast%3DHuetter%26aufirst%3DJ.%26aulast%3DLobell%26aufirst%3DM.%26aulast%3DMuenter%26aufirst%3DK.%26aulast%3DGeiss%26aufirst%3DV.%26aulast%3DEhmke%26aufirst%3DH.%26aulast%3DLang%26aufirst%3DD.%26aulast%3DRadtke%26aufirst%3DM.%26aulast%3DMittendorf%26aufirst%3DJ.%26aulast%3DStasch%26aufirst%3DJ.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520potent%2520and%2520selective%2520azaindole-based%2520Rho%2520kinase%2520%2528ROCK%2529%2520inhibitors%26jtitle%3DChemMedChem%26date%3D2008%26volume%3D3%26spage%3D1893%26epage%3D1904" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit46b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Dai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartandi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soni, N. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pease, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reuter, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osterling, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doktor, S. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albert, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouska, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glaser, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcotte, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidsen, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michaelides, M. R.</span><span> </span><span class="NLM_article-title">Identification of aminopyrazolopyridine ureas as potent VEGFR/PDGFR multitargeted kinase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">386</span><span class="NLM_x">–</span> <span class="NLM_lpage">390</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=386-390&author=Y.+Daiauthor=K.+Hartandiauthor=N.+B.+Soniauthor=L.+J.+Peaseauthor=D.+R.+Reuterauthor=A.+M.+Olsonauthor=D.+J.+Osterlingauthor=S.+Z.+Doktorauthor=D.+H.+Albertauthor=J.+J.+Bouskaauthor=K.+B.+Glaserauthor=P.+A.+Marcotteauthor=K.+D.+Stewartauthor=S.+K.+Davidsenauthor=M.+R.+Michaelides&title=Identification+of+aminopyrazolopyridine+ureas+as+potent+VEGFR%2FPDGFR+multitargeted+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDai%26aufirst%3DY.%26aulast%3DHartandi%26aufirst%3DK.%26aulast%3DSoni%26aufirst%3DN.%2BB.%26aulast%3DPease%26aufirst%3DL.%2BJ.%26aulast%3DReuter%26aufirst%3DD.%2BR.%26aulast%3DOlson%26aufirst%3DA.%2BM.%26aulast%3DOsterling%26aufirst%3DD.%2BJ.%26aulast%3DDoktor%26aufirst%3DS.%2BZ.%26aulast%3DAlbert%26aufirst%3DD.%2BH.%26aulast%3DBouska%26aufirst%3DJ.%2BJ.%26aulast%3DGlaser%26aufirst%3DK.%2BB.%26aulast%3DMarcotte%26aufirst%3DP.%2BA.%26aulast%3DStewart%26aufirst%3DK.%2BD.%26aulast%3DDavidsen%26aufirst%3DS.%2BK.%26aulast%3DMichaelides%26aufirst%3DM.%2BR.%26atitle%3DIdentification%2520of%2520aminopyrazolopyridine%2520ureas%2520as%2520potent%2520VEGFR%252FPDGFR%2520multitargeted%2520kinase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D386%26epage%3D390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit46c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Lin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connolly, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emanuel, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middleton, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gruninger, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuentes-Pesquera, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenberger, L. M.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of pyrazolo[3,4-<i>b</i>]pyridine CDK1 inhibitors as antitumor agents</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">4297</span><span class="NLM_x">–</span> <span class="NLM_lpage">4302</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=4297-4302&author=R.+Linauthor=P.+J.+Connollyauthor=Y.+Luauthor=G.+Chiuauthor=S.+Liauthor=Y.+Yuauthor=S.+Huangauthor=X.+Liauthor=S.+L.+Emanuelauthor=S.+A.+Middletonauthor=R.+H.+Gruningerauthor=M.+Adamsauthor=A.+R.+Fuentes-Pesqueraauthor=L.+M.+Greenberger&title=Synthesis+and+evaluation+of+pyrazolo%5B3%2C4-b%5Dpyridine+CDK1+inhibitors+as+antitumor+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DR.%26aulast%3DConnolly%26aufirst%3DP.%2BJ.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DChiu%26aufirst%3DG.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DYu%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DEmanuel%26aufirst%3DS.%2BL.%26aulast%3DMiddleton%26aufirst%3DS.%2BA.%26aulast%3DGruninger%26aufirst%3DR.%2BH.%26aulast%3DAdams%26aufirst%3DM.%26aulast%3DFuentes-Pesquera%26aufirst%3DA.%2BR.%26aulast%3DGreenberger%26aufirst%3DL.%2BM.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520pyrazolo%255B3%252C4-b%255Dpyridine%2520CDK1%2520inhibitors%2520as%2520antitumor%2520agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D4297%26epage%3D4302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit46d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Witherington, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bordas, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaiba, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garton, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naylor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rawlings, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slingsby, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takle, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, R. W.</span><span> </span><span class="NLM_article-title">6-Aryl-pyrazolo[3,4-<i>b</i>]pyridines: potent inhibitors of glycogen synthase kinase-3 (GSK-3)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">3055</span><span class="NLM_x">–</span> <span class="NLM_lpage">3057</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=3055-3057&author=J.+Witheringtonauthor=V.+Bordasauthor=A.+Gaibaauthor=N.+S.+Gartonauthor=A.+Naylorauthor=A.+D.+Rawlingsauthor=B.+P.+Slingsbyauthor=D.+G.+Smithauthor=A.+K.+Takleauthor=R.+W.+Ward&title=6-Aryl-pyrazolo%5B3%2C4-b%5Dpyridines%3A+potent+inhibitors+of+glycogen+synthase+kinase-3+%28GSK-3%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWitherington%26aufirst%3DJ.%26aulast%3DBordas%26aufirst%3DV.%26aulast%3DGaiba%26aufirst%3DA.%26aulast%3DGarton%26aufirst%3DN.%2BS.%26aulast%3DNaylor%26aufirst%3DA.%26aulast%3DRawlings%26aufirst%3DA.%2BD.%26aulast%3DSlingsby%26aufirst%3DB.%2BP.%26aulast%3DSmith%26aufirst%3DD.%2BG.%26aulast%3DTakle%26aufirst%3DA.%2BK.%26aulast%3DWard%26aufirst%3DR.%2BW.%26atitle%3D6-Aryl-pyrazolo%255B3%252C4-b%255Dpyridines%253A%2520potent%2520inhibitors%2520of%2520glycogen%2520synthase%2520kinase-3%2520%2528GSK-3%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D3055%26epage%3D3057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit46e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Witherington, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bordas, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garland, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickey, D. M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ife, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liddle, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saunders, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, R. W.</span><span> </span><span class="NLM_article-title">5-Aryl-pyrazolo[3,4-<i>b</i>]pyridines: potent inhibitors of glycogen synthase kinase-3 (GSK-3)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1577</span><span class="NLM_x">–</span> <span class="NLM_lpage">1580</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=1577-1580&author=J.+Witheringtonauthor=V.+Bordasauthor=S.+L.+Garlandauthor=D.+M.+B.+Hickeyauthor=R.+J.+Ifeauthor=J.+Liddleauthor=M.+Saundersauthor=D.+G.+Smithauthor=R.+W.+Ward&title=5-Aryl-pyrazolo%5B3%2C4-b%5Dpyridines%3A+potent+inhibitors+of+glycogen+synthase+kinase-3+%28GSK-3%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWitherington%26aufirst%3DJ.%26aulast%3DBordas%26aufirst%3DV.%26aulast%3DGarland%26aufirst%3DS.%2BL.%26aulast%3DHickey%26aufirst%3DD.%2BM.%2BB.%26aulast%3DIfe%26aufirst%3DR.%2BJ.%26aulast%3DLiddle%26aufirst%3DJ.%26aulast%3DSaunders%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DD.%2BG.%26aulast%3DWard%26aufirst%3DR.%2BW.%26atitle%3D5-Aryl-pyrazolo%255B3%252C4-b%255Dpyridines%253A%2520potent%2520inhibitors%2520of%2520glycogen%2520synthase%2520kinase-3%2520%2528GSK-3%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D1577%26epage%3D1580" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit46f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Misra, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rawlins, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bursuker, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kellar, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulheron, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sack, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tokarski, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimball, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webster, K. R.</span><span> </span><span class="NLM_article-title">1<i>H</i>-Pyrazolo[3,4-<i>b</i>]pyridine inhibitors of cyclin-dependent kinases</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1133</span><span class="NLM_x">–</span> <span class="NLM_lpage">1136</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=1133-1136&author=R.+N.+Misraauthor=D.+B.+Rawlinsauthor=H.+Xiaoauthor=W.+Shanauthor=I.+Bursukerauthor=K.+A.+Kellarauthor=J.+G.+Mulheronauthor=J.+S.+Sackauthor=J.+S.+Tokarskiauthor=S.+D.+Kimballauthor=K.+R.+Webster&title=1H-Pyrazolo%5B3%2C4-b%5Dpyridine+inhibitors+of+cyclin-dependent+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMisra%26aufirst%3DR.%2BN.%26aulast%3DRawlins%26aufirst%3DD.%2BB.%26aulast%3DXiao%26aufirst%3DH.%26aulast%3DShan%26aufirst%3DW.%26aulast%3DBursuker%26aufirst%3DI.%26aulast%3DKellar%26aufirst%3DK.%2BA.%26aulast%3DMulheron%26aufirst%3DJ.%2BG.%26aulast%3DSack%26aufirst%3DJ.%2BS.%26aulast%3DTokarski%26aufirst%3DJ.%2BS.%26aulast%3DKimball%26aufirst%3DS.%2BD.%26aulast%3DWebster%26aufirst%3DK.%2BR.%26atitle%3D1H-Pyrazolo%255B3%252C4-b%255Dpyridine%2520inhibitors%2520of%2520cyclin-dependent%2520kinases%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D1133%26epage%3D1136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Collins, I.; Reader, J. C.; Cheung, K. M.; Matthews, T. P.; Proisy, N.; Klair, S. S.</span> Patent Appl. WO2008075007,<span class="NLM_x"> </span><span class="NLM_year">2008</span><span class="NLM_x">; </span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Collins%2C+I.%3B+Reader%2C+J.+C.%3B+Cheung%2C+K.+M.%3B+Matthews%2C+T.+P.%3B+Proisy%2C+N.%3B+Klair%2C+S.+S.+Patent+Appl.+WO2008075007%2C+2008%3B+"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCollins%26aufirst%3DI.%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-ref47_2"><span> <span class="citation_source-journal">Chem. Abstr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">149</span><span class="NLM_x">, </span> <span class="NLM_fpage">104737</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Chem.+Abstr.+2008%2C+149%2C+104737."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=ref47_2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26jtitle%3DChem.%2520Abstr.%26date%3D2008%26volume%3D149%26spage%3D104737" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1IA8" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1IA8','PDB','1IA8'); return false;">PDB: 1IA8</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i19"><a href="/doi/suppl/10.1021/jm900314j">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_28041"></div></div></div></div></div><hr /></hr><p class="last">Experimental procedures for the preparation of compounds <b>19</b>, <b>20</b>, <b>21</b>, (<i><b>R</b></i>)-<b>14</b>, and (<i><b>S</b></i>)-<b>14</b>. Experimental procedures and CHK1 inhibitory data for the preparation of additional analogues related to compounds <b>9</b> and <b>10</b>. Methods for high concentration CHK1 AlphaScreen, DELFIA enzyme inhibition assays for CHK1, CHK2, and CDK1, G2 checkpoint abrogation assay, SRB cytotoxicity assay. Methods for crystal structure determination of CHK1−inhibitor complexes, crystallographic information on the structures of <b>5</b>−<b>10</b>, <b>12</b>, <b>14</b>. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm900314j/suppl_file/jm900314j_si_001.pdf">jm900314j_si_001.pdf (121.26 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm900314j&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Fjm900314j%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2009.52.issue-15%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm900314j" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679a517ebd6324c7","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
